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Abstract 
Hydroxy-iso-evoninic acid is a pyridine diacid alkaloid present in nine natural 
products belonging to the Celastraceae plant family. The relative and absolute 
stereochemistry of the two stereocentres in this compound, which invariably occurs 
as a macrocyclic esterifying ligand between the C-3 and C-13 alcohols of β-
dihydroagarofuran sesquiterpenes, were not assigned during isolation and no 
synthesis has yet been reported. The natural products containing hydroxy-iso-
evoninic acid are of medicinal interest because of their high anti-HIV activity. 
This thesis contains an overview of the pyridine alkaloids present in the 
Celastraceae plant family and background to the benzilic ester rearrangement 
(BER), a variant of the benzilic acid rearrangement (BAR) discovered by Liebig in 
1838. 
The majority of this thesis describes the first synthesis of the pyridine alkaloid 
hydroxy-iso-evoninic acid which utilises a BER as the key synthetic step. The 
development of a tunable diastereoselective BER is also reported, along with the 
initiation of the development of an asymmetric variant. The synthesis of a model of 
dihydro-β-agarofuran core euonyminol is also detailed to enable future assignment 
of the currently unknown stereochemistry of natural hydroxy-iso-evoninic acid. 
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1 Introduction 
1.1 Celastraceae Sesquiterpenoids 
1.1.1 Introduction to the Celastraceae Sesquiterpenoid Family 
The Celastraceae plant family has been a rich source of biologically active secondary 
metabolites, consisting of an array of terpenoids, maytansinoids, alkylamines and 
flavonoids.1 The family is widespread in tropical and subtropical regions, including 
North Africa, South America and South East Asia. The crude plant extracts of the 
Celastraceae have been used abundantly for their medicinal, insecticidal and 
stimulating effects. Their use in traditional Chinese medicine is extremely varied, 
with use in therapies for diseases including rheumatoid arthritis, nephritis, psoriasis 
and cancer.2 They have also been widely used in China as insecticides and insect 
anti-feedants.3  
The most diverse and arguably most biologically interesting class of compounds 
isolated from the Celastraceae are the Celastraceae sesquiterpenoids. These 
compounds are all based on a dihydro-β-agarofuran skeleton with various degrees 
of oxygenation ranging from two additional oxygen groups in the case of boariol,4 to 
up to nine in the case of euonyminol5 (Figure 1.1). 
 
Figure 1.1 - General dihydro-β-agarofuran skeleton for Celastraceae 
sesquiterpenoids.6 
These oxygenated cores are decorated with a range of esterifying residues including 
aliphatic acids, and aromatic and heterocyclic acids including, elaborated nicotinic 
dicarboxylic acids. Changes in the relative positions, the number and configuration 
of these esterifying ligands around the various oxygenated dihydro-β-agarofuran 
cores, leads to the occurrence of over 460 Celastraceae sesquiterpenoids. 
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Due to the number of previous reviews of the Celastraceae sesquiterpenoids 
published in journals and previous PhD theses from the Spivey group,2,6,7 the focus 
of this introduction will be on the pyridine dicarboxylic acid ligands, as this thesis 
details the synthesis of pyridine dicarboxylic acid, hydroxy-iso-evoninic acid. 
1.1.2 Macrocycle Forming Sesquiterpene Pyridine Alkaloids 
Twelve pyridine dicarboxylic acid based esterifying ligands have been identified and 
characterised from the Celastraceae over the past 30 years. They can be separated 
into 2,3- and 3,4-disubstituted pyridines which contain a carboxylic acid group at 
the 3-position (Figure 1.2).6 
2,3-Substituted pyridines: 
 
3,4-Substituted pyridines: 
 
Figure 1.2 - Macrolactone forming pyridine based alkaloids.6 
The macrolactones are either 14- or 15-membered rings where the dihydro-β-
agarofuran is esterified at the C-3 and C-13 positions of one of six of the more highly 
oxygenated cores: evoninol, 4-deoxyevoninol, euonyminol, iso-euonyminol, 4-
deoxy-iso-euonyminol and 4-deoxyeuonyminol. Evonine and neoevonine were the 
first macrocyclide sesquitepene pyridine alkaloids to have their structure elucidated 
in 1972,8 though well over 100 have since been characterised (Figure 1.3). 
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Figure 1.3 - Macrolactone sesquitepene pyridine alkaloids evonine and 
neoevonine.8 
Evoninic acid is the most prevalent of the pyridyl esterifying ligands, currently 
identified in 77 Celastraceae sesquiterpenoids isolated from over 15 different plant 
species.6 Two dimacrolide sesquiterpenoids have also been isolated; triptonines A 
and B, in which one macrolide is formed with a pyridyl dicarboxylic acid unit 
between C-3 and C-13 and the other with a monoterpene moiety between C-8 and 
C-10.9  
The absolute stereochemistry of the sesquiterpenoid cores was determined in 1972 
by anomalous dispersion x-ray diffraction after introduction of a bromine atom.10 
From this assignment and from formal syntheses, the absolute stereochemistry of 
the majority of the pyridyl dicarboxylic acid units have been assigned.11-15 However, 
six remain in which the stereochemistry is still unassigned (where no 
stereochemistry is shown in Figure 1.2, it remains unassigned). 
1.1.3 Biosynthesis of the Pyridyl Diacid Ligands 
It has been suggested that the pyridyl diacid family of ligands originates from either 
nicotinic acid or nicotinamide. It has been proposed that nicotinic acid or a 
derivative is alkylated via a radical coupling process when in vivo (Figure 1.4).16 
 
Figure 1.4 – Whiting’s proposed biosysnthesis of the pyridyl diacid ligands.16 
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It is suggested that a radical centre is generated on a C5 iso-leucine derivative which 
then undergoes regioselective addition to yield the 2- and 4-alkylated diacids. This 
proposed biosynthesis has been supported by a model study in which a nicotinate 
ester salt and an alkyl radical generated in situ by photolysis combine in vitro to give 
alkylation at the pyridine C-6 position (Scheme 1.1). 
 
Scheme 1.1 – Whiting’s biomimetic radical alkylation of a nicotinate salt.16 
Alkylation was observed exclusively at the less hindered C-6-position to give the 3,6-
disubstituted product in 41% yield, and this was considered to provide proof-of-
concept for the proposed biosynthetic pathway. 
The generation of the carbon radical in the biosynthetic pathway is thought to occur 
through the action of a P-450 enzyme. No biosynthetic pathway has been proposed 
for the introduction of the α-hydroxyl group present in many of the pyridyl diacid 
ligands and therefore it seems unlikely that the unknown stereochemistry of two of 
these ligands can currently be proposed by consideration of their biosynthesis. 
1.1.4 Previous Syntheses of the Pyridyl Diacid Ligands 
Only a handful of diacid units have previously been synthesised. White et al. 
assigned the stereochemistry of edulinic acid by synthesis of reduced edulinic acid 
diol 7, although the formal synthesis was not completed (Scheme 1.2).14  
Chapter 1  Introduction 
5 
 
 
Reagents and Conditions; (a) TBSCl, 1H-imidazole, rt; (b) BH3·THF, THF, 0 °C; (c) DMSO, (COCl)2, then 
Et3N (84% over 3 steps); (d) (MeO)2POCHN2, 
tBuOK, THF (90%); (e) (Ph3P)PdCl2, CuI, Et2NH (61%); (f) 
H2, Lindlar catalyst, MeOH (76%); (g), 5% HF/MeCN (100%); (h) LiAlH4, THF, 0 °C (72%). 
Scheme 1.2 – White’s synthesis of reduced edulinic acid 7 to assign the 
stereochemistry.14 
From commercially available methyl (R)-3-hydroxy-2methylpropionate (1), aldehyde 
2 was prepared using a literature 3-step procedure consisting of TBS protection, 
ester reduction to the primary alcohol and oxidation to aldehyde 2.17,18 
Condensation with dimethyl diazomethylphosphonate gave terminal alkyne 3 which 
underwent a Sonogashira coupling with 2-chloro nicotinic ester 4 to afford alkyne 5. 
Partial-hydrogenation with Lindlar’s catalyst afforded (Z)-alkene 6 contaminated 
with 10% of the (E)-isomer which could be separated by column chromatography. 
Deprotection and then reduction of the ester to diol 7 allowed for comparison of 
the optical rotations with material obtained by treatment of cathedulin K-19 with 
LiAlH4 (Scheme 1.3).
14 
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Reagents and Conditions; (a) LiAlH4, THF/Et2O, 0 °C to rt (28%).  
Scheme 1.3 – White’s degradation of cathedulin K-19 to obtain the reduced 
form of edulinic acid, diol 7.14 
From this partial synthesis, (R)-edulinic acid was determined to be the naturally 
occurring stereoisomer. It was not reported if the oxidation of diol 7 to edulinic acid 
was possible. 
Both the racemic and asymmetric syntheses of the most prevalent ligand, evoninic 
acid, have been reported. The racemic synthesis was completed in 1976 and gave 
access to evoninic and epi-evoninic acid which could be separated by preparative 
GC (Scheme 1.4).19 
Reagents and Conditions; (a) EtMgBr, Et2O, rt; (b) heat (60%); (c) NBS, CCl4 (59%); (d) Na, EtOH, 70 °C 
(36%); (e) conc. HCl; (f) CH2N2, MeOH/H2O (61% over 2 steps); (g) KOH, MeOH (51-60%). 
Scheme 1.4 – Pailer and Pfleger’s synthesis of evoninic acid and epi-evoninic acid.19 
The 2,3-subsititution pattern was set up in the formation of the pyridyl ring by the 
reaction of unsaturated ester 9 (prepared by ethyl Grignard reagent addition to 
cyano ester 8)20 and propenal. Bromination at the benzylic position followed by 
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addition of α-methyl malononitrile 12 lengthened the alkyl chain to the required 3-
carbon chain present in diester 13. Decyanation and ester hydrolysis under acidic 
conditions, followed by diazomethane-mediated bis-esterification of the resulting 
diacid, afforded bis-methyl ester 14. The two diastereoisomers could be separated 
at this stage by preparative GC allowing (albeit in yields of just 29% and 45%), after 
hydrolysis, (±)-evoninic acid and (±)-epi-evoninic acid to be isolated in an overall 
yield of 4.6% over the 7 steps.  
More recently, Spivey et al. reported the first asymmetric synthesis of naturally 
occurring (-)-evoninic acid using an enzymatic kinetic resolution (Scheme 1.5).21 
 
Reagents and Conditions; (a) nBuLi, Et2O, -78 °C, then CuI, SBu2, Et2O, 0 °C; (b) Et2O, rt (70%); (c) 
KHMDS, MeI, toluene, -78 °C (dr 96:4, 98%); (d) Lipase P. Fluorescens, pH 7.0 buffer (dr 97:3, ee 
>95%, 46%); (e) KMnO4, H2O, 100 °C (85%). 
Scheme 1.5 – Spivey’s asymmetric synthesis of evoninic acid.21 
Cuprate 15 was generated after halogen-lithium exchange with commercially 
available 2-bromo-3-picoline. This 2-pyridyl Gilman homocuprate underwent 1,4-
addition to unsaturated ester 16 to afford 2,3-dialkyl substituted pyridine 17. α-
Methylation of the potassium enolate of ester 17 with methyl iodide afforded the 
desired syn dimethyl compound 18, with a high level of de, as a racemate. Following 
a screen of hydrolytic enzymes, a lipase was identified to effect efficient 
enantioselective hydrolysis of ester 18 affording acid (-)-19 in high ee. The benzylic 
methyl group was then oxidised by KMnO4 to afford (-)-evoninic acid in an overall 
yield of 30% over 4-steps in >95% ee. This provided not only an asymmetric route to 
evoninic acid, but also one that was shorter and more efficient than that reported 
by Pailer and Pfleger (4.6% yield over 7 steps, see Scheme 1.4).19 
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Another 2,3-disubstituded pyridyl ligand, hydroxy wilfordic acid, has also recently 
been synthesised. Although the naturally occurring stereochemistry of this alkaloid 
is currently unassigned, an asymmetric synthesis was developed allowing access to 
both enantiomers, which were isolated as dimethyl ester 26 (Scheme 1.6).22 
 
Reagents and Conditions; (a) nBuLi, DMF, THF (95%); (b) 21, NaH, THF (85%); (c) TMSCN, chiral urea 
catalyst 27, CF3CH2OH, CH2Cl2, -78 °C (ee 50%, 82%); (d) 6M HCl, MeOH, 90 °C (59%); (e) H2, Pd/C, 
MeOH, rt (83%); (f) KMnO4, H2O, 100 °C; (g) HCl, MeOH (45% over 2 steps).  
Scheme 1.6 – Eun and Seo’s asymmetric synthesis of hydroxy wilfordic acid.22 
The synthesis starts with commercially available 2-bromo-3-picoline which is 
converted to aldehyde 20, which then undergoes a Horner-Wadsworth-Emmons 
reaction to afford enone 22. Asymmetric cyanosilylation proceeded with an ee of 
just 50% when using chiral urea catalyst 27 to give TMS-ether 23. Treatment with 
methanolic HCl converted the cyano group to the corresponding methyl ester while 
also deprotecting the TMS group to give alkene 24. Hydrogenation of the alkene 
afforded ester 25. Benzylic oxidation with KMnO4 (as developed in the Spivey 
synthesis of evoninic acid) followed by methylation, afforded dimethyl ester 
protected hydroxy wilfordic acid 26. Thus, the first asymmetric synthesis of 
diesterified hydroxy wilfordic acid was reported via a 7-step synthetic sequence and 
an overall yield of 14.6% with an ee of 50%. 
These are the only reported syntheses of the pyridine diacid ligands to date. None 
of the 3,4-disubstituted pyridines have previously been synthesised. 
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1.2 Hydroxy-iso-Evoninic Acid 
1.2.1 Background 
Hydroxy-iso-evoninic acid is one of the 3,4-disubstituted pyridine ligands found in 
Celastraceae sesquiternepoid natural products and its synthesis is the focus of this 
thesis. It has been identified in nine Celastraceae sesquiterpenoids, isolated from 
the root barks of Tripteygium wilfordii and Tripterygium hypoglaucum by a 
methanol extraction. All nine natural products contain hydroxy-iso-evoninic acid 
and in all cases this compound forms a 14-membered macrolactone bridge to the 
most highly oxygenated dihydro-β-agarofuran core, euonyminol. The bridge is 
formed between the primary C-13 and the secondary C-3 hydroxyl group on the 
bottom face of the molecule. The products differ in the other esterifying groups 
present (Table 1.1). 
 
Sesquiterpenoid R1 R2 R6 R8 R9 R14 Isolated From 
Hypoglaunine A (28)23 Ac Ac Ac Ac Ac 3Fu T. hypoglaucum 
Hypoglaunine B (29)23 Ac 3Fu Ac Ac Ac Ac T. hypoglaucum 
Hypoglaunine C (30)9,23  Ac Bz Ac Ac Ac Ac T. hypoglaucum  
T. wilfordii 
Triptonine B (31)9,24  - - - - - - T. hypoglaucum  
T. wilfordii 
Wilfordinine (32)15 Ac Bz Bz Ac Ac Ac T. wilfordii 
Wilfordinine B (33)9 Ac Ac Ac Ac Ac Ac T. wilfordii 
Wilfordinine C (34)9 Bz Ac Ac Ac Ac Ac T. wilfordii 
Wilfordconine (35)25 Ac H Ac 3Fu Ac Ac T. wilfordii 
Wilfordlongine (36)26 Ac H Ac Ac Ac Ac T. wilfordii 
Table 1.1 – Celastraceae sesquiterpenoids containing hydroxy-iso-evoninic acid. 
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Even though the naturally occurring absolute and relative stereochemistry of 
euonyminol has previously been assigned,10 as no single crystal x-ray 
crystallographic structure assignment has been reported for any of the nine natural 
products containing hydroxy-iso-evoninic acid and because even the relative 
stereochemistry on the diacid ligand could not be determined by spectroscopic 
methods, the stereocentres in hydroxy-iso-evoninic acid remain unassigned. Both 
the absolute and relative stereochemistry of the two chiral centres are unknown. A 
methyl ether protected model of the euonyminol core containing the full 
functionality on the bottom half of the molecule from C-3 to C-13, has previously 
been prepared within the Spivey group. It is integral in our strategy for the 
assignment of natural hydroxy-iso-evoninic acid, which will be discussed later. 
Additionally, there have been no reports on the attempted degradation of any of 
the natural products listed in Table 1.1 and therefore there is no data reported for 
isolated hydroxy-iso-evoninic acid. However, proton and carbon NMR data reported 
for these compounds show very little variation in the peaks corresponding to the 
carbons and protons of the esterifying ligand hydroxy-iso-evoninic acid, suggesting 
that it exists as the same single stereoisomer in all compounds isolated to date 
(Table 1.2 and Table 1.3) 
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Sesquiterpene H-2` H-5` H-6` H-7` H-9` H-10` 
2823 8.98 7.82 8.69 4.23 1.21 1.36 
2923 9.00 7.83 8.69 4.24 1.19 1.38 
309,23 9.00 7.85 8.69 4.26 1.20 1.39 
319,24 8.99 7.81 8.69 4.24 1.19 1.34 
339 8.98 7.83 8.68 4.23 1.18 1.35 
349 9.00 7.83 8.69 4.25 1.20 1.43 
3525 8.98 7.82 8.69 4.23 1.20 1.36 
3626 9.03 7.85 8.70 4.21 1.18 1.37 
Table 1.2 – Comparison of the proton NMR chemical shifts (δH/ppm) of the 
esterifying ligand hydroxy-iso-evoninic acid in sesquiterpenoids 28-36 taken in 
CDCl3. 
Sesquiterpene C-2` C-3’ C-4’ C-5’ C-6’ 
 2823 151.4 127.9 151.9 123.6 152.6 
 2923 151.7 127.7 152.0 123.6 152.7 
 309,23 151.3 128.5 151.8 123.5 152.5 
 319,24 151.5 127.5 151.8 123.6 152.7 
339 151.3 127.4 151.7 123.5 152.5 
 349 151.5 127.5 151.7 123.5 152.6 
3525 152.6 123.5 151.6 127.5 151.2 
3626 152.6 123.5 151.6 127.5 151.2 
 
Sesquiterpene C-7’ C-8’ C-9’ C-10’ C-11’ C-12’ 
2823 42.3 77.1 17.4 24.3 175.2 167.7 
2923 42.3 77.1 17.4 24.2 175.2 167.7 
309,23 41.8 77.2 17.2 24.0 174.9 167.6 
319,24 41.9 76.8 17.3 24.1 175.2 167.7 
339 41.8 76.8 17.2 24.0 174.9 167.6 
349 41.9 76.7 17.3 24.0 175.1 167.7 
3525 41.8 77.2 17.1 24.0 175.1 167.7 
3626 41.7 77.2 41.9a 23.8 174.8 167.7 
a. The chemical shift and assignment as a triplet in this report would appear to be erroneous. 
Table 1.3 – Comparison of the carbon NMR chemical shifts (δC/ppm) of the 
esterifying ligand hydroxy-iso-evoninic acid in sesquiterpenoids 28-36 taken in 
CDCl3. 
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When considering the 3D structures of the sesquiterpenoids containing hydroxy-iso-
evoninic acid, the similarity in the NMR spectra is unsurprising (Figure 1.5).  
 
Figure 1.5 – Computed molecular structure of (7’S,8’R)-hypoglaunine B (29) 
following energy minimisation (MM2). 
The esterifying ligand is situated underneath the molecule, distant from the varying 
esterifying groups through bonds, and also through space. 
1.2.2 Biological Activity 
As previously discussed, the Celastraceae sesquiterpenoids are known for their wide 
variety of biological properties. Of particular interest for the compounds containing 
hydroxy-iso-evoninic acid is their anti-HIV activity,9,24,27 as has been highlighted in a 
recent anti-HIV natural products review.28 Three of the sesquiterpenoids containing 
hydroxy-iso-evoninic acid have been tested and been found to be highly active 
inhibitors of HIV replication in human lymphocyte cells, although the mechanism of 
this inhibition has yet to be understood (Table 1.4).24 
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Sesquiterpenoid IC50 EC50 TI 
Hypoglaunine A (28) >100 0.13 >769 
Hypoglaunine B (29) >100 0.10 >1000 
Triptonine B (31) >100 <0.1 >1000 
Hypoglaunine D (37) 22.2 NS - 
Triptonine A (38) >100 2.5 >39.4 
IC50 = concentration of test sample that was toxic to 50% of the mock-infected cells. EC50 = 
concentration of test sample that was able to suppress HIV replication by 50%. TI = therapeutic 
index, the ratio of the IC50 and EC50. NS = no suppression. 
Table 1.4 – Anti-HIV activity of the sesquiterpenoids containing hydroxy-iso-
evoninic acid and the importance of the C-8` hydroxyl group.24 
Including the three hydroxy-iso-evoninic acid containing sesquiterpenoids 28, 29 
and 31, a total of 20 compounds were tested for their anti-HIV activity and SAR 
analysis was performed. It was found that an acetoxy group at C-6 increased the 
activity and that whether the pyridyl ligand was 2,3- or 3,4-substituted had no 
effect on the activity. It was also concluded, as highlighted in Table 1.4, that the C-
8` hydroxy group is important for high anti-HIV activity. When hydroxy-iso-evoninic 
acid is replaced by evoninic acid and all other esterifying groups around the 
dihydro-β-agarofuran core are kept unchanged (hypoglaunine A 28 cf. hypoglaunine 
D 37 and also triptonine B 31 cf. triptonine A 38), a dramatic reduction in activity is 
observed. The three sesquiterpenoids containing hydroxy-iso-evoninic acid also 
have unusually high therapeutic indexes in comparison with other active natural 
products (usually a TI of >5 is considered significant).  
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1.2.3 Previous Synthetic Efforts Towards Hydroxy-iso-Evoninic Acid 
Previously within the Spivey group, the synthesis of hydroxy-iso-evoninic acid was 
attempted using the same strategy as was applied in the synthesis of evoninic acid 
(see Scheme 1.5).21 It was found that the unnatural 2,3-substituted regioisomer of 
the natural product, which is not a known compound and which we called hydroxy 
evoninic acid (41), could be synthesised from an intermediate en route to evoninic 
acid: compound 18 (Scheme 1.7).29 
 
Reagents and Conditions; (a) Davis oxaziridine, KHMDS, 25 °C (dr 75:25, 78%); (b) NaOH, MeOH, 60 
°C (dr 70:30, 96%); (c) KMnO4, H2O, 100 °C (dr 70:30, 92%). 
Scheme 1.7 – Shukla’s synthesis of hydroxy evoninic acid (41) from intermediate 18 
(see Scheme 1.5).29 
Installation of the α-hydroxy group proceeded with Davis oxaziridine to afford α-
hydroxy ester 39, which was hydrolysed to form acid 40. Oxidation of the benzylic 
methyl group with KMnO4 afforded hydroxy evoninic acid (41) in a yield of 61% over 
the final three-steps. 
Unfortunately, the enolate methylation chemistry used to introduce the methyl 
group α- to the ester in intermediate 18 was unsuccessful when attempted on the 
analogous 3,4-substituted compound. The synthesis of the requisite α,β-dimethyl 
ester 43 (the regioisomer of ester 18) via direct conjugate addition to a tiglate (or 
angelate) was also unsuccessful (Scheme 1.8).29  
 
Scheme 1.8 – Shukla’s attempts at the formation of α,β-dimethyl ester 43.29 
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Shukla found that ester 42 could be obtained by addition of the Gilman cuprate 
obtained from 4-bromo-3-picoline, to methyl crotonate. However, inexplicably, no 
conditions could be found to effect α-methylation of this ester despite the success 
of this reaction on regioisomer 17. It is possible that the success of the α-
methylation in the case of the 2-pyridyl system can be attributed to transient 
pyridine N-methylation then intramolecular methyl transfer. This would be 
geometrically precluded for the 4-pyridyl system. Attempts to avoid α-methylation 
by performing the 1,4-addition with methyl tiglate [(E)-44] were also unsuccessful. 
Nitrile 45 was also synthesised by an analogous 1,4-addition process, but α-
methylation of this substrate to give α-methyl nitrile 46 could not be realised 
without methylation of the nitrile nitrogen to afford an iminoketene. This led to the 
design of a new retrosynthetic strategy incorporating a benzilic ester 
rearrangement (BER) as the key step to install the α-hydroxy quarternary centre 
(Scheme 1.9). 
 
Scheme 1.9 – New retrosynthetic strategy towards hydroxy-iso-evoninic acid 
incorporating a BER. 
In this strategy, the benzylic acid is masked as a methyl group as in the syntheses of 
evoninic acid and hydroxy wilfordic acid.21,22 Access to methyl ester 47, prior to 
ester hydrolysis and benzylic oxidation, was envisaged by promotion of a BER in 
MeOH (the BER will be introduced later in Chapter 1.3). To test this new strategy, 
model phenyl diketone 52 was synthesised and a BER was attempted (Scheme 
1.10).30 
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Reagents and Conditions; (a) H2O2, MeOH, 1M NaOH (52%); (b) AlMe3, H2O, CH2Cl2 (64%); (c) VOCl3, 
CH3CN (51%); (d) Cu(OAc)2, MeOH (dr 50:50, 60%). 
Scheme 1.10 – Sheng’s synthesis of model phenyl diketone 52 and a trial BER.30 
Epoxidation of commercially available enone 49 using hydrogen peroxide31 gave 
epoxy ketone 50 which was ring opened with Me3Al in the presence of water to 
afford α-hydroxy ketone 51.32,33 This could in turn be oxidised to diketone 52 with 
VOCl3.
34 Using Cu(OAc)2 as the Lewis acid promoter, a BER was effected and 
quarternary α-hydroxy ester 53 was formed as a 1:1 mixture of diastereoisomers. 
Although the BER was quite slow (60% conversion in 140 h), the retrosynthetic 
approach envisioned in Scheme 1.9 was shown to be feasible.  
 
1.3 The Benzilic Ester Rearrangement 
1.3.1 Background and Mechanism 
The BER is analogous to the benzilic acid rearrangement (BAR) reported by J. Liebig 
in 1838, which was the first rearrangement reaction to be discovered. The 
rearrangement is named after benzilic acid, the product of this first reported BAR 
which ensued on treatment of benzil with alcoholic potassium hydroxide at 
elevated temperature (Scheme 1.11).35  
 
Reagents and Conditions; (a) KOH, MeOH, 65 °C. 
Scheme 1.11 – Liebig’s benzilic acid rearrangement.35 
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The BER was reported later by Doering et al. in 1956.36 The nucleophile in a BER is 
an alkoxy group rather than a hydroxy group and hence results in the formation of 
quarternary α-hydroxy esters rather than acids. 
A mechanism for the BAR was first proposed by Ingold37 and later corroborated by 
Yamabe38 in a detailed computational study (Figure 1.6). 
 
Figure 1.6 – Proposed mechanism of the BAR according to Ingold37 and Yamabe.38  
The process begins with the reversible 1,2-addition of an alcohol to one of the 
carbonyl groups of the 1,2-diketone substrate to form a deprotonated ketone 
hydrate intermediate. 1,2-Migration then occurs in the rate determining step and 
the quarternary α-hydroxy acid is formed. An investigation into effects on the rate 
of 1,2-migration under basic conditions have been performed by Bowden et al. They 
investigated a variety of 2,2`-, 3,3`- and 4,4`-substituted benzils with electron 
donating (-OMe) and electron withdrawing (-Cl) groups.39 They found that the rates 
significantly increased when the benzils contained electron withdrawing groups, 
suggesting that a there is a build-up of negative charge on the migrating carbon 
during the 1,2-migration. This observation has also been corroborated in the 
computational study performed by Yamabe.38 It was also found that ortho-
substituents slowed the reactions, probably as the result of proceeding via a more 
sterically hindered transition state. Although no studies have been performed on 
the rates of the BER under neutral or acidic conditions, it is likely that the same 
effects observed for Lewis acid promoted pinacol rearrangements hold for the 
BER.40 It has been shown through both experimental and computational work, that 
groups which can stabilise carbon cationic character at the migratory carbon show 
greater migratory aptitude. This supports the proposal of a build up of positive 
charge on the migrating group during the 1,2-migration. The different transition 
states are shown in the figure below (Figure 1.7). 
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Figure 1.7 – 1,2-Migration transition states under basic and Lewis acidic conditions. 
The 1,2-migration has been shown to be irreversible whether promoted under basic 
or Lewis acidic conditions.41 However, there are some exceptions. To the best of our 
knowledge, there is only one reported case of a retro-BAR, and in this example 
there is an expansion from a 5- to 6-membered ring (Scheme 1.12).42 
 
Scheme 1.12 – Wallach’s first reported retro-BAR.42 
Retro-BER’s on the other hand, appear to occur more commonly but apparently 
only when there is a release of ring strain. Since the work of Takeshita et al. on the 
retro-BER of [2+2]-cycloaddition products,43,44 this reaction has been utilised in the 
synthesis of natural product stereoisomers hinesol and agarospirol, and also 
meloscine (Schemes 1.13 and 1.14). 
 
Reagents and Conditions; (a) hν, EtOAc, 7 h, then Na2CO3 (aq.) (79%). 
Scheme 1.13 – Takeshita’s use of the retro-BER for the synthesis of hinesol  
and its epimer agarospirol.45 
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Reagents and Conditions; (a) K2CO3, MeOH, rt (98%). 
Scheme 1.14 – Bach’s use of the retro-BER for the synthesis of meloscine.46 
In both examples, the retro-BER is spontaneous due to the release of ring-strain 
when expanding from a 4- to a 5-membered ring. In the first example (Scheme 
1.13), the retro-BER occurs after [2+2] cycloaddition and in the second example 
(Scheme 1.14), after deprotection of the TMS ether. In both cases, the 5-membered 
ring 1,2-diketone is isolated in its mono-enol form. 
The first reported BER’s were promoted under basic conditions (e.g. LiOH,47 KOH48). 
An unusual variant of the BER, also promoted under basic conditions, has been 
found to occur with benzil using guanidine as the nucleophile (Scheme 1.15).49 
 
Reagents and Conditions; (a) NaOH, MeOH, 65 °C, 5 min (92%). 
Scheme 1.15 – Kitajima’s BER variant after treatment of benzil with guanidine.49 
In an analogous example, a base promoted BER with urea was utilised in an 
expedient synthesis of phenytoin, an anti-epileptic pharmaceutical (Scheme 1.16).50 
 
Reagents and Conditions; (a) KOH, heat. 
Scheme 1.16 – Blitz’s synthesis of phenytoin utilising a base promoted BER.50 
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However, a variety of other conditions not involving bases have since been 
employed to promote BER’s.51 Examples of Lewis acid BER promoters include 
ZnCl2,
52 CuCl53 and Cu(OAc)2.
54 High temperature water (HTW), defined as water at 
300-380 °C in the report, has also been used to promote a BAR.55,56 In this work, 
Savage et al. found that a BAR was promoted under neutral and basic conditions, 
though it is thought the reaction occurs under the neutral conditions due to the 
presence of hydroxide anions in HTW. They also report the occurrence of a BAR 
under acidic HTW conditions, the first and only report of a BAR catalysed by a 
Brønsted acid. HTW promoted BAR’s are not synthetically useful yet however, as 
high conversion is only achieved at pH>10 and under these highly basic conditions, 
mainly decomposition products of benzilic acid are isolated, including diphenyl 
methane, benzophenone, phenylacetophenone and 2-phenylmethylphenol. There is 
one other report in which a BER is promoted under neutral conditions, although the 
substrate is a strained 4-membered ring (Scheme 1.17).57 
 
Reagents and Conditions; (a) MeOH, heat. 
Scheme 1.17 – Denis’s BER under neutral conditions.57 
It was found that by simply stirring cyclobutan-1,2-dione in methanol, a BER was 
realised affording the ring-contracted 3-membered ring product. 
1.3.2 Stereoselective Variants of the BER 
Although there are many examples of high diastereoselectivity in BER’s, these are 
only reported for cyclic substrates where the BER results in a ring-contraction and 
the ring constraints control the diastereoselectivity. For example, the BER used in 
the synthesis of carbohydrate moiety K252a is completely diastereoselective and 
the CuCl promoter is used to oxidise the substrate to the 1,2-diketone as well as 
promoting the BER (Scheme 1.18).53 
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Reagents and Conditions; (a) CuCl, MeOH/CH2Cl2 (95%). 
Scheme 1.18 –Wood’s highly diastereoselective BER of a cyclic substrate en route to 
K252a.53 
To date, there is only one report where the diastereoselectivity of a BER has been 
influenced beyond that determined by the substrate itself.54 Burke et al. found that 
for their substrate, by lowering the concentration of the BER promoter Cu(OAc)2 
(also used to oxidise their α-hydroxy ketone precursor to the 1,2-diketone in situ), 
the diastereoselectivity was increased (Table 1.5).  
 
Entry Cu(OAc)2 (mol%) Yield (%) anti:syn 
1 100 70 2.1:1 
2 50 75 2.7:1 
3 25 74 3.6:1 
4 10 87 4.5:1 
5 5 73 4.6:1 
Table 1.5 – Burke’s study of the influence of promoter concentration on the 
diastereoselectivity in a BER.54 
Burke rationalised the increased diastereoselectivity by looking at the copper bound 
and unbound intermediates and later performed a 13C-labelling study to confirm 
that the benzylic group migrates exclusively in preference to the phenyl group in 
these reactions (Figure 1.8).54,58 
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Figure 1.8 – Burke’s rationalisation of the change in diastereoselectivity with 
promoter concentration.54 
Burke proposes that nucleophilic addition to the 1,2-diketone occurs according to 
the Felkin-Anh model. At lower concentrations of Cu(OAc)2, more material proceeds 
via the intermediate conformation leading to the anti-diastereoisomer as in this 
conformation, the carbonyl is anti-periplanar to the adjacent alkoxy group. As the 
migrating group has an orthogonal approach to maximise orbital overlap according 
to the Deslongchamps model,59 the major product is the anti-diastereoisomer. 
However, as copper is moderately oxophilic and can chelate between the carbonyl 
and alkoxy oxygen as shown in the intermediate leading to the syn-diastereoisomer, 
a reduced selectivity for the anti-diastereoisomer is observed when more promoter 
is present. In other words, a balance between the copper-chelated and copper-free 
intermediates is proposed. However, the substrate investigated contains four 
oxygen atoms and a variety of copper chelates can be envisaged. 
 
1.4 Aims and Objectives 
1.4.1 Synthesis of (±)-Hydroxy-iso-Evoninic Acid 
The primary target of the work described in this thesis, was to achieve the first 
synthesis of (±)-hydroxy-iso-evoninic acid. With the successful promotion of a BER 
of model diketone 52 (see Scheme 1.10) it was decided to follow the retrosynthetic 
strategy demonstrated in Scheme 1.9, making 1,2-diketone 48 the first key 
intermediate target. As enone 54 is not commercially available, the synthesis of this 
was first required before the subsequent steps used in the model synthesis 
demonstrated in Scheme 1.10 could be tested on the desired system (Scheme 
1.19). 
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Scheme 1.19 – Proposed strategy for the synthesis of 1,2-diketone 48. 
A BER of 1,2-diketone 48 was then to be explored in order to obtain methyl ester 
47. Finally, by following Shukla’s synthesis of unnatural hydroxy evoninic acid (see 
Scheme 1.7), the synthesis was to be completed by hydrolysing the ester followed 
by benzylic oxidation to afford the target compound hydroxy-iso-evoninic acid 
(Scheme 1.20).  
 
Scheme 1.20 – Proposed final steps for the synthesis of hydroxy-iso-evoninic acid. 
This strategy was anticipated to give access to all four possible stereoisomers of 
hydroxy-iso-evoninic acid but had the potential to be adapted to the preparation of 
a single stereoisomer by performing an asymmetric epoxidation of enone 54 and 
then later performing a diastereoselective BER of chiral 1,2-diketone 48.  
1.4.2 Development of a Diastereoselective BER 
As the study by Burke et al., described above, is the only previous investigation in 
which the diastereoselectivity of a BER has been attempted to be manipulated, and 
because their substrate is highly oxygenated and thus their findings unlikely to 
prove general, it was planned to investigate control of diastereoselectivity in acyclic 
BERs further. It was recognised that it would be highly advantageous to develop 
switchable conditions so that once the relative stereochemistry present in natural 
hydroxy-iso-evoninic acid had been determined, the required diastereoisomer could 
be targeted by choice of appropriate conditions.  
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Envisaging possible complications in the synthesis of diketone 48 due to the basicity 
of the pyridyl nitrogen and because many of the common BER promoters are known 
to chelate strongly to pyridyl nitrogens, it was decided to initially employ ortho-tolyl 
diketone 56 as a model substrate on which to develop the BER conditions and to 
prepare this substrate using the same synthetic sequence as used in the synthesis of 
the phenyl diketone 52 (see Scheme 1.10) (Scheme 1.21). 
 
Scheme 1.21 – Proposed model diketone 56 for methodology studies towards a 
diastereoselective BER. 
It was planned to determine the ratio of the diastereomeric esters 57a and 57b by 
proton NMR or failing that, by GC or HPLC. Influencing the diastereoselectivity was 
to be attempted by investigating different BER promoters, then by varying 
temperature, concentration, solvent, nucleophile and investigating additives in the 
reaction. 
1.4.3 Assignment of the Stereochemistry of Hydroxy-iso-Evoninic Acid 
A dimethyl ether protected model of the dihydro-β-agarofuran core euonyminol 
(the common core in the nine sesquiterpenoids containing hydroxy-iso-evoninic 
acid) in which all the functionality of the bottom face is present, has previously 
been synthesised within the Spivey group (Figure 1.9).7 
 
Figure 1.9 – Euonyminol and Webber’s model containing the full functionality of the 
bottom face.7 
Previously, only <1 mg of dimethyl ether protected euonyminol model 58 was 
isolated following the 18-step asymmetric synthesis in which the chirality is 
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introduced by desymmetrisation in a Zr-based Sharpless-type epoxidation (Scheme 
1.22).7,60 
 
Reagents and Conditions; (a) Zr(OiPr)4, L-(+)-DIPT, CH2Cl2, TBHP, 4 Å MS, -20 °C (92% ee, 90%). 
Scheme 1.22 – Outline of Webber’s 18-step synthesis of euonyminol model 58.7,60 
Since only small quantities of material had been brought through this synthesis, not 
all of the compounds had been fully characterised and the final methyl ether 
deprotection had not been attempted. Therefore, an additional aim of this project 
was to repeat the synthesis of euonyminol model 58 to allow for complete 
characterisation of all intermediates and to look for conditions to perform the final 
methyl ether deprotection. 
As demonstrated by Tables 1.2 and 1.3, the NMR peaks corresponding to the 
esterifying ligand hydroxy-iso-evoninic acid show very little variation with changes 
to the esterifying ligands on the top face of the dihydro-β-agarofuran core. As the 
enantiomerically enriched euonyminol model 58 contains the full functionality on 
the bottom face, it is an ideal substrate to link with all four possible stereoisomers 
of synthesised hydroxy-iso-evoninic acid and compare the NMR data to the natural 
sesquiterpenoids with the intention of assigning the naturally occurring 
stereochemistry (Scheme 1.23). 
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Scheme 1.23 – Strategy for assigning the naturally occurring stereoisomer of 
hydroxy-iso-evoninic acid. 
There is only one literature report on the successful linking of a pyridyl diacid 
esterifying ligand with a sesquiterpenoid core to form the 14-membered lactone 
characteristic of this class of compounds. Yamada et al. successfully linked evoninic 
acid to an evonine-derived β-dihydroagarofuran core 62 in their semi-synthesis of 
evonine using intermediates obtained from degradation of natural evonine (Scheme 
1.24).61 
 
 
  
Chapter 1  Introduction 
27 
 
 
 
 
Reagents and Conditions; (a) Ph3CCl, pyridine, 60 °C (95%); (b) 10% KOH/MeOH, 70 °C (71%); (c) 
ethyl chloroformate, Et3N, DME, rt; (d) 4-DMAP, Et3N, DME, 90 °C (34% over 2 steps); (e) 80% AcOH, 
50 °C (82%); (f) CrO3, pyridine, 65 °C (70%); (g) 50% AcOH, 85 °C (68%); (h) CH2N2; (i) NaH, DMF, rt 
(12%); (j) BCl3, CH2Cl2, rt; (k) Ac2O, pyridine, 70 °C (35% over 2 steps). 
Scheme 1.24 – Yamada’s macrolactone formation in the synthesis of evonine.61 
Alcohol 60 was prepared from methyl ester protected evoninic acid using a known 
3-step procedure.8 Alcohol 60 was protected by forming a trityl derivative, the ester 
group was hydrolysed and the resulting acid treated with ethyl chloroformate to 
afford mixed anhydride 61. Anhydride 61 was then esterified with primary alcohol 
62 (a derivative of sesquiterpenoid core evoninol), to afford ester 63. Deprotection 
of the trityl group, oxidation to the corresponding carboxylic acid, then 
deprotection of the acetonide moiety and finally esterification of the acid group, 
afforded methyl ester 64 ready for macrolactonisation. Treatment of methyl ester 
64 with NaH successfully promoted macrolactonisation without requirement of 
protection of the tertiary alcohol albeit in a yield of just 12%. Deprotection of the 
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methyl ether groups followed by acetylation resulted in the semi-synthesis of 
evonine. It was found that all required secondary alcohol groups could be esterified 
leaving the tertiary alcohol free as required for the natural product. 
There is much room for improvement in the formation of the macrolactone, as the 
current method requires several protecting group manipulations. However, it is 
encouraging that following treatment of the diol obtained from acetonide 
deprotection of compound 64 with NaH, the desired secondary alcohol cyclises onto 
the hindered methyl ester. In the light of this precedent, the same strategy of 
esterifying the primary alcohol with the benzylic ester present in the esterified 
hydroxy-iso-evoninic acid derivative, followed by an equivalent cyclisation, was 
envisaged in our work. It was anticipated that conditions could be found to 
selectively esterify the primary C-13 alcohol without the need to protect the free 
secondary and tertiary alcohols. As benzylic acids are generally more reactive 
towards carbodiimide assisted esterification than aliphatic esters, and because the 
α-quarternary centre present in hydroxy-iso-evoninic acid would probably hinder 
attack at this position, it was considered likely that the benzylic acid would also 
esterify more rapidly than the aliphatic one leading to the following synthetic plan 
(Scheme 1.25). 
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Scheme 1.25 – Plan for linking hydroxy-iso-evoninic acid with model core 58 to 
enable assignment of the naturally occurring stereochemistry of the Celastraceae 
diacid pyridine alkaloids. 
In the event that the desired selectivity for ester formation at the benzylic over the 
aliphatic acid could not be achieved, the acid functionalities on the hydroxy-iso-
evoninic acid derivative could be manipulated to ensure this outcome. 
1.4.4 Development of an Asymmetric BER 
As previously discussed, there is currently no reported asymmetric BER. Although, 
due to the presence of a chiral centre present in diketone 48, only a 
diastereoselective BER is required for the asymmetric synthesis of hydroxy-iso-
evoninic acid; it was envisaged that an asymmetric BER would be of wide utility and 
to that end it was hoped that it would be possible to also initiate an investigation 
into an asymmetric variant of the BER. Two substrates were planned to be 
investigated: 1,2-diketones 65 and 67 (Scheme 1.26). 
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Scheme 1.26 - Target substrates with which to investigate an asymmetric BER. 
Benzyl diketone 65 was selected as it is known that benzylic groups can migrate 
under mild conditions in BER’s, increasing the chances of developing conditions for 
inducing asymmetry in the reaction. It was also planned to prepare the possibly 
more challenging phenyl diketone 67 as the esters 68a and 68b, which would be 
formed upon a BER, show more prevalence in pharmaceuticals and natural 
products. The plan was to explore chiral ligands in conjugation with whichever 
transition metal proved to be most effective in promoting a diastereoselective BER 
in the aforementioned investigation. 
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2 Results and Discussion 
2.1 Synthesis of Hydroxy-iso-Evoninic Acid 
2.1.1 Synthesis of 1,2-Diketone Using the Model Route 
In order to adapt Sheng’s synthesis of phenyl diketone 52 (see Scheme 1.10) for the 
synthesis of desired picoline diketone 48, the preparation of picoline enone 54 was 
first required. Three methods were considered: via an aldol condensation, via a 
Wittig reaction and via a Heck coupling reaction (Figure 2.1). 
 
Figure 2.1 – Possible routes to picoline enone 54. 
Before attempts could be made at an aldol condensation or a Wittig reaction, the 
synthesis of known aldehyde 69 was required. It is known that commercially 
available 3,4-lutidine can be selectively oxidised to the alcohol62 or the carboxylic 
acid63 at the 4-methyl group, as this benzylic position is better able to accommodate 
a negative charge by delocalisation onto the pyridyl nitrogen, when compared to 
the 3-methyl group. Due to the higher yield reported for oxidation of the 4-methyl 
group to the carboxylic acid using SeO2, it was decided to repeat this literature 
reaction and then reduce the ester derived from this acid to the aldehyde using 
DIBAL-H. In the procedure reported for the oxidation to the carboxylic acid, 3,4-
lutidine is heated in diphenyl ether at 150 °C in the presence of SeO2. However, it 
was found that by performing the reaction in dioxane and only heating to 105 °C, 
the 4-methyl group was only oxidised as far as the desired aldehyde 69 (Scheme 
2.1). 
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Reagents and Conditions; (a) SeO2, dioxane, 105 °C, 20 h (47%). 
Scheme 2.1 - Selective oxidation of 3,4-lutidine to aldehyde 69 using SeO2. 
Formation of aldehyde 69 was confirmed by comparison of its NMR data with the 
literature values and by mass spectrometry. This provides an improved procedure 
over those reported in the literature for accessing known aldehyde 69. Previous 
one-step procedures either require a gaseous reagent at 400 °C64 or show poor 
selectivity between oxidation to the aldehyde and the carboxylic acid.65 
With aldehyde 69, a Wittig reaction using commercially available ylide 71 was 
explored (Scheme 2.2). 
 
Reagents and Conditions; (a) 1.1 eq. ylide 71, H2O, 100 °C, 2 h (55%). 
Scheme 2.2 – Formation of enone 54 via a Wittig reaction.66 
The reaction was performed in water, as this solvent is known to accelerate Wittig 
reactions of stabilised ylides.66 A ratio of 77:23 of the trans- and cis-enones was 
formed and to facilitate the analysis of subsequent NMR spectra, it was decided to 
separate the two isomers. The predominant trans-isomer could be separated from 
the cis-isomer by flash chromatography, however, it could not be isolated from the 
triphenylphosphine oxide by-product. 
To avoid the formation of triphenylphosphine oxide, an aldol condensation reaction 
was investigated (Table 2.1). 
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Entry Conditions Outcome 
167 10% NaOH, EtOH, 0 °C to rt, 4.5 h Consumption of aldehyde 69, no desired 
products 
268 10% NaOH, EtOH, -20 °C, 30 min Aldol 72 in 38% yield 
3 10% NaOH, EtOH, -10 °C, 30 min 62% yield of aldol 72 
4 10 eq. TFA, MeOH, 60 °C, 17 h Recovered aldehyde 69 
Table 2.1 – Attempts at the formation of enone 54 via an aldol condensation. 
Following a procedure for the aldol condensation between 2-methylbenzaldehyde 
and acetone, although consumption of aldehyde 69 was observed, no desired 
enone 54 or aldol product 72 was observed (entry 1).67 A paper detailing the aldol 
reactions of pyridine aldehydes with acetone, demonstrated the difficulty in 
performing the aldol reaction when the aldehyde is at the 4-position of a pyridyl 
ring.68 They found that a temperature of -20 °C was optimal, though a yield of just 
20.7% was obtained. When repeating these conditions with a 3-methyl substituent 
the aldol product 72 was successfully formed in a yield of 38% which was 
compromised by the competitive formation of symmetrical dibenzylacetone 
derivative 73 in 32% yield (entry 2). By increasing the temperature to -10 °C, the 
yield was increased to 62% and afforded aldol product 72 exclusively (entry 3). No 
reaction was observed when the aldol reaction was attempted using acidic 
conditions (entry 4). Heating aldol product 72 under acidic conditions allowed for 
conversion to Z-enone 54 in a high yield (Scheme 2.3). 
 
Reagents and Conditions; (a) 20% HCl, MeOH, 65 °C (89%). 
Scheme 2.3 – Dehydration of aldol 72 to form enone 54. 
Due to the moderate yields of the aldol condensation route over the 3-steps from 
3,4-lutidine, it was decided to also investigate the possibility of a Heck reaction of 4-
bromo-3-picoline (70) with MVK before proceeding with the synthesis of 1,2-
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diketone 48. Although 4-bromo-3-picoline is not commercially available, its 
synthesis is known. Its preparation from 3-picoline-N-oxide by nitration and then a 
1-step procedure for aromatic substitution and deoxygenation, was investigated 
first (Scheme 2.4).69,70 
 
Reagents and Conditions; (a) conc. HNO3/conc. H2SO4, 0 to 100 °C (52%); (b) 15 eq. PBr3, EtOAc, 0 to 
65 °C, 3 h (10-50%). 
Scheme 2.4 – Two-step synthesis of 4-bromo-3-picoline (70).69,70 
Standard conc. HNO3/conc. H2SO4 conditions successfully nitrated N-oxide 74 at the 
4-position to afford 4-nitro pyridine 75.69 Reaction with PBr3 to effect aromatic 
substitution followed by deoxygenation was found to be irreproducible.70 If 
deoxygenation of 4-nitro pyridine N-oxide 75 occurred first, the pyridyl system was 
not electrophilic enough to participate in the aromatic substitution and 4-nitro-3-
picoline 76 was isolated as a major product alongside oligomerisation products. It 
was thought that splitting this procedure into separate steps by following a more 
recent synthesis of 4-bromo-3-picoline (70) might provide a more reliable route 
(Scheme 2.5).71 
 
Reagents and Conditions; (a) AcOH/AcBr, 80 °C, 3 h (91%); (b) 4 eq. PBr3, EtOAc, 65 °C, 30 min (72%). 
Scheme 2.5 - Three-step synthesis of 4-bromo-3-picoline (70).71 
From 4-nitro pyridine 75, aromatic substitution was found to proceed in high yield 
when HBr was generated in situ from a AcBr/AcOH mixture.71 No reaction was 
observed when refluxing in aqueous HBr. The resulting 4-bromo-N-oxide 77 was 
deoxygenated by heating with PBr3. It was found that PPh3 was not competent for 
this transformation. 
Chapter 2  Results and Discussion 
35 
 
With an efficient procedure established for the synthesis of 4-bromo-3-picoline, a 
Heck reaction with MVK using a procedure reported for the coupling of MVK with 2-
bromotoluene was attempted (Scheme 2.6).72  
 
Reagents and Conditions; (a) 4 eq. MVK, 10 mol% Pd(OAc)2, 40 mol% PPh3, 2 eq. Et3N, DMF, 100 °C 
(34%). 
Scheme 2.6 – Heck coupling of 4-bromo-3-picoline with MVK.72 
It was initially considered that the reaction was unsuccessful because no product 
was obtained following work-up. However, by avoiding aqueous work-up and using 
4 equivalents of MVK, a yield of 34% of enone 54 was achieved. Although it is likely 
this yield could be further optimised, with the synthesis of 4-bromo pyridine 70 
requiring 3-steps, it was clear that an aldol reaction after a 1-step synthesis of 
aldehyde 69 was the best method to synthesise enone 54 on the scale required to 
complete the synthesis of hydroxy-iso-evoninic acid and so no further work was 
carried out to optimise this Heck reaction (see Table 2.1, entry 3). 
With enone 54 in hand, the synthetic route developed for the model system was 
followed (see Scheme 1.10), and epoxidation of enone 54 was performed (Scheme 
2.7). 
 
Reagents and Conditions; (a) 35% H2O2, 2M NaOH, MeOH, rt, 2.5 h (54%). 
Scheme 2.7 – Nucleophilic epoxidation of enone 54. 
Nucleophilic epoxidation occurred in 54% yield, which is comparable with that 
obtained on the model (52%, Scheme 1.10) and no N-oxide formation was observed 
which was considered to be a likely by-product if electrophilic epoxidation had been 
attempted. The synthesis was continued by attempting to ring-open epoxide 78 
with Me3Al (Table 2.2).
32  
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Entry Temperature Outcome 
132 -78 °C Recovered epoxy ketone 78 
2 -78 to 0 °C 82% yield of epoxy alcohol 80 
3 -40 °C 50% conversion to epoxy alcohol 80 
Reagents and Conditions; 4 eq. Me3Al, 4 eq. H2O, CH2Cl2, 2.5 h. 
Table 2.2 – Attempted ring-opening of epoxide 78 with Me3Al. 
On attempting the reaction at -78 °C under the same conditions as used on the 
model, no reaction was observed (entry 1). Allowing the reaction to warm up to 0 °C 
afforded only epoxy alcohol 80 which was isolated in 82% yield and presumably 
arises from 1,2-addition to the carbonyl group (entry 2). By repeating the reaction 
at -40 °C no desired α-hydroxy ketone 79 was formed, only a slower conversion to 
epoxy alcohol 80 was observed by inspection of 1H NMR spectra (entry 3). 
To eliminate the possibility of 1,2-addition to ketone 78, it was decided to reduce 
the ketone to epoxy alcohol 81 before ring-opening the epoxide. This would add 
just one step to the sequence if the resulting 1,2-diol 82 could be dioxidised to 1,2-
diketone 48. The reduction was achieved with NaBH4 (Scheme 2.8). 
 
Reagents and Conditions; (a) NaBH4, MeOH, 0 °C to rt, 15 min (dr 57:43, 95%). 
Scheme 2.8 – Reduction of epoxy ketone 78 to epoxy alcohol 81. 
The reduction gave a 57:43 ratio of erythro and threo diastereoisomers which were 
assigned by comparison to similar substrates in the literature.73 The ring-opening of 
this epoxide was then attempted under various conditions (Table 2.3). 
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Entry Conditions Outcome 
133 3 eq. AlMe3, CH2Cl2, 0 °C to rt, 16 h Recovered epoxide 81 
233 10 eq. AlMe3, 6 eq. H2O, CH2Cl2, 0 °C to rt, 16 h Recovered epoxide 81 
374 Me2Cu(CN)Li2, Et2O, -78 °C to rt, 18 h Recovered epoxide 81 
4 5 eq. MeLi, THF, 0 °C, 30 min Unidentified product 
5 2 eq. MeLi, THF, 0 °C, 30 min Unidentified products 
6 2 eq. MeLi, THF, -78 °C, 30 min Recovered epoxide 81 
775 1.1 eq. Me4AlLi, hexane/CH2Cl2, 0 °C to rt, 16 h Recovered epoxide 81 
875 3 eq. Me4AlLi, CH2Cl2, 40 °C, 18 h Unidentified products 
974 4 eq. MeMgBr, THF, 0 °C, 17 h Recovered epoxide 81 
Table 2.3 – Attempts at ring-opening epoxy alcohol 81 with methyl organometallic 
reagents. 
Attempts at the ring-opening reaction with varying equivalents of Me3Al and in the 
presence or absence of water, resulted only in recovery of epoxy alcohol 81 (entries 
1 and 2).33 Upon addition of Me2Cu(CN)Li2, for which addition to epoxides is known 
to proceed with inversion as opposed to retention as observed with Me3Al, a 
gummy complex immediately formed, probably due to chelation of the pyridyl 
nitrogen to the copper.74 Hence, no desired reaction occurred under these 
conditions (entry 3). Reaction with excess MeLi resulted in conversion to an 
unidentified product (entry 4). By reducing the amount of MeLi to 2 equivalents, 1 
equivalent to deprotonate the alcohol and 1 equivalent to perform the ring-
opening, the formation of the same undesired product could not be avoided, 
though this product was isolated in a 1:1 ratio with a new product which appeared 
to contain an epoxide (entry 5). Cooling the reaction to -78 °C in the hope of 
avoiding unwanted side reactions resulted in recovery of the starting material 
(entry 6). It was therefore decided to return to aluminium complexes with the 
addition of the more reactive species Me4AlLi. However, using only 1 equivalent 
resulted simply in recovery of starting material and using an excess resulted in a 
mixture of unidentified products (entries 7 and 8).75 Finally, addition of a methyl 
Grignard reagent failed to instigate a reaction (entry 9).74 It is possible the aryl 
methyl group is sterically hindering the addition to the epoxide, and/or that the 
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pyridyl nitrogen is making the build up of positive charge at the benzylic position 
less favourable than in the case of the successful model system. Alternatively, the 
pyridyl lone pair of electrons may coordinate too strongly to the aluminium metal 
reagents to allow them to act as effective methyl nucleophiles.  
2.1.2 New Strategy Towards 1,2-Diketone 48 
Without even trace amounts of diol 82 observed up to this point, an alternate route 
to diketone 48 was considered (Figure 2.2). 
 
Figure 2.2 – New retrosynthetic strategy to diketone intermediate 48. 
It was hoped that 4-bromo pyridine 70 would participate in an allylation with an 
allylic electrophile obtained from commercially available 3-penten-2-ol. This 
approach takes advantage of the symmetry of the allyl intermediate and so requires 
no consideration of SN2 or SN2’ selectivity. Problems with dihydroxylation of alkene 
83 or dioxidation of the resulting 1,2-diol 82 were not envisaged. 
Due to 4-bromo pyridine 70 requiring a 3-step synthesis (see Scheme 2.3), it was 
decided to target ortho-tolyl alkene 92 as a model substrate on which to develop 
allylation reaction conditions using 2-bromotoluene as the aryl bromide. Before 
discussion of this, the following scheme summarises the synthesis of the various 
allylic electrophiles that were investigated in the allylations discussed in this section 
(Scheme 2.9). 
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Reagents and Conditions; (a) 0.5 eq. PBr3, Et2O, 0 °C, 2 h,then rt, 1 h (68%); (b) 1.1 eq. Ac2O, 1.1 eq. 
pyridine, Et2O, rt, 21 h (69%); (c) 1.2 eq. 2-picolinic acid, 1.3 eq. DCC, 1.2 eq. 4-DMAP, CH2Cl2, 0 °C to 
rt, 1 h (95%); (d) 1.1 eq. TMSCl, pyridine/Et2O (1:10), 0 °C to rt, 2.5 h (72%); (e) 1.1 eq. ClCO2Me, 1.1 
eq. pyridine, Et2O, 0 °C to rt (53%); (f) 1.5 eq. Bu3SnAlEt2, 5 mol% Pd(PPh3)4, THF, -78 to 0 °C to rt, 2 h 
(70%). 
Scheme 2.9 – Allylic compounds synthesised from 3-penten-2-ol for use in allylation 
reactions. 
The yields for the synthesis of allylic bromide 84,76 acetate 85,77 formate 8878 and 
TMS ether 87 were limited by their volatility. To maximise these yields, only volatile 
solvents were used in the reactions and during work-up. These solvents were then 
removed carefully under a flow of nitrogen. Previously unknown picolinate ester 86 
was synthesised according to standard Steglich esterification conditions.79 The 
synthesis of allylic stannane 89 was also successful using (SnBu3)2
80 rather than 
Bu3SnAlEt2
81 when catalysed by Pd(PPh3)4, though the reaction produced a large 
amount of tin by-products which were difficult to remove from the extremely 
apolar allylic stannane 89. Bu3SnAlEt2 was prepared by deprotonation of Bu3SnH 
followed by addition of Et2AlCl and was used directly as a THF solution. 
A range of model allylation reactions were attempted that could be used directly 
with the commercially available 2-bromotoluene (90) or following its conversion to 
an aryl metal in situ (Table 2.4). 
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Entry X Y Conditions Outcome 
182 Br OAc 3 eq. Et4NCl, 4 eq. 
nBuMe2N, 0.5 eq. 
Pd/C, DMF, 1 eq. H2O, 100 °C, 16 h 
Recovered 90 
283 Br OAc 0.1 eq. PhBr, 3.3 eq. Zn, 0.2 eq. CoBr2, 
0.1 eq. ZnBr2, AcOH, MeCN, 60 °C, 16 h 
Recovered 90 
and 85 
384 Br OAc 1.5 eq. (SnBu3)2, 0.1 eq. Pd(dppf)Cl2, 
DMF, 120 °C, 16 h 
38% 
4 Br Br 2 eq. tBuLi or 1 eq. nBuLi, -78 to 0 °C,  
2 h 
11% yield 
585 MgBr OAc 4 mol% NiCl2(PPh3)2, THF, rt, 16 h 17% yield 
686  MgBr OTMS 4 mol% NiCl2(PPh3)2, THF, rt, 16 h Only biaryl 93 
observed 
786 MgBr OTMS 4 mol% Pd(dppf)Cl2, THF, rt, 16 h 0.1:1, alkene 
92 : biaryl 93 
887 MgBr OCO-(2-
pyridyl) 
0.5 eq. CuBr∙SMe2, THF, -78 to 0 °C, 1 h  99% yield 
Table 2.4 – Allylation reactions with aryl bromide 90. 
A Pd/C catalysed reaction with allylic acetate 85 was attempted first which did not 
require transmetallation.82 Although examples were only provided for the allylation 
of aryl iodides, it was decided to attempt the reaction with 2-bromotoluene (90). 
The mechanism proposed starts with oxidative addition into the aryl-halide bond 
and as the aryl bromide was recovered intact from the reaction mixture, it was clear 
that this bromide was not reactive enough under these conditions (entry 1). 
Gosmini’s cobalt catalysed procedure has been successfully used with aryl 
bromides, though only with allyl acetate itself.83 The mechanism proposed is 
reduction of Co(II) to Co(I) by zinc dust which immediately forms a strong (ŋ2-
allylOAc)-cobalt(I) complex. These complexes have been shown to be highly reactive 
towards aryl halides. However, it appears that this cobalt(I) complex did not form 
with secondary allylic acetate 85 as it was recovered and no reaction was observed 
(entry 2). Another procedure in which an aryl bromide can be used directly is via 
Stille coupling. Addition of (SnBu3)2 to an aryl bromide in the presence of a Pd 
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catalyst and allyl acetate can afford the allylated product.84 No investigation into 
whether the reaction proceeds via the allyl or aryl stannane has previously been 
performed and only examples employing allyl acetate itself have been reported. 
Pleasingly, the reaction between 2-bromotoluene and allylic acetate 85 was 
successful, and afforded alkene 92 in a moderate yield (entry 3). As the yield was 
not particularly high and removal of the tin by-products was laborious, it was 
decided to continue to look for alternative methods. Performing halogen-lithium 
exchange and quenching with allylic bromide 84 did result in the formation of a 
small amount of alkene 92, although the majority of the material was lost due to 
isomerisation to the presumably more thermodynamically stable styrene (entry 4). 
Kumada couplings were then considered. Using a nickel catalyst with allylic acetate 
85 resulted in the formation of product in just 17% yield (entry 5).85 Using TMS 
protected allylic ether 87 under the same conditions resulted in complete 
conversion to biaryl 93 (entry 6) and switching the catalyst to a palladium catalyst 
appeared to only slightly slow down the rate of formation of this biaryl, allowing co-
formation of the desired alkene 92 in just 10% yield (entry 7).86 Finally, a SN2’ 
reaction with allylic picolinate 86 as the electrophile using conditions developed by 
Kobayashi et al. was attempted.87 After formation of the aryl Grignard reagent, 
transmetallation with copper occurs to generate MgBr2, which coordinates to the 
picolinate making this a particularly effective leaving group. Although not required 
for our symmetrical allylic moiety, the substitution has been shown to proceed 
exclusively through a SN2’ mechanism with a range of substrates. It has also been 
shown that the substitution occurs with extremely high levels of chirality transfer, 
allowing for an asymmetric synthesis, as chiral 3-penten-2-ol is readily accessed 
through a kinetic resolution of the carbonate88 or by a lipase resolution.89 The 
reaction between the aryl Grignard reagent obtained from 2-bromotoluene and 
allylic picolinate ester 86 afforded desired alkene 92 in essentially quantitative yield 
(entry 8).  
The optimal allylation conditions (Table 2.4, entry 8) were applied to the pyridyl 
system. Unfortunately, the reaction was unsuccessful, as upon addition of the Cu(I) 
complex, a viscous mixture formed presumably as the result of coordination of the 
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pyridyl nitrogen to the copper centre and no desired product was isolated. Efforts 
therefore focused on optimising the Stille coupling (Table 2.4, entry 3) on the 
required pyridyl system (Scheme 2.10). 
 
Reagents and Conditions; (a) 1.5 eq. (SnBu3)2, 10 mol% Pd(dppf)Cl2, DMF, 120 °C, 16 h (39%). 
Scheme 2.10 – Optimisation of the Stille coupling between bromo pyridine 70 and 
allylic acetate 85. 
Repeating the Stille coupling on the pyridyl system did afford some of the desired 
alkene 83, though a major product was aryl stannane 94. As mentioned above, no 
study into whether the reaction proceeds via the aryl or allyl stannane has been 
reported. Therefore, aryl stannane 94 was isolated and resubjected to the reaction 
conditions (Scheme 2.11). 
 
Reagents and Conditions; (a) 0.1 eq. Pd(dppf)Cl2, DMF, 120 °C, 16 h. 
Scheme 2.11 – Attempted Stille coupling using preformed aryl stannane 94. 
No alkene 83 was observed and biaryl 95 was the major product formed during the 
reaction, as deduced by analysis of the LCMS data recorded on the crude reaction 
mixture. It was therefore presumed that the reaction was proceeding via the allylic 
stannane and so it was decided to prepare allylic stannane 89 as described by 
Trost81 (see Scheme 2.9). The Stille coupling between aryl bromide 70 and allyl 
stannane 89 was then investigated (Table 2.5).  
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Entry Conditions Outcome 
184 1 eq. 70, 1.3 eq. 89, 10 mol% 
Pd(dppf)Cl2, DMF, 120 °C, 16 h 
0% 
290 1 eq. 70, 1.3 eq. 89, 10 mol% Pd(PPh3)4, 
toluene, 100 °C, 16 h 
17% conversion to alkene 
83 
3 1 eq. 70, 1.3 eq. 89, 10 mol% Pd(PPh3)4,  
DMF, 120 °C, 16 h 
54% yield of alkene 83 
Table 2.5 – Stille coupling with preformed allyl stannane 89. 
When performing the reaction using the same solvent and catalyst as used 
successfully for the model coupling (cf. Table 2.4, entry 3), surprisingly, no alkene 
83 was observed (entry 1). It was therefore decided to change the catalyst and 
solvent to those commonly used in Stille couplings with allylic stannanes, i.e. 
Pd(PPh3)4 and toluene.
91 This resulted in the formation of a small quantity alkene 
83, though the majority of aryl bromide 70 was recovered (entry 2). Switching the 
solvent back to DMF but keeping the catalyst as Pd(PPh3)4, the isolated yield was 
improved to 54% with complete consumption of aryl bromide 70 (entry 3). 
Formation of biaryl 95 limited the yield. Increasing the amount of allylic stannane 89 
did not improve the yield so the amount of this was held at 1.3 eq. to minimise 
problems with tin removal during work-up. It was originally decided to proceed with 
this method to synthesise alkene 83, though when performing the reaction on a 
scale greater than 250 mg, the yields decreased significantly. As the reaction is 
heated at 120 °C, the cause of this is unclear. 
Another catalysed cross-coupling reaction was attempted where an allylic indium 
species is formed in situ (Scheme 2.12). 
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Reagents and Conditions; (a) 5 mol% Pd2dba3·CHCl3, 20 mol% Xantphos, 2 eq. In, 0.5 eq. InCl3, 3 eq. 
LiCl, 2 eq. nBuNMe2, DMF, rt, then 1 eq. 70, 100 °C. 
Scheme 2.12 – Allylation by in situ formation of an allylic indium species.92 
This followed a procedure from a paper which described the first successful 
reactions of aryl bromides with allyl indium species. The success of these coupling 
reactions was attributed to the larger bite angle of Xantphos as compared to 
previous investigated ligands. However, the conditions did not afford alkene 83, 
possibly due to the presence of the γ-substituent, and/or the basicity of the pyridyl 
nitrogen, and/or the steric hindrance caused by the 3-methyl substituent on the aryl 
bromide 70. 
In view of the limited success thus far achieved for allylation reactions with aryl 
bromide 70 and due to its 3-step preparation, it was decided not to investigate 
allylations of the corresponding aryl iodide as this derivative requires a 4-step 
synthesis which has been shown to be low yielding.29 Instead, chemistry developed 
by Akiba et al. was considered. Akiba has reported that 1,4-dihydropyridine 
phosphonates can act as equivalents of a pyridine that is nucleophilic at the 4-
position.93 Allyl bromide and a selection of alkyl halides were reported as potential 
electrophiles (Scheme 2.13). 
 
Scheme 2.13 – Akiba’s use of 1,4-dihydropyridinesphosphonates in the formation of 
4-substituted pyridines.93 
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Akiba reported that by using ethyl chloroformate, the phosphonate ester formed 
exclusively at the 4-position. Deprotonation and then trapping with an alkyl halide 
electrophile, installed the alkyl substituent α to the phosphonate ester. A further 2 
equivalents of base are then required to remove the formate and phosphonate 
esters. The procedure was attempted using 3-picoline in the hope that the 3-methyl 
substituent wouldn’t reduce the selectivity for the 4-position (Table 2.6). 
 
Entry Solvent Ratio of 96:97 (yield) 
1 THF 1:0.3 
2 MeCN 1:0 (88%) 
Reagents and Conditions; (a) 1 eq. EtOCOCl, 0 °C, 30 min then 1 eq. P(OEt)3, rt, 16 h. 
Table 2.6 – Formation of phosphonate ester 96. 
Using THF as the solvent, as was used by Akiba et al., resulted in a mixture of 4- and 
6-substituted phosphonate esters (entry 1). However, by switching the solvent to 
MeCN, 4-substituted phosphonate ester 96 was formed exclusively in a high yield 
and this compound could be taken through to the next step with no purification 
required after removal of the solvent (entry 2). Using commercially available allyl 
bromide, a trial allylation was performed and upon its success, 3-bromopent-2-ene 
(84) was used to obtain the desired alkene 83 (Table 2.7). 
 
Entry R Yield 
1 H 79% of alkene 98 
2 CH3 53% of alkene 83 
Reagents and Conditions; (a) 1.1 eq. nBuLi, THF, -78 °C, 40 min, then 1.1 eq. allyl bromide, 30 min, 
then 0 °C, 40 min, then -78 °C, 2.2 eq. nBuLi, then 0 °C, 45 min. 
Table 2.7 – Alkylation reactions of 4-phosphonate ester 96. 
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The yield with commercially available allyl bromide (entry 1) was higher than that 
achieved for 3-bromopent-2-ene (entry 2) likely due to the greater steric hindrance 
of the secondary bromide. However, a yield of 53% was considered a significant 
improvement in all previous routes given the low cost of the starting materials and 
the avoidance of the 3-step synthesis of aryl bromide 70. It was therefore decided 
to proceed with this procedure in future for the synthesis of intermediate alkene 
83.  
Returning to the synthesis of the BER precursor diketone 48 (see Figure 2.2), 
dihydroxylation of alkene 83 was attempted (Table 2.8). 
 
Entry Conditions Outcome 
194 0.4 mol% K2OsO4, 2.2 eq. NMO, 3 eq. 
citric acid, tBuOH/H2O (1:1), rt, 18 h 
Irreproducible 
295 1 mol% OsO4, 2.2 eq. NMO, THF/H2O 
(10:1), rt, 17 h 
Irreproducible 
3 0.4 mol% OsO4, 2.2 eq. NMO, 
acetone/H2O (4:1), rt, 6 h 
Recovered alkene 83 
496 0.4 eq. NaIO4, 0.3 eq. LiBr, AcOH, 95 °C, 
18 h; then conc. in vacuo; then 3.3 eq. 
K2CO3, MeOH, rt, 30 min 
Unidentified product, 
possibly glycol bond 
cleavage to acid 
597 0.5 mol% RuCl3, 1.5 eq. NaIO4, 1M H2SO4, 
EtOAc, MeCN, H2O, 0 °C, 5 min 
Glycol bond cleavage to 
aldehyde (36% yield) 
Table 2.8 – Attempts at dihydroxylation of alkene 83. 
Although moderate yields of 1,2-diol 82 were obtained using standard Sharpless 
dihydroxylation conditions (entry 1),94 the reaction was found to be highly 
unreliable and when low yields were obtained, alkene 83 had largely decomposed. 
Under these conditions the reaction mixture is at pH 4 and at this acidity it is 
possible that alkene 83 is in the aqueous layer due to protonation of the pyridyl 
nitrogen. It was therefore decided to use OsO4 in a high THF/H2O ratio; 
unfortunately, this showed no improvement (entry 2).95 By switching the solvent 
mixture to acetone/H2O, decomposition was prevented though the starting material 
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was completely recovered (entry 3). NaIO4 was used in acetic acid as the acidic 
conditions have been reported to avoid cleavage of the glycol bond. However, it 
was found that with alkene 83, cleavage could not be avoided and a mixture of 
products was formed (entry 4).96 Dihydroxylation was then attempted with RuO4 
with which it has also been shown that under highly acidic conditions, cleavage of 
the glycol bond is prevented.97 However, alkene 83 was cleaved within 5 min and 
only the aldehyde cleavage product was observed (entry 5).  
It was therefore decided to form diol 82 in a stepwise procedure via epoxide 99 
which could be ring-opened to diol 82. Epoxidation was attempted with m-CPBA 
(Scheme 2.14). 
 
Reagents and Conditions; (a) 1 eq. m-CPBA, CH2Cl2, 0 °C, 2 h. 
Scheme 2.14 – Epoxidation of alkene 83. 
Although just 1 equivalent of m-CPBA was used, a mixture of N-oxide and 
epoxide/alkene products was obtained. Envisaging that N-oxide formation may be 
hard to avoid, it was decided to obtain epoxide 99 from bromohydrin 100 (Scheme 
2.15). 
 
Reagents and Conditions; (a) 1 eq. NBS, THF/H2O, 0 °C, 1 h (regioisomers 60:40); (b) 2M NaOH, 
MeOH, 60 °C, 1 h (dr 52:48, 84% over 2 steps); (c) 10% HClO4 (aq.), MeCN, rt, 16 h (dr 52:48, 70% 
over 3 steps). 
Scheme 2.15 – Formation of 1,2-diol 82 via bromohydrin 100 and epoxide 99. 
Formation of bromohydrin 100 proceeded cleanly without any bromination of the 
pyridyl ring. The reaction proceeded with higher regioselectivity when performed in 
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MeCN/H2O rather than in THF/H2O (with the major regiosomer shown above), but 
in a slightly lower yield. As the regioselectivity is inconsequential following epoxide 
formation, THF/H2O was selected as the solvent system. Ring-closure to epoxide 99 
proceeded smoothly upon treatment under basic conditions and this epoxide could 
then be opened to 1,2-diol 82 under highly acidic conditions.98 Although some 
elegance is lost in this 3-step procedure, the sequence can comfortably be 
completed in 24 h as column chromatography is required just once after formation 
of epoxide 99. 
Dioxidation of 1,2-diol 82 was investigated next (Table 2.9). 
 
Entry Conditions Outcome 
199 2.5 eq. IBX, DMSO, rt, 2 h Trace amounts of 
diketone 48 
2100 3 eq. PhICl2, 5 mol% TEMPO, 6 eq. 
pyridine, CHCl3, 50 °C, 2.5 h 
Complex mixture 
3101 10 eq. DMSO, 3 eq. TFAA, -60 °C, 1 h; then 
7 eq. Et3N, THF, 5 °C, 15 min 
55% 
4 10 eq. DMSO, 3 eq. TFAA, -60 °C, 1 h; then 
7 eq. iPr2NEt, THF, 5 °C, 15 min 
47% 
5102 2.2 eq. (COCl)2, 4.4 eq. DMSO, -78 °C, 15 
min; then 6 eq. Et3N, CH2Cl2, 0 °C, 15 min 
53% 
6 2.2 eq. (COCl)2, 4.4 eq. DMSO, -78 °C, 15 
min; then 6 eq. Et3N, CH2Cl2, -78 °C, 2 min 
75% 
Table 2.9 – Dioxidation of 1,2-diol 82. 
For all of the reactions summarised in Table 2.9, aqueous work-up was avoided to 
maximise the potential yields. IBX was first considered as an oxidant as it has been 
reported as a mild oxidant for which glycol bond cleavage products are not 
generally observed99 although these are not unknown.103 Unfortunately, the IBX 
dioxidation of 1,2-diol 82 resulted predominantly in cleavage products and only 
trace amounts of diketone 48 were observed (entry 1). Radical oxidation using 
TEMPO resulted in a complex mixture of products possibly due to the potential to 
form stable benzylic radicals (entry 2).100 It was then decided to attempt a Swern 
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oxidation. Activating the DMSO with TFAA afforded the desired diketone in a yield 
of 47% accompanied by the formation of decomposition products (entry 3).101 It 
was hoped that by switching to a more hindered base the amount of decomposition 
products could be limited, however, this did not materialise and a similar yield was 
achieved when employing Hünig’s base in place of Et3N (entry 4). Switching the 
DMSO activator to oxalyl chloride also did not improve the yield of the reaction 
(entry 5),102 but the attractiveness of the shorter reaction time led to these 
conditions being used in optimising the quenching procedure. It was noted that 
during the above Swern oxidations, the bright yellow colour characteristic of 1,2-
diketones was darkening after addition of the base. By shortening the time after 
addition of the base to 2 min at -78 °C and immediately eluting the solution onto a 
silica column before the mixture had the opportunity to warm, the yield was 
increased to 75% and was found to be reproducible on a scale of up to 250 mg 
(limited by the volume of the reaction mixture due to the rate it could be 
transferred to the column of silica before decomposition) (entry 6). This dioxidation 
procedure was selected as the final step in the synthesis of diketone 48. 
2.1.3 BER and the Completion of the Synthesis of Hydroxy-iso-Evoninic 
Acid 
With a route to diketone 48 established, promotion of a BER was investigated 
(Table 2.10). 
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Entry Conditions dr (47a:47b)a,b Yield 
1 CuCl - 0% 
2 Ca(OH)2
c 45:55 64% 
3 ZnCl2 36:64 90% 
4 0.05M NaOH 57:43 81% 
5 0.05M BaO 57:43 80% 
a. dr calculated by integration of the 1H NMR spectrum of Me esters and the two benzylic 
signals. b. diastereoisomers were assigned by comparison of NMR spectra with spectra of tolyl 
esters 57a and 57b which were assigned previously.   c. 48 h reaction time. 
Reagents and Conditions; (a) 1 eq. BER promoter, MeOH, 40 °C, 16 h. 
Table 2.10 – Promotion of a BER of diketone 48. 
A few common BER promoters were investigated. When CuCl was added to a 
solution of diketone 48 in MeOH, a viscous substance immediately formed, likely 
due to the pyridyl nitrogen coordinating to the azaphilic copper centre. This 
resulted in decomposition of diketone 48 (entry 1). Ca(OH)2 and ZnCl2 were both 
successful in promoting a BER, although the reaction in the presence of ZnCl2 was 
much faster (64% in 48 h cf. 90% in 16 h, entries 2 and 3). Both conditions slightly 
favoured diastereoisomer 47b. A BER also occurred under basic conditions and 
interestingly slightly favoured the opposite diastereoisomer 47a (entry 5). This 
selectivity switch will be discussed later. Without knowing which diastereoisomer of 
hydroxy-iso-evoninic acid was required for the synthesis of naturally occurring 
hydroxy-iso-evoninic acid, an investigation into improving the levels of dr on this 
substrate was not pursued, though the switch in selectivity observed was 
considered to be extremely promising for the eventual development of a 
stereoselective synthesis. 
To complete the synthesis, hydrolysis of methyl ester 47 was required followed by 
benzylic oxidation, as employed in the synthesis of evoninic acid (Scheme 2.16).21 
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Reagents and Conditions; (a) 2M NaOH, MeOH, 65 °C, 1 h (dr 45:55, 83%); (b) 4 eq. KMnO4, H2O, 100 
°C, 16 h. 
Scheme 2.16 – Ester hydrolysis and attempted benzylic oxidation. 
Basic ester hydrolysis afforded acid 55 in a high yield. Due to the poor solubility of 
acid 55 in organic solvents, salts were removed after neutralisation with 1M HCl, by 
sonication in MeCN and then passing the resulting suspension through a pad of C18 
silica using MeCN as the eluent. Benzylic oxidation of the resulting monoacid 55 was 
unsuccessful in water21 due to cleavage of the glycol bond. This cleavage was not 
observed by Shukla in the synthesis of its regioisomer, hydroxy evoninic acid,29 
possibly due to the quarternary alcohol forming a hydrogen bond to the pyridyl 
nitrogen to give a stable 6-membered ring (Figure 2.3). 
 
Figure 2.3 – Possible intramolecular hydrogen bonding in the precursor to Shukla’s 
hydroxy evoninic acid. 
However, it was found that if the oxidation was performed under basic conditions, 
as was originally reported by Criegee, no glycol bond cleavage was observed as long 
as care was taken to remove all salts from mono-acid 55 (Scheme 2.17).104 
 
Reagents and Conditions; (a) 4.5 eq. KMnO4, 1M NaOH, 100 °C, 1 h (dr 45:55, 92%). 
Scheme 2.17 – Benzylic oxidation under basic conditions.104 
Diacid 101 was found to only be soluble in DMSO or H2O making removal of salts 
formed after neutralisation problematic. However, it was found that salts could be 
removed by passing the aqueous solution of diacid 101 through a ZipTip®. The C18 
ZipTip® is prepared with a 5% TFA (aq.) solution and an aqueous solution of diacid 
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101 is passed through the tip. When eluting with 100% H2O, diacid 101 sticks to the 
ZipTip® allowing for the removal of salts. Diacid 101 can then be retrieved from the 
ZipTip® by washing with 50% MeCN/H2O. The dr remains constant through both the 
ester hydrolysis and benzylic oxidation steps. 
This completed the first synthesis of (±)-hydroxy-iso-evoninic acid (101). The 
synthesis developed is a 9-step sequence which requires purification by column 
chromatography just 4 times and was completed in an overall yield of 25%. 
2.1.4 Isolation and Assignment of the Four Possible Stereoisomers 
As the stereochemistry of naturally occurring hydroxy-iso-evoninic acid is unknown 
and no spectral data for it is available, a method of separating the four 
stereoisomers was required. To allow for easier separation by chiral HPLC of the 
enantiomers, it was decided to attempt to convert the diastereoisomers of ester 47 
to a compound for which the diastereoisomers could be separated by flash 
chromatography. Ester 47 was reduced to 1,2-diol 102 in the hope that the resulting 
diastereoisomers would separate by flash chromatography (Scheme 2.18). 
 
Reagents and Conditions; (a) 4 eq. LiAlH4, THF, rt, 16 h (76%); (b) 6 eq. KMnO4, 1M NaOH, 100 °C, 2 h 
(64%). 
Scheme 2.18 – Reduction of ester 47 to 1,2-diol 102 and oxidation to diacid 101. 
Although the reduction proceeded smoothly with LiAlH4, the resulting 
diastereoisomers of 1,2-diol 102 appeared as a single spot on the TLC plate. It was 
shown however, that these could also be oxidised to diacid 101 by treatment with 
KMnO4 under basic conditions in a yield of 64%. 
Separation of the mixture of the four methyl ester stereoisomers by chiral HPLC was 
then investigated. It was found that the (+)-(S,S)-ester 47b could be isolated using a 
Chiralcel® OD-H column (Figure 2.4) and that the (-)-(S,R)-ester 47a could be 
isolated using a Chiralcel® IC column (Figure 2.5). 
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Conditions; Chiralcel ODH; Temp: 8 °C; Flow Rate: 0.75 ml/min; Injection: 7 microlitres; Solvent: 
hexane/IPA = 90:10; Sample Conc.: 10 mg/mL in IPA/EtOAc, 9:1. 
Peak 1 – 21.3 min, (+)-(S,S)-ester 47b; Peak 2 – 26.6 min, (S,R)- and (R,S)-ester 47a; Peak 3 – 30.2 
min, (-)-(R,R)-ester 47b. 
Figure 2.4 – HPLC conditions to isolate (+)-(S,S)-ester 47b. 
Conditions; Chiralcel IC; Temp: 10 °C; Flow Rate: 1.2 ml/min; Injection: 5 microlitres; Solvent: 
hexane/IPA = 85:15; Sample Conc.: 10 mg/ml in IPA. 
Peak 1 – 21.1 min, (-)-(S,R)-ester 47a; Peak 2 – 27.3 min, (+)-(R,S)-ester 47a; Peak 3 – 29.5 min, 
(R*,R*)-ester 47b; Peak 4 – 31.7 min, (R*,R*)-ester 47b.  
Figure 2.5 – HPLC conditions to isolate (-)-(S,R)-ester 47a. 
An imbalance of diastereoisomers was injected into the HPLC which allowed each 
diastereoisomer to be assigned to a peak by comparison of the integration in the 
HPLC trace and 1H NMR spectra. A semi-preparative OD-H column was available 
allowing easy isolation of (+)-(S,S)-ester 47b, which was found to be highly 
crystalline after slow evaporation of CH2Cl2. A small quantity of (-)-(S,R)-ester 47a 
was isolated from the analytical IC column as a white solid. Enantiomeric purity was 
confirmed by analytical chiral HPLC of both isolated stereoisomers. 
2.1.5 Configurational Assignment of the Stereoisomers 
With HPLC methods developed to isolate a single enantiomer of each 
diastereoisomer of ester 47, assignment of their stereochemistry was required. 
Cocrystallisation with single enantiomer chiral carboxylic acids that could hydrogen 
bond to the pyridyl nitrogen were considered so that the stereochemistry in ester 
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47 could be determined by a standard x-ray diffraction experiment. A search of the 
crystal structure database revealed that tartaric acid and malic acid were found to 
be the most common chiral acids to cocrystallise with pyridyl containing molecules 
(Table 2.11). 
Entry Enantiomer of ester 47 Chiral acid Description 
1 (+)-(2S,3S)-ester 47b (+)-tartaric acid Flat cubic crystals 
2 (+)-(2S,3S)-ester 47b (-)-malic acid Unsuitable fan-like 
crystals 
3 (-)-(2S,3R)-ester 47a (+)-tartaric acid Amorphous solid 
4 (-)-(2S,3R)-ester 47a (-)-malic acid Amorphous solid 
Conditions; Cocrystallisation performed using the vapour diffusion method in MeOH/hexane.105 
Table 2.11 – Cocrystallisation attempts with (+)-tartaric acid and (-)-malic acid. 
Flattened cubic crystals were isolated when (+)-(2S,3S)-ester 47b was cocrystallised 
with (+)-tartaric acid though the x-ray diffraction pattern was too weak to resolve 
(entry 1). Cocrystallising with (-)-malic acid afforded a highly crystalline substance, 
although unfortunately the crystals were fan-like and so unsuitable for x-ray 
diffraction (entry 2). Attempts at cocrystallising (-)-(2S,3R)-ester 47a with these 
acids only resulted in amorphous solids (entries 3 and 4). 
As isolated (+)-(2S,3S)-ester 47b was highly crystalline following slow evaporation of 
CH2Cl2, assignment of the stereochemistry was attempted by anomalous dispersion 
x-ray diffraction, made possible by the high ratio of heteroatoms to carbon 
atoms.106 Pleasingly, this was found possible by analysis of the Flack parameters 
(Figure 2.6).107,108 
 
Figure 2.6 – Molecular structure of (+)-(2S,3S)-ester 47b assigned by a single crystal 
anomalous dispersion x-ray structure determination. 
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After successful assignment of the (+)-(2S,3S)-ester 47b, efforts focused on 
obtaining a high quality crystal of (-)-(2S,3R)-ester 47a. This was eventually achieved 
by the vapour diffusion method using CH2Cl2/hexane as the solvent system and 
leaving for a number of days. Needle-like crystals were obtained and pleasingly, 
were of high enough quality to assign the stereochemistry, again by analysis of the 
Flack parameters from a single crystal x-ray structure determination experiment 
(Figure 2.7).107,108 
 
Figure 2.7 - Molecular structure of (-)-(2S,3R)-ester 47a assigned by a single crystal 
anomalous dispersion x-ray structure determination. 
To allow for future assignment of the natural configuration of hydroxy-iso-evoninic 
acid, e.g. after hydrolysis of one of the natural products containing the ligand, the 
final steps of the synthesis were completed with each of the isolated single 
enantiomers to obtain spectroscopic data and optical rotation values for the two 
diastereomeric hydroxy-iso-evoninic acids 101a and 101b (Scheme 2.19). 
 
Reagents and Conditions; (a) 2M NaOH, MeOH, 65 °C, 1 h (82%); (b) 4 eq. KMnO4, 1M NaOH, MeOH, 
100 °C, 1 h (83%). 
Scheme 2.19 – Synthesis of enantiomerically pure (+)-(2S,3R)-diacid 101a and (+)-
(2S,3S)-diacid 101b. 
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The final diacid enantiomers (+)-101a and (+)-101b were purified by reverse phase 
HPLC to complete the synthesis and optical rotation values of *α+20D +12.8 (c = 0.20, 
H2O) for (2S,3R)-101a and *α+
20
D +6.7 (c = 0.25, H2O) for (2S,3S)-101b, were 
obtained. 
2.2 Development of a Diastereoselective BER 
2.2.1 Synthesis of Tolyl Diketone 
Following the successful completion of the synthesis of hydroxy-iso-evoninic acid 
from alkene 83, and the discovery of a high yielding procedure to obtain tolyl alkene 
92 (Table 2.4, entry 8), it was decided to follow the same strategy for the synthesis 
of model tolyl diketone 56 as was successfully employed in the synthesis of pyridyl 
diketone 48 (Scheme 2.20). 
 
Scheme 2.20 – Strategy for accessing model diketone 56. 
In the absence of the pyridyl nitrogen, potential problems with N-oxide formation 
during epoxidation of alkene 92, as previously encountered, were no longer a 
concern. Hence, there was no need to form the bromohydrin, and direct 
epoxidation of alkene 92 was attempted (Table 2.12). 
 
Entry Conditions Yield dr 
1 1.2 eq. m-CPBA, CH2Cl2, 0 °C to rt, 2 h 26% 66:34 
2109 4 x 10-4 M Na2.EDTA, 11 eq. CF3COCH3, 7.7 
eq. NaHCO3, 5 eq. Oxone®, MeCN, 2 h, 0 °C 
76% 43:57 
Table 2.12 – Epoxidation of alkene 92. 
Epoxidation with m-CPBA was low yielding (entry 1). Generation of a reactive 
dioxirane generated in situ under neutral conditions wherein a pH 7-7.5 was 
maintained by the presence of NaHCO3, afforded epoxide 103 in an improved yield 
of 76% (entry 2). A switch in the major diastereoisomer was observed under each 
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set of conditions. It is likely that one diastereoisomer decomposes faster in the 
reaction with m-CPBA and hence a lower yield is obtained. Ring-opening, again 
under the same conditions as used previously for the pyridyl series (see Scheme 
2.15), afforded 1,2-diol 104 which could be oxidised using IBX in DMSO to afford 
diketone 56 (Scheme 2.21). 
 
Reagents and Conditions; (a) 10% HClO4 (aq.), MeCN, 0 °C to rt, 19 h (82%); (b) 2.5 eq. IBX, DMSO, rt, 
19 h (80%). 
Scheme 2.21 – Final steps in the synthesis of model diketone 56. 
IBX, which is a cheaper alternative (and precurosor) to the Dess-Martin periodinane, 
was prepared from 2-iodobenzoic acid and found to oxidise 1,2-diol 104 to 1,2-
diketone 56 which was again isolated as a bright yellow liquid.99 The reaction was 
performed in DMSO due to the poor solubility of IBX in other common organic 
solvents, though it was easily removed by repeated aqueous washings followed by 
FC. 
2.2.2 Development of a Diastereoselective BER 
With an expedient route to diketone 56 developed, the promotion of a BER with 
Cu(OAc)2, as used with model phenyl diketone 52, was attempted (Scheme 2.22). 
 
Reagents and Conditions; (a) 1 eq. Cu(OAc)2, MeOH, 40 °C, 5 days (91% conversion). 
Scheme 2.22 –BER of diketone 56 with Cu(OAc)2. 
Unlike with phenyl diketone 52, a BER did not occur at room temperature. This is 
likely due to the ortho-methyl group causing greater steric hindrance in the 
transition state and so increasing the activation energy. Warming the reaction to 40 
°C resulted in a BER albeit the reaction was very slow with the reaction requiring 5 
days to reach 91% conversion. No diastereoselectivity was observed in the reaction 
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though it was found that the dr could be conveniently measured by integration of 
the proton signals highlighted in the figure below (Figure 2.8). 
 
 
Figure 2.8 – 1H NMR spectrum of a crude reaction mixture and the peaks integrated 
to measure the dr in the BER studies. 
A range of Cu(II) Lewis acids were then screened to investigate their influence on 
the dr of a BER (Table 2.13). 
 
Entry Lewis acid Conversion to ester 57 dr (57a:57b) 
1a Cu(OAc)2 91% 50:50 
2 Cu(OTf)2 9% 50:50 
3 CuF2 100% 47:53 
4 CuCl2 23% 45:55 
5 CuBr2 30% 44:56 
6 CuSO4·5H2O 9% 50:50 
7 CuO 39% 55:45 
a. Reaction left for 5 days. 
Reagents and Conditions; (a) 1 eq. diketone 56, 1 eq. Lewis acid, MeOH, 40 °C, 72 h. 
Table 2.13 – BER’s of diketone 56 with Cu(II) Lewis acids. 
Replacing the counter-ion acetate (entry 1) with triflate (entry 2) resulted in a much 
slower reaction possibly due to a more electron deficient copper centre 
destabilising the build up of positive charge in the transition state. Cu(II) halides also 
promoted a BER (entries 3-5). The halide counter-ion had little effect on the dr 
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though the rate was significantly faster with a fluoride counter-ion (entry 3). As we 
have seen that EWG groups decrease the reaction rate, it is possible that this 
increase in rate is due to the smaller size of fluoride anion creating less steric 
hindrance in the transition state. CuBr2 did promote a faster reaction than CuCl2 as 
was expected (entries 4 and 5). CuSO4·5H2O gave poor conversion and a 1:1 dr 
(entry 6). Interestingly, CuO favoured the opposite diastereoisomer (entry 7), a 
likely reason for which will be discussed later. 
As a more electron deficient copper centre has been found to decrease the rate of 
reaction, Cu(I) promoters were also investigated (Table 2.14). 
 
Entry Lewis acid Conversion to ester 57 dr (57a:57b) 
1 CuCl 91% 45:55 
2 CuBr 100% 47:53 
3 CuI 4% 50:50 
4 CuCN 12% 48:52 
5 CuBF4 50% 46:54 
6 CuBr·SMe2 100% 50:50 
7 CuBr·PPh3 0% - 
8 Cu2O 100% 53:47 
Reagents and Conditions; (a) 1 eq. diketone 56, 1 eq. Lewis acid, MeOH, 40 °C, 72 h. 
Table 2.14 – BER’s of diketone 56 with Cu(I) Lewis acids. 
In general, Cu(I) complexes gave an improved rate of reaction, although, little 
variation in diastereoselectivity was observed with different halide counter-ions 
(entries 1-3). The rate was significantly lower when promoted by CuI, fitting with 
the hypothesis that the size of the counter-ion can hinder the rate of the reaction 
(entry 3). CuCN and CuBF4 promoted BER’s but without greatly effecting the dr 
(entries 4 and 5). Having dimethyl sulfide coordinated to the copper complex had 
little effect on the reaction (entry 6) though triphenylphosphine completely 
prevented the reaction (entry 7). Again, the metal oxide Cu2O promoted a switch in 
the favoured diastereoisomer relative to the other Cu(I) salts (entry 8). 
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Zn(II) complexes were investigated next (Table 2.15). 
 
Entry Lewis acid Conversion to ester 57 dr (57a:57b) 
1 ZnCl2 9% 25:75 
2a ZnCl2 100%
b 38:62 
3 ZnBr2 22% 34:66 
4 ZnI2 24% 30:70 
5 Zn(OTf)2 0% - 
6 Zn(CN)2 0% - 
7 ZnO 10% 54:46 
a.  Reaction heated at 60 °C. b. Conversion after 48 h. 
Reagents and Conditions; (a) 1 eq. diketone 56, 1 eq. Lewis acid, MeOH, 40 °C, 72 h. 
Table 2.15 – BER’s of diketone 56 with Zn(II) Lewis acids. 
In general, BER’s promoted by Zn(II) complexes were considerably slower than 
observed previously with Cu(I) and Cu(II) complexes. Promoting a BER with ZnCl2 
resulted in a much improved dr of 25:75 though the reaction rate was extremely 
slow (entry 1). By heating the reaction to a higher temperature the rate was 
increased so that after 48 h the reaction had gone to completion (entry 2). 
Unfortunately, this improved rate resulted in a reduction in the dr to 38:62. 
Changing the halide to iodide or bromide resulted in a drop in dr (entries 3 and 4). 
Triflate and cyanide complexes failed to promote BER’s (entries 5 and 6). Yet again, 
the metal oxide, ZnO, favoured the opposite diastereoisomer though the conversion 
was a considerably lower than previously observed (entry 7). 
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A variety of other metal chlorides were also investigated (Table 2.16). 
 
Entry Metal halide Conversion to ester 
57 
dr 
(57a:57b) 
1 AgCl <1% 50:50 
2-12 RuCl3, TiCl4, PdCl2, SnCl4, IrCl3, CeCl3, 
LaCl3, AlCl3, BCl3, ZrCl4, HfCl4 
0% to ester 57, 
conversion to acetal 
105 
- 
13-
15 
NiBr2, InCl3, BaCl2 0% - 
16 FeCl3 3% (40% conv. to 
acetal 105) 
31:69 
Reagents and Conditions; (a) 1 eq. metal halide, MeOH, 40 °C, 72 h. 
Table 2.16 – BER’s of diketone 56 with other metal halides. 
In the presence of AgCl, only a very small amount of diketone 56 was converted to 
ester 57 with no influence on the dr (entry 1). Lewis acids that are known to be 
highly oxophilic only resulted in the formation of acetal 105 from addition of MeOH 
to the least hindered ketone with no BER products detected (entries 2-12).110 NiBr2, 
InCl3 and BaCl2 all failed to promote a BER (entries 13-15). FeCl3 was the only Lewis 
acid to produce a mixture of ester 57 and acetal 105 (entry 16). 
The interesting switch in the favoured diastereoisomer when the BER was 
promoted by a metal oxide was investigated and is summarised in the table below 
(Table 2.17). 
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Entry BER promoter Conversion to ester 57 dr (57a:57b)  
1 CuO 40%a 55:45 
2 Cu2O 100%
 a 54:56 
3 ZnO 10% a 53:47 
4 BaO 100% b 62:38 
5 NaOH 100% b 60:40 
6 NaH 100% b 56:44 
a. Conversion after 72 h. b. Conversion after 18 h. 
Reagents and Conditions; (a) 1 eq. Lewis acid, MeOH, 40 °C. 
Table 2.17 – BER conditions favouring ester 57a. 
Of the metal oxides investigated (entries 1-4), BaO gave the highest 
diastereoselectivity (entry 4). It was noted that BaO is the most basic of the metal 
oxides screened due to its highly ionic character,111 and so bases NaOH and NaH 
were also assayed. Both gave comparable diastereoselectivities to that observed 
with BaO (entries 5 and 6) supporting the hypothesis that it is the basicity of the 
metal oxides that is responsible for the switch in diastereoselectivity relative to 
other metal salts/Lewis acids. 
Concentration studies were performed and it was found that although the rate 
increased with concentration in the presence of Lewis acids to an extent, the 
diastereoselectivity was not affected (Table 2.18). 
 
Entry Equivalents of CuCl Conversion to ester 57 dr (57a:57b) 
1 2 67% 43:57 
2 4 79% 43:57 
3 8 63% 43:57 
4 16 49%a 43:57 
a. 2% conversion to acetal 105. 
Reagents and Conditions; (a) CuCl, MeOH, 40 °C, 72 h. 
Table 2.18 – Effect on rate and dr with the concentration of Lewis acid present. 
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An optimum rate was reached when 4 equivalents of CuCl were used (entry 2). 
Increasing the concentration of CuCl further than this resulted in a decreased rate 
of reaction (entries 3 and 4). This could be due to the hemiacetal intermediate 
formed prior to 1,2-migration, spending more time coordinated to multiple copper 
centres thereby restricting the lone pairs of electrons on the sp3 hybridised oxygen 
atoms from assisting the migration. The concentration of Lewis acid BER promoter 
having no effect on the dr is contrary to what was observed in Burke’s study.54 
In the presence of metal oxides or bases, there was a large increase in the 
diastereoselectivity with concentration (Table 2.19). 
 
Entry Concentration of NaOH in MeOH  dr (57a:57b) 
1 0.05 M 60:40 
2 0.10 M 63:37 
3 0.21 M 68:32 
4 0.42 M 84:16 
5a 0.42 M 55:45 
a.  Reaction performed at 20 °C for 22 h. 
Reagents and Conditions; (a) NaOH, MeOH, 40 °C, 18 h. 
Table 2.19 – Effect of concentration on base promoted BER’s. 
Increasing the molarity to 0.42M improved the diastereoselectivity to 84:16 
although a number of decomposition products were observed for the first time in 
these BER’s (entry 4). In the attempt to reduce the amount of decomposition 
products, the temperature was reduced to 20 °C (entry 5). However, this resulted in 
a much lower dr of 55:45. Although, as previously discussed, BER’s are generally 
considered not to be reversible, it was thought that an equilibrium could explain the 
drop in selectivity with temperature. To test this theory, a known ratio of esters 57a 
and 57b were treated to base promoted BER conditions to look for a change in 
selectivity (Scheme 2.23). 
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Reagents and Conditions; (a) 0.42M NaOH in MeOH, 40 °C. 
Scheme 2.23 – Test to investigate the possibility of a reversible 1,2-migration in the 
base promoted BER of diketone 56. 
Although a small change in dr was observed over time, it was not comparable to 
that observed in the BER of diketone 56 with 0.42M NaOH in MeOH (see Table 2.19, 
entry 4). It appears that this change in diastereoselectivity arises from the faster 
degradation of diastereoisomer 57b over 57a and that 1,2-migration is irreversible. 
The use of co-solvents was also investigated, firstly in the presence of a Lewis acid; 
CuCl2 was selected as the Lewis acid due to the slow rate of reaction and modest dr 
observed in MeOH (Table 2.20). 
 
Entry Solvent Outcome 
1 CH2Cl2/MeOH (1:1) Majority converted to a mixture of 
unidentified products but no ester 57 
detected 
2 THF/MeOH (1:1) Recovered the majority of diketone 56 
3 toluene/MeOH (1:1) Recovered the majority of diketone 56 
Reagents and Conditions; (a) 1 eq. diketone 56, 1 eq. CuCl2, solvent, 40 °C, 72 h. 
Table 2.20 – The effect of co-solvents on the BER of diketone 56 promoted by CuCl2. 
No ester 57 was detected in any of the reactions containing co-solvents (entries 1-
3), only decomposition products were observed in a CH2Cl2/MeOH mixture (entry 
1). These solvent mixtures were also investigated for use with the NaOH promoted 
BER (Table 2.21). 
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Entry Solvent System Outcome 
1 CH2Cl2/MeOH (1:1) Mixture of unidentified products 
2 THF/MeOH (1:1) Mixture of unidentified products 
3 toluene/MeOH (1:1) Mixture of unidentified products 
Reagents and Conditions; (a) 0.05M NaOH in MeOH, 40 °C, 16 h. 
Table 2.21 - The effect of co-solvents on the BER of diketone 56 promoted by NaOH. 
Again, no desired ester 57 was observed using co-solvents (entries 1-3) so no 
further efforts were made in this direction. 
Changing the alcohol/solvent was also explored (Table 2.22). 
 
Entry Conditions Outcome dr (a:b) 
1 0.42M tBuOK in tBuOH, rt, 
22 h 
tBu ester 105 : diketone 56 
74:26 
61:39 
2 0.42M KOH in iPrOH, rt, 
22 h 
Mixture of unidentified 
products 
- 
3 1 eq. CuCl2, CF3CH2OH, 40 
°C, 18 h 
Recovered diketone 56 - 
4 1 eq. CuCl2, 
tBuOH, 40 °C, 
18 h 
Recovered diketone 56 - 
Table 2.22 – Changing the solvent/nucleophile. 
With a bulkier alcohol under basic conditions at room temperature, greater 
diastereoselectivity was achieved than was previously observed with MeOH at the 
same molarity (entry 1 cf. Table 2.19, entry 5). This could be explained by an 
increase in the energy of the transition states due to greater steric strain and hence 
greater selectivity is observed as well as lower conversion. Using iPrOH as the 
solvent resulted in a complex mixture with complete consumption of diketone 56 
and with no ester 107 observed (entry 2). To look at solvent effects in the presence 
of Lewis acids, CuCl2 was selected due to the moderate rates of reaction it gives and 
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observable diastereoselectivity. Unfortunately, it would not promote a BER with the 
more electron deficient alcohol solvent CF3CH2OH (entry 3) or the sterically 
hindered alcohol solvent tBuOH (entry 4). 
The table below summarises the optimal procedures found for promoting a 
diastereoselective BER of diketone 56 (Table 2.23). 
 
Entry Conditions dr (57a:57b) 
1 0.42M NaOH in MeOH, 40 °C, 18 h 84:16 
2 1 eq. ZnCl2, MeOH, 40 °C, 72 h 25:75 
3 1 eq. ZnCl2, MeOH, 60 °C, 72 h 38:62 
Table 2.23 – Optimal conditions for promoting diastereoselective BER’s of diketone 
56. 
Although synthetically useful dr’s were obtained which favour either 
diastereoisomer of ester 57, the extremely slow reaction time of the BER promoted 
by Lewis acids limits their usefulness (entry 2) and warming the reaction causes a 
significant reduction in the dr (entry 3). It would have been expected that the BER of 
pyridyl diketone 48 would be slower than tolyl diketone 56 when promoted by 
Lewis acids, due to the unfavourable build-up of positive charge para- to the pyridyl 
nitrogen in the transition state of the 1,2-migration. However, this was not the case 
with the ZnCl2 promoted BER of pyridyl diketone 48 which went to completion in 16 
h compared with the tolyl diketone 56 undergoing only 9% conversion after 72 h. It 
was considered that the basicity of the pyridyl lone pair may be increasing the rate 
of reaction, possibly by ligating to the metal centre. To test this hypothesis, the 
effects of adding pyridine and 2,6-lutidine into the BER were investigated (Table 
2.24). 
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Entry Lewis 
acid 
Additive Conversion dr 
(53a:53b) 
Colour 
1 CuCl2 - 16% 47:53 Yellow 
2 CuCl2 pyridine 47% 47:53 Deep green/blue 
3 CuCl2 2,6-
lutidine 
100% 47:53 Lilac 
4 ZnCl2 - 5% 47:53 Bright yellow (no 
change) 
5 ZnCl2 pyridine 13% 47:53 Bright yellow (no 
change) 
6 ZnCl2 2,6-
lutidine 
15% 42:58 Bright yellow (no 
change) 
7 Ca(OH)2 - 52% 43:57 Dark yellow 
8 Ca(OH)2 pyridine 75% 46:54 Dark yellow 
9 Ca(OH)2 2,6-
lutidine 
70% 42:58 Dark yellow 
Reagents and Conditions; (a) 1 eq. Lewis acid, 2 eq. additive, rt, 30 h. 
Table 2.24 – The effects of pyridine and 2,6-lutidine on the BER of phenyl diketone 
52. 
The most dramatic rate effect was observed with CuCl2 though the additives did not 
affect the dr (entries 1-3). A dramatic increase in conversion from 16% to 100% in 
the presence of 2,6-lutidine was observed over the 30 h reaction duration (entry 3). 
Interestingly, the colour of the reaction mixtures with CuCl2 and the additives varied 
greatly suggesting that pyridyl copper complexes are formed, which is an interesting 
observation when considering an asymmetric BER. It is possible that the pyridyl 
nitrogen coordinated to the copper is decreasing the electropositivity of the copper 
centre and hence decreasing the destabilisation of the build-up of positive charge in 
the rearrangement transition state.  
No colour differences were observed when using additives with ZnCl2 and a less 
dramatic increase in rate was observed (entries 4-6). A slight change in dr was 
observed in the presence of 2,6-lutidine (entry 6). Again, there was an increase in 
rate in the presence of the additives in combination with Ca(OH)2 and no distinctive 
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colour differences between the three reactions were observed (entries 7-9). Slight 
variations in the dr were found in these reactions promoted by Ca(OH)2. A possible 
explanation for the increase in rate with ZnCl2 and Ca(OH)2 is shown in the figure 
below (Figure 2.9). 
 
Figure 2.9 – Possible rational for the increase in rate with pyridyl additives in the 
BER promoted by ZnCl2 and Ca(OH)2. 
It is conceivable that the pyridyl nitrogen helps to free the metal centre from the 
tertiary hydroxy group after assisting the 1,2-migration, freeing the metal centre to 
promote further BER reactions. 
2.2.3 Stereochemical Assignment of the Diastereoisomers from the 
Model BER’s 
Burke et al. assigned the diastereoisomers of the resulting ester obtained from a 
BER of his diketone substrate (see Scheme 1.5) by performing a stereospecific E2-
elimination to give stereodefined alkenes.112 It was hoped that the same tactic 
could be employed for ester 57 if the elimination was performed on an imbalance 
of diastereoisomers (Scheme 2.24).  
 
Scheme 2.24 – Proposed E2-elimination of a derivative of esters 57a and 57b. 
This first required the conversion of the α-hydroxy group into a leaving group. A 
high yield was required for this transformation to ensure that the major 
diastereoisomer of ester 57 remained the major diastereoisomer after conversion 
to the leaving group. As Burke converted his α-hydroxyl group to an acetate, this 
was attempted first (Table 2.25). 
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Entry Conditions Outcome 
1 2.2 eq. Ac2O, 1.1 eq. pyridine, 0.1 eq. 4-
DMAP, Et2O, 45 °C, 5 h 
Recovered ester 57 
2 Ac2O, 12% H2SO4, 45 °C, 19 h 65% yield of acetate 110 
Table 2.25 – Conversion of the hindered α-hydroxyl group to acetate 110. 
Using standard acetylation conditions as used previously by Burke, no reaction was 
observed (entry 1). Heating the reaction offered no improvement and it is likely that 
sterics are preventing the acetylation. However, by warming under acidic conditions 
with acetic anhydride as the solvent, acetate 110 was obtained in a yield of 65%, 
but with complete retention of dr (entry 2). E2-elimination of acetate 110 was then 
explored (Table 2.26). 
 
Entry Conditions Outcome 
1 5 eq. Ac2O, AcOH, 16 h Recovered acetate 110 
2 5 eq. NaH, THF, 60 °C, 16 h Mixture of undesired products 
3 DBN (neat), 100 °C, 16 h Mixture of undesired products 
Table 2.26 – Attempted E2-elimination to assign the diastereoisomers of ester 57. 
No trace of unsaturated esters 109a and 109b could be detected following 
treatment with base, due to either decomposition or recovery of starting ester 110 
(entries 1-3). Attempts at converting the α-hydroxy group to a mesyl or tosyl 
derivative were unsuccessful. An alternate assignment method was therefore 
required. 
It was decided to assign the diastereoisomers by performing a diastereoselective 
synthesis of diol 111a (Scheme 2.25).  
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Scheme 2.25 – Strategy for assigning the diastereoisomers of ester 57 by a 
diastereoselective synthesis. 
The synthesis of (E)-allylic alcohol 113 has previously been reported,113 so it was 
planned to epoxidise and then stereospecifically open the epoxide with retention of 
configuration at the benzylic position.33 This would afford 1,2-diol 111a which could 
either be oxidised to methyl ester 57a or a known ratio of esters 57a and 57b could 
be reduced to give this compound. Assignment of the diastereoisomers could then 
be made by comparison of 1H NMR data for the authentic diol 111a with the 
unequal mixture of diols obtained from the reduction. 
The 3-step procedure reported by Stratakis was followed to synthesise (E)-allylic 
alcohol 113 (Scheme 2.26).113 
 
Reagents and Conditions; (a) 1.5 eq. MeI, CH2Cl2, 0 °C to rt, 18 h (rotamers 1:1, 75%); (b) 1.2 eq. o-
tolylaldehyde, CH2Cl2, rt, 17 h (49%); (c) 2.6 eq. LiAlH4, 0.2 eq. AlCl3, Et2O, 0 °C to rt, 2 h (82%). 
Scheme 2.26 – Synthesis of (E)-allylic alcohol 113.113 
As ylide 114 is commercially available and inexpensive, methylation of it was used 
to form ylide 115 rather than treatment of the required α-halo ester with 
triphenylphosphine. This reaction was relatively high yielding and afforded a 1:1 
ratio of rotamers of ylide 115, as was observed previously. A Wittig reaction of the 
stabilised ylide 115 with ortho-tolylaldehyde afforded (E)-unsaturated ester 116 
exclusively which was then reduced to (E)-allylic alcohol 113 (assigned previously by 
Stratakis).114 
Epoxidation of (E)-allylic alcohol 113 followed by ring-opening was then performed 
(Scheme 2.27). 
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Reagents and Conditions; (a) 10 mol% VO(acac)2, 1.2 eq. TBHP, toluene, 40 °C, 16 h (76%); (b) 3 eq. 
Me3Al, hexane, -78 to 0 °C, 4 h (76%). 
Scheme 2.27 - Synthesis of 1,2-diol 111a as a single diastereoisomer. 
Epoxidation successfully yielded epoxide 112 after syn-addition of the peroxide, 
with the distinctive colour change to orange/red then back to dark green being 
observed. Epoxide 112 was ring-opened with Me3Al to afford 1,2-diol 111a as a 
single diastereoisomer as was expected from the transition state proposed by 
Roberts (Figure 2.10).33 
 
Figure 2.10 – Transition state explaining the retention of stereochemistry at the 
benzylic position after epoxide ring-opening with Me3Al.
33 
By consideration of available material, it was then decided to reduce a known ratio 
of esters 57a and 57b to a mixture of primary alcohols 111a and 111b (Scheme 
2.28). 
 
Reagents and Conditions; (a) 2.2 eq. LiAlH4, THF, 0 °C to rt, 2 h (100%). 
Scheme 2.28 – Reduction of a known ratio of esters 57a and 57b to 1,2-diols 111a 
and 111b to allow diastereoisomer assignment. 
As the reduction was quantitative, a mixture containing ester 57b as the major 
diastereoisomer was reduced with LiAlH4 to a mixture containing diol 111b as the 
major diastereoisomer. Overlaying the proton and carbon NMR spectra allowed for 
unambiguous assignment of the diastereoisomers: the major diastereoisomer 
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formed by Lewis acidic BER’s was the (2R*,3R*) diastereoisomer, whereas the major 
diastereoisomer formed under basic conditions is the (2R*,3S*) diastereoisomer. 
2.2.4 13C-Labelling Studies 
On the basis of migratory aptitude, the benzylic group is expected to have migrated 
during these rearrangements rather than the methyl group. Although the same 
product is observed whichever group migrates, in order to investigate the role of 
Lewis acidic and basic promoters, and when contemplating the design of an 
asymmetric BER, it was considered important to know which group migrated.40 To 
confirm the hypothesis that the benzylic group is migrating, 13C-labelling studies 
were performed. By mapping the carbon atoms during a BER in which the methyl 
and benzyl groups could migrate, the required position of a 13C-label to determine 
the migratory group could be determined (Figure 2.11). 
 
Figure 2.11 – Mapping of carbon atoms after 1,2-migration of the benzylic or 
methyl groups in the BER. 
It is clear that a 13C-label at C-2 or C-3 should suffice to confirm which group is 
migrating. The location of the label was expected to be easily be determined by 13C 
NMR spectrometry due to the large difference in chemical shifts of an alkyl or 
carbonyl carbon in the spectrum. It was found that a potential source of a 13C-label 
was from acetone which is available as mono-labelled 2-13C or di-labelled 1,3-13C. To 
simplify the analysis, it was decided to proceed with mono-labelled 2-13C acetone in 
order to install a 13C-label at C-2 in the 1,2-diketone. 
It was hoped that an aldol reaction of 13C-labelled acetone 117 with o-
methylbenzaldehyde would afford labelled enone 118 which could in turn be taken 
through to labelled tolyl diketone 119 according to the chemistry used in the 
synthesis of model phenyl diketone 52 (see Scheme 1.10) (Scheme 2.29). 
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Scheme 2.29 – Strategy for installing a 13C-label at C-2 to afford 13C-labelled 
diketone 119. 
Due to the high cost of 13C-labelled acetone 117, the synthesis was first attempted 
using unlabelled acetone. Known conditions to perform an aldol-condensation 
between acetone and o-methylbenzaldehyde were attempted (Scheme 2.30).115 
 
Reagents and Conditions; (a) 1.3 eq. acetone, 0.37M NaOH (aq.), EtOH, 0 °C, 4 h (75%). 
Scheme 2.30 – Aldol-condensation of acetone with o-methylbenzaldehyde to afford 
enone 120.115 
No aldol product was observed in the reaction though the yield of enone 120 was 
compromised by the formation of dba derivative 121 which could be removed by 
performing multiple FCs. The similarity in Rf values, presumably as the result of π-
interactions, made this separation particularly difficult. 
With enone 120 in hand, epoxidation was explored (Table 2.27). 
 
Entry Conditions Outcome 
131 35% H2O2, 2M NaOH, MeOH, rt, 16 h Recovered enone 120 
2 35% H2O2, 2M NaOH, MeOH, 50 °C, 16 h Recovered enone 120 
3116 TBHP, DBU, DCM, 0 °C to rt. 18 h Recovered enone 120 
4117 Et2Zn, O2, toluene, 16 h Recovered enone 120 
Table 2.27 – Attempted epoxidation of enone 120. 
No epoxidation was observed when repeating the conditions successfully applied by 
Sheng on the phenyl system (entry 1) and moreover heating the solution also did 
not allow the reaction to proceed (entry 2).31 A procedure using a mixture of TBHP 
and DBU, which was apparently developed for unreactive α,β-unsaturated lactones 
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where epoxidation is often very slow when using hydrogen peroxide, was 
attempted next. However, again, no reaction was observed (entry 3).116 It was 
considered that the extreme unreactivity of enone 120 might be due to strong 
intermolecular π-interactions caused by restricted rotation brought about by the 
tolyl methyl group (cf. the phenyl analogue). It was therefore decided to make one 
final attempt using a procedure performed in toluene in an attempt to break up 
such π-interactions. However, epoxidation using the autoxidation product of 
diethylzinc in toluene was also unsuccessful (entry 4).117 Concluding that we would 
need to reduce the conjugation in the system to allow epoxidation, enone 120 was 
reduced to allylic alcohol 123 using a Luche reduction (Scheme 2.31).118 
 
Reagents and Conditions; (a) CeCl3·7H2O, NaBH4, MeOH (61%). 
Scheme 2.31 – Luche reduction of enone 120.118 
The required reduction was successful in the presence of CeCl3·7H2O, giving allylic 
alcohol 123 in 61% yield. Interestingly, in the absence of this Lewis acid the 
corresponding allylic methyl ether was obtained in 69% yield, rather than the 
desired allylic alcohol 123.  
To avoid the laborious purification of enone 120 when bringing material through 
the sequence, it was decided to perform the Luche reduction on a mixture of enone 
120 and dba derivative 121 formed during the aldol-condensation (see Scheme 
2.30) (Scheme 2.32). 
 
Reagents and Conditions; (a) 1.3 eq. acetone, 0.37M NaOH (aq.), EtOH, 0 °C, 4 h; (b) CeCl3·7H2O, 
NaBH4, MeOH (64% over 2 steps).  
Scheme 2.32 – Luche reduction to ease the removal of the dba derivative 121 
formed in the aldol-condensation. 
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The Luche reduction was successful and as anticipated, made separation of diallylic 
alcohol 124 from desired allylic alcohol 123 by FC much easier. It was therefore 
decided use this device to avoid laborious purification after the aldol-condensation 
when repeating the synthesis using 13C-labelled material.  
Efficient conditions for epoxidation of allylic alcohol 123 to give epoxy alcohol 125 
were then explored (Table 2.28). 
 
Entry Conditions Outcome (dr) 
1 m-CPBA, CH2Cl2, rt, 16 h 70% (60:40) 
2119 VO(acac)2, TBHP, toluene, 40 °C, 18 h 85% (62:38) 
Table 2.28 – Electrophilic epoxidation of allylic alcohol 125. 
Although m-CPBA afforded desired epoxy alcohol 125 in good yield (entry 1), it was 
found that using TBHP with VO(acac)2 gave a more consistent and also improved 
yield of 85% (entry 2).119 Under both sets of conditions, a similar dr was observed. 
By analogy with similar reactions in the literature, the major diastereoisomer from 
this epoxidation was tentatively assigned as being the erythro isomer.120,121 
Ring-opening followed by oxidation completed the synthesis of required 1,2-
diketone 56 in a reaction sequence suitable for 13C-label introduction (Scheme 
2.33). 
 
Reagents and Conditions; (a) Me3Al, hexane, -78 to 0 °C (dr 66:34, 67%); (b) IBX, DMSO, rt (80%). 
Scheme 2.33 – Completion of the synthesis of 1,2-diketone 56. 
The dr was maintained in the ring-opening of epoxide 125 with Me3Al which was 
regioselective due to chelation of aluminium to the hydroxyl and epoxide oxygen 
atoms with a build-up of positive charge occurring at the benzylic position (see 
Figure 2.10 above).33 This afforded previously synthesised 1,2-diol 104 which could 
be oxidised to 1,2-diketone 56 with IBX (see Scheme 2.21 above).  
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The optimised sequence of reactions was repeated using 2-13C-labelled acetone 117 
to access 13C-labelled diketone 119 (Scheme 2.34). 
 
Reagents and Conditions; (a) 1.3 eq. 117, 0.37M NaOH (aq.), EtOH, 0 °C, 4 h; (b) 1 eq. CeCl3·7H2O, 
1.5 eq. NaBH4, 0 °C to rt, 15 min (51% over 2 steps); (c) 10 mol% VO(acac)2, 1.2 eq. TBHP, toluene, 40 
°C, 16 h (dr 41:59, 65%); (d) 3 eq. Me3Al, hexane, -78 to 0 °C, 4 h (dr 43:57, 67%); (e) 2.5 eq. IBX, 
DMSO, rt, 18 h, (79%). 
Scheme 2.34 – Synthesis of 2-13C-labelled diketone 119. 
All steps proceeded in comparable yields to those observed using unlabelled 
material as would be expected. 13C-Labelled diketone 119 was then exposed to both 
Lewis acid and base promoted BER conditions (Scheme 2.35). 
 
Reagents and Conditions; (a) 1 eq. CuCl, MeOH, 40 °C, 66 h (dr 45:55); (b) 0.21M NaOH, MeOH, 40 
°C, 16 h (dr 59:41). 
Scheme 2.35 – BER of 13C-labelled diketone 119 under Lewis acidic and basic 
conditions to investigate which group is migrating. 
Under both sets of conditions, the 13C-label ended up in the α-position to the 
carbonyl group in ester 129. No product was observed containing the 13C-label in 
the carbonyl group by 13C NMR. This confirmed that as expected, the benzylic group 
is exclusively migrating in these BER reactions. 
2.2.5 Proposed BER Transition States 
With the diastereoisomers of ester 57 assigned† and confirmation that the benzylic 
group is exclusively migrating established, transition states were proposed to 
rationalise the diastereoselectivity observed (Figure 2.12). 
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Figure 2.12 – Predicted transition states to rationalise the diastereoselectivity 
observed in the BER of diketone 56. 
We propose that the major intermediate in both pathways is the hemiacetal ‘Felkin-
Anh’ product. We then propose that under Lewis acid promoted conditions, the 
Lewis acid chelates between the methyl ether and carbonyl oxygens allowing for 
smooth orbital overlap for 1,2-benzylic group migration assisted by the hydroxyl 
group lone pair of electrons. This leads to ester diastereoisomer 57b. By contrast, 
the base deprotonates the hydroxy group forming the alkoxide which chelates to 
the carbonyl oxygen via the counter-ion allowing for smooth orbital overlap for 1,2-
benzylic group migration assisted in this case by the methyl ether lone pair. This 
leads to the formation of ester diastereoisomer 57a as the major product. 
Interestingly, this contrasts with the transition states predicted by Burke et al. for 
the Cu(OAc)2 promoted BER of their diketone substrate (see Figure 1.8).
54 Using 
their predicted transition state, a BER promoted by Lewis acids would lead to the 
formation of ester 57a as the major diastereoisomer. As previously discussed, it is 
possible that their system is complicated by the presence of extra heteroatoms. 
 
† Note that all previous depictions of diastereoisomers of BER’s on diketone 56 in this thesis 
show the correct relative stereochemistry. 
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2.3 Synthesis of Euonyminol Model 
The synthesis of the euonyminol model up to the key desymmetrisation step has 
previously been published.60 Using the procedures reported therein, a large scale 
synthesis of epoxide 137 was completed starting from 100 g of naphthalene 
(Scheme 2.36). 
 
Reagents and Conditions; (a) NH3 (aq.), 5.6 eq. Na, EtOH/Et2O, -78 °C, 3 h (89%); (b) 1.8 eq. NaOAc, 
CH2Cl2, 1.2 eq. peracetic acid in AcOH, 0 °C to rt, 1.5 h (67%); (c) 10 eq. KCN, H2O/MeCN, 85 °C, 4 
days (64%); (d) 0.1 eq. VO(acac)2, 4 eq. TBHP, CH2Cl2/toluene, 70 °C, 21 h (72%); (e) 4 eq. Me3Al, 
CH2Cl2/hexane, 50 °C, 16 h (87%); (f) 3 eq. MsCl, 3 eq. Et3N, CH2Cl2, -10 °C to rt, 17 h (69%); (g) DBU, 
110 °C, 17 h (74%); (h) 1.1 eq. L-(+)-DIPT, 1.1 eq. Zr(OiPr)4·
iPrOH, 2.4 eq. TBHP, 4 Å MS, CH2Cl2, -42 °C 
then 1 eq. diallylic alcohol 136, then -20 °C, 42 h (ee 48%, 95%). 
Scheme 2.36 – Synthesis of euonyminol model up the desymmetrisation step. 
Due to the large quantities of reagents and solvents required, the final 7 steps in the 
above synthesis were performed in 3 batches. The Birch reduction of naphthalene 
proceeded in high yield as complete conversion to triene 130 was observed allowing 
the avoidance of a difficult work-up to remove the mono-reduced product. 
Epoxidation of resulting triene 130 proceeded in a moderate yield due to the 
formation of some bis-epoxide despite careful monitoring of the reaction. Due to a 
rise in the cost of Et2AlCN which was originally used to ring-open epoxide 131, a 
large excess of KCN was used instead (as has also been done previously within the 
Spivey group).122 Although this required a longer reaction time, it afforded the 
desired cyanohydrin 132 in a yield of 64%. Diastereoselective bis-epoxidation 
controlled by chelation to the hydroxy group on the bottom face of the molecule, 
afforded bis-epoxide 133 which was then regioselectively ring-opened with Me3Al 
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to afford triol 134. Selective mesylation of the two secondary hydroxyl groups was 
followed by anti-elimination in neat DBU to furnish meso-diallylic alcohol 136. A Zr-
based Sharpless-type asymmetric epoxidation then afforded the desired (+)-epoxide 
137 in high yield although the high enantioselectivity achieved previously was not 
reproduced.60 The reaction was repeated 5 times and ee’s of 22%, 38%, 32%, 28% 
and 39% were obtained (as determined by HPLC).60 Webber also failed to reproduce 
the high ee reported originally by Weston,60 but did not use molecular sieves when 
performing the reaction, unlike the conditions reported by Weston.7 It is therefore 
likely that the ee was compromised by the presence/quality of the molecular sieves. 
As methyl ether deprotection of euonyminol model compound 58 has not been 
achieved yet, it was decided to hold the majority of material as stable crystalline 
chiral epoxide 137. To this end, the synthesis was continued on a small scale (~500 
mg of allylic alcohol 137).  
Thus, a Yamaguchi esterification with enantiomerically pure (-)-(S)-2-
methoxypropionic acid was performed according to the method developed by 
Webber (Scheme 2.37).7 
 
Reagents and Conditions; (a) 1 eq. 138, 1.05 eq. 2,4,6-trichlorobezoyl chloride, 1.05 eq. Et3N, 
0.55 eq. 4-DMAP, toluene, 60 °C, 20 h (79%). 
Scheme 2.37 – Yamaguchi esterification with (-)-(S)-2-methoxypropionic acid (138). 
It was found that the dr could be determined by integration of the methyl ether 
peaks in the 1H NMR spectrum. A kinetic resolution occurred during the 
esterification. For example, allylic alcohol 137 with an ee of 22% improved to a de of 
48% after esterification to ester 139. Unfortunately, the diastereoisomers of ester 
139 were not separable by FC and when passed through the HPLC, they could not 
be detected using our DAD (i.e. no absorption in the region >200 nm). 
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Webber had performed some optimisation on the next step in the synthesis, which 
is an Ireland-Claisen rearrangement, that under the reaction conditions proceeds to 
give two epimers lactones 140a and 140b which Webber was able to assign by x-ray 
crystallography.7 The ratio of these epimers reflects both the ratio of silyl ketene 
acetal stereoisomers formed following ester α-deprotonation/silylation and the 
proportion proceeding through a boat vs. a chair transition state.123 For cyclic 
systems, particularly cyclohexenyl systems, both boat- and chair-like transition 
states are plausible, making prediction of the stereochemical outcome of the 
reaction difficult.124  
After determining the optimal order of addition of reagents, the effect of the nature 
of the base was examined by Webber (Table 2.29). 
 
Entry Base Conversion to 140 Ratio of epimers 140a:140b 
1a LHMDS 51% 53:47 
2a (S,S)-141 82% 54:46 
3a (R,R)-141 39% 58:42 
a. Reported by M. Webber.  
Reagents and Conditions; (a) 2 eq. TMSCl, -78 °C, then 1 eq. base, 1h, then rt, 16 h. 
Table 2.29 – Webber’s findings during optimisation of the Ireland-Claisen 
rearrangement.7 
LHMDS was first investigated due to its success in Ireland-Claisen rearrangements 
that were not lactate variants.125 This base afforded little selectivity for the desired 
epimer 140a (entry 1). Considering the work of Zakarian which employed Koga-type 
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bases to install quarternary stereocentres by matching the chirality of the ester and 
the base,126 chiral amine bases were applied (entries 2 and 3). It appeared that in 
this case, the chirality of the base had little effect on the selectivity although the 
conversion was much greater when using (S,S)-141 as the base (entry 2). When this 
procedure was repeated by Webber on a large scale to bring material through to 
the final product, a significant amount of material was lost and it was noted that 
even on a small scale the reaction was capricious.  
Cognisant of this reported irreproducibility and bearing in mind the new realisation 
that the dr of ester 139 could be measured by inspection of its 1H NMR spectrum, I 
decided to do a further brief investigation into this lactate variant of the Ireland-
Claisen rearrangement (Table 2.30). 
 
Entry Base Ester 139 : 
Lactone 140 
Change in dr of ester 
139 
Epimers 
140a:140b 
1 (S,S)-141 1:0 no change - 
2 (S,S)-141·nBuLi decomposition - - 
3 Et2NLi 1:0 77:23 to 65:35 - 
4 NaHMDS 1:0 77:23 to 68:32 - 
5 LHMDS 1:1 77:23 to 0:1 65:35 
Table 2.30 – Investigation into the lactate variant of the Ireland-Claisen. 
When repeating Webber’s conditions using (S,S)-141 as the base, no reaction was 
observed (entry 1). It was noted that previously when preparing the lithium amide 
from the secondary amine, an excess of nBuLi was used. It was therefore thought 
that a more reactive (S,S)-141·nBuLi complex could have been formed inadvertently 
by Webber during formation of the silyl ketene acetal and hence this complex was 
deliberately prepared. Unfortunately, only decomposition products were observed 
(entry 2). Treatment with Et2NLi or NaHMDS, two bases that had not been screened 
previously, did not result in the formation of any lactone 140 although a change in 
the dr of starting ester 139 was observed suggesting that 
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deprotonation/reprotonation or some decomposition was occurring under these 
conditions. In both cases there was a greater consumption of the diastereoisomer 
containing the required chirality on the decalin core (entries 3 and 4). Repeating the 
conditions using LHMDS as the base resulted in a 50% conversion to lactone 140 in 
an improved epimeric ratio of 65:35 to that previously reported (entry 5, cf. 53:47 
entry 1, Table 2.29). Interestingly, only the minor diastereoisomer ester 139b was 
recovered from the reaction suggesting that a kinetic resolution is occurring in 
favour of the reaction of ester 139a containing the desired chirality on the decalin 
core (entry 5). 
To confirm the hypothesis that a kinetic resolution is occurring and not simply a 
reprotonation of the silyl ketene acetal, recovered ester 139b was resubmitted to 
the reaction conditions (Scheme 2.38). 
 
Reagents and Conditions; (a) 2.2 eq. TMSCl, 1.1 eq. LHMDS, THF, -78 °C, 30 min, then 60 °C, 15 h (dr 
62:38, 9% conv.). 
Scheme 2.38 – Ireland-Claisen rearrangement of the minor diastereoisomer ester 
139b. 
The reaction proceeded with only 9% conversion, a much lower conversion than 
that observed previously with the mixture of diastereoisomers of ester 139 (cf 55% 
with 72:28, 140a:140b). A comparable ratio of epimers was obtained to that 
previously observed. Although it was shown that the reaction was much slower with 
ester 139b, it was decided to perform a D2O quench to rule out the possibility that 
one face of the silyl ketene acetal is simply just reprotonating selectively over the 
other (Scheme 2.39). 
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Reagents and Conditions; (a) 2.2 eq TMSCl, 2.2 eq. LHMDS, THF, -78 °C, 30 min; then 60 °C, 4 h. 
Scheme 2.39 – D2O quench following exposure of esters 139a and 139b to 
rearrangement conditions. 
Again, only minor diastereoisomer ester 139b was recovered from the reaction and 
no incorporation of deuterium was observed. We concluded that a kinetic 
resolution is occurring. Although this would compensate for the poor 
enantioselectivity obtained in the desymmetrisation epoxidation step, the primary 
goal was to complete the synthesis in order to repeat the chemistry later in the 
sequence on a larger scale and to fully characterise these intermediates. Therefore, 
the rearrangement in which LHMDS was used as the base was driven to completion 
to allow the synthesis of a sufficient quantity of required epimer 140a (Scheme 
2.40). 
 
Reagents and Conditions; (a) 2.2 eq. TMSCl, 2.2 eq. LHMDS, THF, -78 °C, 30 min; then 60 °C for 14.5 
h (38% yield of 140a, 20% yield of 140b). 
Scheme 2.40 – Conditions for the Ireland-Claisen rearrangement to bring material 
through the final steps of the synthesis. 
Considering that the fully oxygenated system required in the synthesis of 
euonyminol itself may show different selectivity in the Ireland-Claisen, it was 
decided to proceed with the synthesis bringing through material in 50 mg batches 
despite the low yield of 38% of epimer 140a. The proceeding 3 steps were 
thereafter repeated without major complications (Scheme 2.41). 
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Reagents and Conditions; (a) 10 eq. KOH, 10 eq. MeI, THF, 60 °C, 3 h (96%); (b) 4.2 eq. LiAlH4, THF, 0 
°C, 2.5 h (63%); (c) 3 eq. Ac2O, 1 eq. 4-DMAP, pyridine, rt, 1 h (99%). 
Scheme 2.41 – Synthetic steps from lactone 140 to acetate 144. 
Lactone-opening under basic conditions in the presence of MeI afforded methyl 
ether protected ester 142 in a yield of 96%. When the reduction of ester 142 to 
alcohol 143 was first attempted, reduction of the nitrile group was also observed, as 
confirmed by loss of nitrogen from the mass spectrum. It is thought that this was 
caused by a combination of using a fresh bottle of LiAlH4 and the larger scale the 
reaction was performed on. By repeating with extra care to keep the temperature 
below 0 °C and adding LiAlH4 in small portions, nitrile reduction was avoided and 
alcohol 143 was isolated in a yield of 63%. Acetylation of primary alcohol 143 then 
afforded acetate 144 in a quantitative yield. 
The synthesis was continued with epoxidation of alkene 144 with m-CPBA (Table 
2.31). 
 
Entry Scale Ratio of 145a:145b Yield of 145a and 145b 
1 10 mg 96:4 96% 
2 26 mg 66:34 88% 
Reagents and Conditions; (a) 1.3 eq. m-CPBA, CH2Cl2, rt, 3.5 h. 
Table 2.31 – Change in selectivity as a function of the scale of reaction in the 
epoxidation of alkene 144. 
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When the reaction was repeated on a 10 mg scale, a small amount of the undesired 
epoxide diastereoisomer 145b was also formed, though at this point due to there 
being only 4% conversion to this diastereoisomer, it was only later identified as 
epoxide 145b, resulting from epoxidation on the more hindered bottom face of the 
C-3 - C-4 alkene (entry 1). It is likely that the larger scale reaction generates more 
heat and hence the selectivity is reduced. As epoxide 145b had not yet been 
identified, when the reaction was repeated on a larger scale of 26 mg, precaution to 
cool the reaction were not taken. This larger scale caused the ratio of epoxides 
145a/145b to decrease from 96:4 to 66:34 (entry 2). However, this did allow for 
isolation of minor diastereoisomer 145b which allowed us subsequently to gain 
insight into the mechanism of the next step, which was THF ring formation. 
It was found that THF ring formation proceeded with both diastereoisomers of 
epoxide 145 to afford epimeric alcohols 146a and 146b (Scheme 2.42).  
 
Reagents and Conditions; (a) 3 eq. BBr3, 5 eq. LiI, CH2Cl2, -78 °C, 3 h (78% of 146a, 52% of 146b). 
Scheme 2.42 – THF-ring formation from diastereoisomeric epoxides 146a and 146b. 
As previously reported, upon treatment of epoxide 145a with BBr3, the 12-OMe 
cyclises to ring-open the epoxide. However, as the cyclisation was found to also 
occur with epoxide 145b, this suggests that this substitution process is proceeding 
through a SN1-type mechanism with the generation of at least a partial cation at the 
ring-fusion carbon (Figure 2.13). 
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Figure 2.13 – Proposed mechanism for the formation of alcohol 146b. 
We propose that the BBr3 coordinates to the epoxide causing it to open and 
generate a tertiary carbocation at the ring-fusing carbon atom. The methyl ether 
oxygen then closes onto the empty p-orbital to form a 5-membered ring. The 
generated bromide anion then attacks the carbon atom of the methyl ether to 
generate methyl bromide in an SN2-type reaction. After aqueous work-up, alcohol 
146b is obtained. 
Oxidation of the secondary alcohol using the Dess-Martin periodinane was then 
required. It was hoped that this would allow both epimers to converge to ketone 
147 (Scheme 2.43). 
 
Reagents and Conditions; (a) 1.5 eq. DMP, CH2Cl2, rt, 2 h (92% for the oxidation of 146a). 
Scheme 2.43 – Expected convergence of alcohols 146a and 146b to give ketone 147 
by oxidation with DMP. 
As previously observed, alcohol 146a was oxidised to ketone 147 in a high yield. 
Epimer 146b, unfortunately, would not oxidise to ketone 147 and instead was 
converted to a mixture of products as evidenced by analysis of the methyl ether 
peaks in the 1H NMR spectrum of the crude reaction mixture. Due to the small scale 
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the reaction was performed on, no attempt was made to isolate and identify the 
resulting products. The failure of epimer 146b to undergo clean oxidation might be 
explained by the proximity of the acetate protecting group to the iodine centre in 
the intermediate formed following reaction of the alcohol with the DMP. This is 
clearly demonstrated when the intermediates are modelled in 3D (Figure 2.14). 
                 
  Axial epimer 146a               Equatorial epimer 146b 
Figure 2.14 – Computed molecular structure of the intermediates of alcohols 146a 
and 146b when reacted with DMP following energy minimisation (MM2). 
To complete the synthesis of the methyl ether protected model 58, 1,2-addition to 
the least hindered face of ketone 147 was attempted (Table 2.32). 
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Entry Conditions Scale Outcome 
1a 4 eq. MeMgCl, THF, rt, 4 h 1 mg 75% yield 
2 4 eq. MeMgCl, THF, rt, 4h 3 mg no reaction 
3 8 eq. MeMgCl, THF, rt, 4 h 6 mg 50% yield of 2° alcohol 
146b 
4127 5 eq. CeCl3, 10 eq. MeMgCl, THF, -78 °C to 
rt, 4 h 
1 mg no reaction 
5 4 eq. MeLi, THF, -78 °C, 1 h 1 mg decomposition 
6 4 eq. MeMgI, THF/Et2O, 0 °C to rt, 4 h 4 mg Conversion to 
unknown product 
7 4 eq. MeMgBr, 1 eq. LiCl, THF, rt, 3 h 2 mg Conversion to 
unknown product 
a. Reaction performed by M. Webber.7 
Table 2.32 – 1,2-Addition of methyl organometallic reagents to ketone 147. 
Webber reported a 75% yield of alcohol 58 from addition of MeMgCl to ketone 147 
at room temperature in THF (entry 1).7 Unfortunately, this result could not be 
repeated. Upon addition of 4 eq. MeMgCl, as used by Webber, no reaction was 
observed (entry 2). It was thought that because of the very small scale the reaction 
was originally performed on, a larger excess of MeMgCl may have been added than 
was reported. Therefore, the reaction was attempted with 8 eq. MeMgCl (entry 3). 
This did not result in the formation of desired alcohol 58, though reduced product 
alcohol 146b was obtained in 50% yield. Due to the absence of any β-hydrogens on 
the Grignard reagent, this reduced product must be obtained from a single-electron 
transfer (SET) mechanism,128 as has previously been observed in cyclic ketones 
flanked by two  -ether groups.129 Use of CeCl3 to enhance the rate of Grignard 
reagent addition and hence potentially limit the extent of undesired side reactions 
was then explored.127 After adding MeMgCl to a premixed solution of ketone 147 
and CeCl3, no reaction was observed (entry 4). Due to the apparent lack of activity 
and with signals corresponding to the enolate of the acetate group observed in the 
1H NMR spectra of the crude material of the above reactions, it was decided to 
attempt addition with MeLi due to its higher nucleophilicity. Using an excess of 
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MeLi at -78 °C resulted in decomposition into a complex mixture (entry 5). Due to 
the small scale these trial reactions were performed on, addition of just the 
required 2 equivalents of MeLi would be difficult to accurately achieve. Wanting to 
avoid decomposing more of valuable ketone 147, it was decided to generate MeMgI 
immediately prior to use and attempt addition of this Grignard reagent which is 
reported to be slightly more reactive than MeMgCl as previously used. It was clear 
that the acetate group was no longer present, though the 1H NMR spectrum did not 
correspond to that of the desired alcohol product 58 previously formed (entry 6). 
Addition of LiCl to break up the aggregates of MeMgCl to generate a more reactive 
species resulted in consumption of ketone 147 but afforded no desired product 
(entry 7).130 
As a control reaction, the addition of MeMgCl to cyclohexanone was performed 
(Scheme 2.44). 
 
Reagents and Conditions; (a) 3 eq. MeMgCl, THF, rt, 3 h (94%). 
Scheme 2.44 – Addition of MeMgCl to cyclohexanone. 
Unsurprisingly, this reaction gave the expected tert-alcohol 148 in good yield 
following work-up, clearly indicating that the Grignard reagent was of good quality. 
The reason for the failure to reproduce MeMgCl addition to ketone 147 is therefore 
unclear. As alluded to above, the deshielding of the diastereotopic C-13 signals in 
the 1H NMR spectrum after aqueous work-up and their return after passing through 
a plug of silica, suggests that the acetate is enolising in the reaction. This explains 
why the acetate group is unreacted though it is still unclear why the ketone remains 
intact. Alkoxides formed during Grignard reagent additions are known to cause 
complexities throughout the course of the reaction and it is possible that formation 
of the enolate is doing this.131 Both the alkoxide species formed during the reaction 
and the Schlenk equilibrium, including equilibria involving association, must be 
considered (Figure 2.15).132 
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Figure 2.15 – Schlenk equilibrium.133 
Unlike in diethyl ether, Grignard reagents in THF solutions differ very little in terms 
of their state of association/aggregation with varying concentration, therefore 
variances in the level of association of MeMgCl as a function of the scale on which 
the reactions were performed is unlikely to be a strong factor in the 
irreproducibility.134 Due to the small Schlenk equilibria constant in THF, there is a 
higher concentration of R2Mg and MgX2 in THF than in diethyl ether where RMgX is 
the predominant species.135 It is not always clear which species is active within the 
Schlenk equilibrium, so small variations in other variables including temperature, 
concentration and the presence of salts, can greatly affect the course of a reaction. 
Unlike most of the intermediates en route to it, euonyminol model dimethyl ether 
58 was previously fully characterised by Webber. This, and the fact that time 
constraints precluded the re-synthesis of ketone 147, meant that a deeper 
investigation into the irreproducibility of the Grignard addition was not conducted. 
Unfortunately, this also meant that it was not possible to investigate the coupling of 
the euonyminol model with the four diastereoisomers of hydroxy-iso-evoninic acid. 
2.4 Asymmetric BER 
2.4.1 Synthesis of Diketone Substrates 
As discussed earlier, two substrates were selected with which to develop an 
asymmetric BER. Benzyl diketone 65 was selected due to the high migratory 
aptitude of benzyl groups, whereas phenyl diketone 67 was selected because the 
products contain a structural motif found in many bioactive products. 
Although phenyl diketone 67 is commercially available, it was decided to synthesise 
it from commercially available alkyne 149 as a trial reaction for the synthesis of 
analogues in the future due to the ready availability of aryl alkynes. Alkyne 149 was 
oxidised according to Seebach’s procedure (Scheme 2.45).136 
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Reagents and Conditions; (a) 4.1 eq. NaIO4, 2 mol% RuO2·XH2O, CCl4/MeCN/H2O, rt, 1 h (72%). 
Scheme 2.45 – Oxidation of alkyne 149 to phenyl diketone 67.136 
The oxidation was high yielding and phenyl diketone 67 was isolated after simply 
passing the material, after aqueous work-up, through a plug of silica making the 
synthesis extremely time efficient. 
The synthesis of benzyl diketone 65 was then explored. Diketone 65 is a known 
compound and a 2-step procedure has previously been reported, whereby the 
oxidation of epoxy ketone 50 is the key step in the sequence (Scheme 2.46).137 
 
Reagents and Conditions; (a) 2 mol% Fe(tpp)OTf, dioxane, reflux, 15 min (85%). 
Scheme 2.46 – Suda’s key step in the 2-step preparation of diketone 65.137 
However, as the catalyst for this transformation requires a 2-step preparation from 
an expensive Fe-porphyrin precursor, it was decided to target 1,2-diol 153 first, as 
oxidation with IBX had been shown earlier in this thesis to be high yielding when 
employing similar tolyl 1,2-diol 104 as a substrate (Scheme 2.47). 
 
Reagents and Conditions; (a) 1.1 eq. vinyl magnesium bromide, THF, 0 °C to rt, 30 min (40%); (b) 1.2 
eq. m-CPBA, CH2Cl2, 0 °C to rt, 16 h (dr 58:42, 98%); (c) 1.1 eq. LiAlH4, THF, rt, 18 h (99%). 
Scheme 2.47 – Preparation of 1,2-diol 153. 
1,2-Addition of vinyl magnesium bromide to commercially available 
phenylacetaldehyde 150 afforded allylic alcohol 151 in a moderate yield. It is 
thought likely, however, that this can be improved by transmetallating the vinyl 
nucleophile to an organocerate to minimise enolisation of this substrate. 
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Epoxidation with m-CPBA proceeded in high yield to afford epoxy alcohol 152 which 
could then be reductively opened to afford targeted 1,2-diol 153. 
Dioxidation of 1,2-diol 153 with IBX gave diketone 65 (Scheme 2.48). 
 
Reagents and Conditions; (a) 2.5 eq. IBX, DMSO, rt, 16 h (23%). 
Scheme 2.48 – Formation of benzyl diketone 65. 
A yield of just 23% was achieved for the oxidation, possibly due to the volatility of 
diketone 65, 44% of which, by analysis of its 1H NMR spectrum, was isolated in the 
enol form. It is possible that a Swern oxidation to avoid the required work-up for 
removal of DMSO, will give an improved yield. 
2.4.2 Promoting a BER of the Asymmetric Substrates 
Attempts at promoting a BER of phenyl diketone 67 were made first (Table 2.33). 
 
Entry Temperature Additives Reaction 
Time 
Conversion to hemiacetal 
154 
1 40 °C - 18 h 0% 
2 60 °C - 22 h 10 
3 50 °C 1 eq. pyridine 66 h 100% 
4 50 °C 1 eq. 2,6-lutidine 66 h 100% 
Reagents and Conditions; (a) 1 eq. CuCl, MeOH. 
Table 2.33 – Attempts to promote a BER of phenyl diketone 67 using CuCl, with and 
without additives. 
In light of the interesting observations regarding copper-pyridyl complexation when 
promoting a BER of tolyl diketone 56 (see Table 2.24), it was decided to try and 
promote the BER of phenyl diketone 67 with copper based Lewis acids. When using 
CuCl as a promoter alone at 40 °C, no reaction was observed (entry 1). Increasing 
the temperature to 60 °C gave a 10% conversion to previously unreported 
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hemiacetal 154 (entry 2). As phenyl groups are known to be poorer migrating 
groups than benzyl groups, it is likely that this is the reason for the failure of the 
reaction. The use of pyridine (entry 3) and 2,6-lutidine (entry 4) as additives in the 
reactions only increased the conversion to hemiacetal 154. 
In view of time limitations, it was decided to focus further studies on benzyl 
diketone 65 (Scheme 2.49). 
 
Reagents and Conditions; (a) 1 eq. CuCl, MeOH, 50 °C, 20 h (86%). 
Scheme 2.49 – BER of benzyl diketone 65. 
As expected, the tautomers obtained from the oxidation with IBX (see Scheme 2.48) 
are in equilibrium under the Lewis acid promoted BER conditions, and so full 
conversion to α-hydroxy ester 66 was observed from a mixture of starting materials 
using CuCl as promoter in a yield of 86%. As the enantiomers of ester 66 have 
previously been assigned,138 only separation of the enantiomers by chiral HPLC and 
comparison of optical rotation values is required for rationalising any 
stereoselectivity obtained. 
Unfortunately, time constraints did not permit the exploration of chiral catalysts to 
effect an asymmetric BER though the planned strategy to achieve this is described 
in the future work section below. 
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3 Conclusions 
In summary, the first synthesis of (±)-hydroxy-iso-evoninic acid has been achieved. 
By obtaining the optical rotations for the enantiomers of both possible 
diastereoisomers, the assignment of naturally occurring hydroxy-iso-evoninic acid is 
now possible if e.g. hydrolysis of one of the Celastraceae sesquiterpenoids is 
performed. 
A diastereoselective BER has been developed allowing a specific diastereoisomer to 
be targeted by altering the reaction conditions. Although the levels of dr are not yet 
optimal, tunable conditions have been demonstrated for the first time in a BER 
reaction. 
All intermediates en route to euonyminol model 58 have been fully characterised 
despite the unexpected failure of the final methyl addition to ketone 147. 
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4 Future Work 
4.1 Assigning the Naturally Occurring Stereochemistry 
It is likely that the formation of an enolate of the acetate group is interfering in the 
Grignard reagent addition to ketone 147. Therefore, when repeating the synthesis 
from chiral epoxy alcohol 137, a different non-enolisable protecting group will be 
introduced. 
After completion of the synthesis of euonyminol model 58, conditions for methyl 
ether deprotection will be explored (Scheme 4.1). 
 
Scheme 4.1 – Required methyl ether deprotection of model euonyminol 58. 
Due to the stability of model compound 58, there is high confidence that one of the 
many known methyl ether deprotection methods, including Me3SiI,
139 BBr3,
140 
AlX3/EtSH,
141 AlCl3/TBAI,
142 SiCl4/NaI
143, will be successful in affording tetraol 
euonyminol model 155. 
As previously discussed, the formation of the 14-membered macrolactone of 
euonyminol model 155 with each of the stereoisomers of hydroxy-iso-evoninic acid 
is planned. Due to the high steric hindrance of addition to the aliphatic acid in 
hydroxy-iso-evoninic acid and as the aromatic acid has higher acidity, it is likely that 
this will esterify faster when subjected to carbodiimide coupling conditions (Figure 
2.16). 
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Figure 4.1 – Proposed selective esterification of the aromatic acid group. 
The rate determining step in DCC coupling reactions has been shown to be the 
formation of the O-acylisourea intermediate 156.144 Due to the higher acidity of the 
aromatic acid, O-acylisourea intermediate 156 should form selectively from the 
reaction with a carbodiimide. It can be expected that the only primary alcohol 
present in deprotected euonyminol model 155 will act as the nucleophile to form 
ester 157 from which a 3-step sequence to close the macrolide ring can be 
envisioned (Scheme 4.2). 
 
Scheme 4.2 – Proposed synthesis of macrocycle sesquiterpenoid model 59. 
Esterification of the remaining free acid with diazomethane would afford methyl 
ester 159 and based on the successful macrolactonisation performed by Yamada,61 
it is expected that treatment with NaH would afford 14-membered lactone 159. 
After acetylation of the secondary alcohol, the 1H and 13C NMR data of model 
sesquiterpenoids 59 containing all 4 possible stereochemistries will be compared to 
that reported for the natural Celastraceae sesquiterpenoids (see Tables 1.2 and 
1.3).  
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4.2 Asymmetric Synthesis of Hydroxy-iso-Evoninic Acid 
Once the stereochemistry of naturally occurring hydroxy-iso-evoninic acid has been 
assigned, an asymmetric synthesis targeting the correct enantiomer of the required 
diastereoisomer will be attempted. The absolute stereochemistry will be set up in 
the allylation of a 3-picoline derivative (Figure 4.2). 
 
Figure 4.2 – Required asymmetric allylation for the stereoselective synthesis of 
hydroxy-iso-evoninic acid. 
As previously discussed, 4-bromo-3-picoline is not very stable and requires a 3-step 
preparation from commercially available 3-picoline-N-oxide. Conversion of this aryl 
bromide to an aryl metal complex or aryl iodide to perform asymmetric allylation 
reactions is therefore unattractive. 
However, a recent report by Denmark et al. details the asymmetric cross-coupling 
reaction of aryl bromides and allylic silanoate 160 (Scheme 4.3).145 
 
Reagents and Condtions; (a) 2.5 mol% allylpalladium chloride dimer, 20 mol% ligand 161, toluene, 
70 °C, 6-24 h (66-78%, er > 98:2). 
Scheme 4.3 – Denmark’s asymmetric Pd-catalysed cross-coupling of allylic 
silanoates and aryl bromides.145 
A selection of aryl bromides were successfully coupled under these conditions, 
including a heterocycle and aryls containing ortho-substituents. All examples 
proceeded with high chirality transfer which was rationalised by consideration of 
the relevant transition states (Figure 4.3). 
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Figure 4.3 – Denmark’s proposed transition states to rationalise the high levels of 
chirality transfer. 
Due to the steric clash caused by the two alkyl groups in axial positions, no (Z)-
alkene containing product 163 was observed. Unfortunately, an investigation into 
different alkyl groups on the allylic moiety has not yet been reported. It is likely 
however, that two methyl substituents, as required for the synthesis of hydroxy-iso-
evoninic acid, would suffice to give a sufficient energy difference between the two 
possible transition states to allow for high levels of chirality transfer (Scheme 4.4). 
 
Scheme 4.4 – Proposed application of Denmark’s procedure to the synthesis of 
chiral alkene 83 en route to hydroxy-iso-evoninic acid. 
Although this method requires an 11-step synthetic sequence for the preparation of 
chiral allylic silanolate 160, the high levels of enantiomeric excess achievable, the 
number of suitable aryl bromides reported, and the avoidance of increasing the 
number of linear steps, makes this method attractive. 
The relative stereochemistry can then be controlled later in the synthesis by 
applying a diastereoselective BER as developed in this thesis. 
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4.3 Development of an Asymmetric BER 
With the selection and preparation of benzyl diketone 65 as the substrate with 
which to investigate an asymmetric variant of the BER now completed, catalytic 
conditions must be found to avoid the use of large amounts of potentially expensive 
chiral ligands. Although the BER can be promoted with sub-stoichiometric amounts 
of Lewis acid promoter,54 the rate of the reaction becomes too slow to be of 
synthetic use. As previously discussed, a dramatic rate increase was observed when 
using pyridyl additives with a CuCl2 promoter and this was postulated to be due to 
the formation of Cu-pyridyl complexes. It is therefore thought that success is likely 
when using chiral electron rich pyridine based ligands like those depicted below, 
with a copper-based Lewis acid (Figure 4.4). 
 
Figure 4.4 – Potential chiral catalysts for the promotion of an asymmetric BER. 
2,2’-Bipyridines,146 phenanthrolines,147 and electron rich BOX,148 PyBOX149 and 
QUIPHOS150 ligands that form complexes with Cu(I) and Cu(II) salts should be 
considered initially. 
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Experimental 
General Directions 
All reactions were performed under anhydrous conditions, in oven-dried glassware and 
under a nitrogen atmosphere. Anhydrous Solvents: MeCN, Et2O, CH2Cl2 and THF were 
used directly following passage under nitrogen through Al2O3 columns in a Grubb dry-
solvent system (Innovative Technology Inc.). MeOH was used after distillation over 
CaH2. Reagents: These were purchased from commercial sources and handled 
according to COSHH regulations. TMSCl was distilled over CaH2 prior to use. 
Chromatography: Flash chromatography (FC) was performed on silica gel (Merck 
Kieselgel 60 F254 230-400 mesh) and reverse phase chromatography on C18 silica gel 
(Fluka Kieselgel 90 F254 230-400 mesh) according to the method of W. C. Still.
151 Thin 
Layer Chromatography (TLC) was performed on Merck aluminium-backed plates pre-
coated with silica (0.2 mm, 60 F254) which were visualized either by quenching of 
ultraviolet fluorescence (λmax = 254 nm) or by charring with KMnO4 TLC dip. HPLC: see 
Appendices for conditions. Melting points: were determined on a Khofler hot stage. 
Infra red spectra: were recorded as neat liquids on Perkin-Elmer Paragon 1000 Fourier 
transform spectrometer. Only selected absorbances (νmax) are reported. 
1H NMR 
spectra: These were recorded at 400 MHz on a Bruker AMX-400 instrument. Chemical 
shifts (δH) are quoted in parts per million (ppm) and referenced to CDCl3 or D2O, the 
residual solvent peak. Coupling constants (J) are reported to the nearest 2 significant 
figures. 13C NMR spectra: These were recorded at 100 MHz on a Bruker AMX-400 
instrument. Chemical shifts (δC) are quoted in ppm and referenced to the CDCl3, the 
residual solvent peak. 13C multiplicities were determined by DEPT or/and by 
comparison of integrals. Mass spectra: Low resolution mass spectra (m/z) were 
recorded on either a VG platform II or VG AutoSpec spectrometers, with only 
molecular ions (M+, MH+, MNH4+) and major peaks being reported with intensities 
quoted as percentages of the base peak. High Resolution Mass Spectrometry (HRMS) 
measurements are valid to ± 5ppm. 
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(2S*,3R*)- and (2R*,3R*)-Methyl 2-hydroxy-2-methyl-3-(3-methylpyridin-4-
yl)butanoate (47a and 47b) 
 
Oxalyl chloride (229 µL, 2.71 mmol, 2.2 eq.) in CH2Cl2 (1.6 mL) was cooled to – 78 ˚C. 
DMSO (384 µL, 5.41 mmol, 4.4 eq) was added and the solution stirred for 5 min. 1,2-
Diol 82 (240 mg, 1.23 mmol, 1 eq.) in CH2Cl2 (1.5 mL) was added dropwise and the 
solution was stirred for a further 15 min. Triethylamine (1.02 mL, 7.38 mmol, 6 eq.) 
was added dropwise. After 3 min the reaction mixture was quickly pushed onto a short 
silica column while the solution was transferred via a pipette and then the column was 
eluted with CH2Cl2. After concentration in vacuo, the bright yellow liquid 1,2-diketone 
48 was redissolved in MeOH (25 mL) and ZnCl2 (203 mg, 1.23 mmol, 1 eq.) was added. 
The mixture was stirred at 40 ˚C for 18 h then concentrated in vacuo to leave a yellow 
oil. CH2Cl2 (20 mL) was added followed by NaHCO3 (aq.) (15 mL). The organic layer was 
removed and the aqueous layer was further extracted with CH2Cl2 (3 x 15 mL) and the 
combined organic extracts were dried over MgSO4 and concentrated in vacuo to leave 
a pale yellow oil. Purification by FC (1:49, MeOH/CH2Cl2) afforded esters 47a and 47b 
(235 mg, 1.05 mmol, 86%, dr 35:65) as a pale yellow oil. Rf 0.47 (MeOH/CH2Cl2, 1:9); 
νmax/cm
-1 (neat) 3505 (OH), 1730 (C=O), 1596 (pyr), 1452 (CH3), 1255 (CH), 1175 (C-O), 
1116 (C-O), 840 (C-O-C); 47a: δH (CDCl3, 400 MHz) 8.40-8.35 (2H, NCH), 7.49 (1H, d, J 
5.2 Hz, NCHCH), 3.89 (3H, s, OCH3), 3.43 (1H, q, J 7.0 Hz, ArCH), 2.38 (3H, s, ArCH3), 
1.20 (3H, s, COHCH3), 1.18 (3H, d, J 7.0 Hz, ArCHCH3); δC (CDCl3, 100 MHz) 177.30 (s), 
150.60 (d), 149.45 (s), 147.38 (d), 131.81 (s), 123.08 (d), 76.87 (s), 53.12 (q), 40.53 (d), 
24.59 (q), 16.90 (q), 16.20 (q). 47b: δH (CDCl3, 400 MHz) 8.40-8.35 (2H, NCH), 7.47 (1H, 
d, J 5.2 Hz, NCHCH), 3.54 (3H, s, OCH3), 3.35 (1H, q, J 7.2 Hz, ArCH), 2.30 (3H, s, ArCH3), 
1.55 (3H, s, COHCH3), 1.35 (3H, d, J 7.0 Hz, ArCHCH3); δC (CDCl3, 100 MHz) 176.69 (s), 
150.64 (d), 150.53 (s), 147.46 (d), 130.73 (s), 122.05 (d), 76.42 (s), 52.41 (q), 40.90 (d), 
25.31 (q), 16.24 (q), 14.92 (q); MS (ESI) m/z 224 (MH+, 100), 225 (13); HRMS (ESI) 
224.1281 calcd for C12H18NO3
+ (MH+), found 224.1281, Δ = 0.0 ppm. 
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(-)- (2S,3R)-Methyl 2-hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoate (47a) 
 
After the above procedure a small sample of (-)-(S,R)-ester 47a was isolated as white 
crystals by chiral HPLC using an analytical IC column (see Appendix). Data as above. mp 
54-56 ˚C (CH2Cl2); *α+
25
D -8.4 (c = 0.33, CH2Cl2).  
 (+)-(2S,3S)-Methyl 2-hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoate (47b) 
 
After the above procedure a small sample of (+)-(S,S)-ester 47b was isolated as a white 
soide by chiral HPLC using a semi-prep OD-H column. Data as above. mp 55-57 ˚C 
(CH2Cl2); *α+
25
D +11.2 (c = 0.92, CH2Cl2). 
(±)-4-(3-Methylpyridin-4-yl)pentane-2,3-dione (48) 
 
Oxalyl chloride (464 µL, 3.21 mmol, 2.2 eq.) in CH2Cl2 (2 mL) was cooled to – 78 ˚C. 
DMSO (278 µL, 6.42 mmol, 4.4 eq) was added and the solution stirred for 5 min. 1,2-
Diol 82 (290 mg, 1.49 mmol, 1 eq.) in CH2Cl2 (1.5 mL) was added dropwise and the 
solution was stirred for a further 15 min. Triethylamine (1.24 mL, 8.94 mmol, 6 eq.) 
was added dropwise. After 3 min the reaction mixture was quickly pushed onto a short 
silica column while the solution was transferred via a pipette and then the column was 
eluted with CH2Cl2. Purification by FC (MeOH/CH2Cl2, 0:100 to 1:99) afforded 1,2-
diketone 48 (214 mg, 1.12 mmol, 75%) as a bright yellow liquid. Rf 0.45 (MeOH/CH2Cl2, 
1:19); νmax/cm
-1 (neat) 2982 (CH3), 2930 (CH3), 1716 (C=O), 1594 (pyr), 1405 (CH), 1031 
(pyr), 954 (CH); δH (CDCl3, 400 MHz) 8.59 (1H, s, NCH), 8.52 (1H, d, J 5.6 Hz, NCHCH), 
7.31 (1H, d, J 5.6 Hz, NCHCH), 4.84 (1H, q, J 7.0 Hz, ArCH), 2.54 (3H, s, ArCH3), 2.34 (3H, 
s, COCH3), 1.45 (3H, d, J 7.0 Hz, ArCHCH3); δC (CDCl3, 100 MHz) 197.72 (s), 196.89 (s), 
151.56 (d), 147.90 (d), 146.13 (s), 131.68 (s), 121.19 (d), 40.43 (d), 24.34 (q), 16.22 (q), 
15.94 (q); MS (ESI) m/z 192 (MH+, 100), 193 (16), 233 (7), 251 (6); HRMS (ESI) 192.1019 
calcd for C11H14NO2
+ (MH+), found 192.1020, Δ = +0.5 ppm. 
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(±)-4-ortho-Tolylpentane-2,3-dione (52) 
 
Solid IBX (10.1 g, 59% pure by 1H NMR, 21.2 mmol, 2.5 eq.) was added to 1,2-diol 104 
(1.65 g, 8.48 mmol, 1 eq.) in DMSO (10 mL) and the mixture was stirred at room 
temperature for 19 h. The resulting suspension was passed through a pad of Celite® 
washing with CH2Cl2. The filtrate was washed with water (30 mL), dried over MgSO4 
and concentrated in vacuo to leave a bright yellow oil. Purification by FC 
(CH2Cl2/hexane, 1:4) afforded 1,2-diketone 52 (1.30 g, 6.83 mmol, 80%) as a bright 
yellow liquid. Rf 0.86 (CH2Cl2); νmax/cm
-1 (neat)2931 (CH3), 2873 (CH3), 1712 (C=O), 1453 
(CH3), 1355 (CH), 1029 (aromatic); δH (CDCl3, 400 MHz) 7.20 (1H, m, ArH), 7.15 (2H, m, 
ArH), 6.94 (1H, m, ArH), 4.77 (1H, q, J 6.8 Hz, ArCHCH3), 2.46 (3H, s, ArCH3), 2.24 (3H, s, 
COCH3), 1.38 (3H, d, J 6.8 Hz, ArCHCH3); δC (CDCl3, 100 MHz) 199.32 (s), 198.39 (s), 
136.89 (s), 136.56 (s), 131.23 (d), 127.43 (d), 126.72 (d), 126.52 (d), 40.96 (d), 24.80 
(q), 19.63 (q), 16.26 (q); MS (EI) m/z 190 (M+, 13), 147 (14), 119 (100), 85 (16), 71 (18); 
HRMS (EI) 190.0994 calcd for C12H14O2, found 190.0991, Δ = -1.6 ppm. 
(2S*,3R*)- and (2R*,3R*)-Methyl 2-hydroxy-2-methyl-3-phenylbutanoate (52a and 
53b)30 
 
Typical procedure (entry 3, Table 2.24): 
CuCl2 (15 mg, 0.114 mmol, 1 eq.) and 2,6-lutidine (13 µL, 0.114 mmol, 1 eq.) were 
added to 1,2-diketone 52 (20 mg, 0.114 mmol, 1 eq.) in MeOH (2 mL). The mixture was 
stirred at 40 °C for 66 h then diluted with CH2Cl2 (15 mL) and washed with brine (15 
mL). The organic layer was dried over MgSO4 then concentrated in vacuo. Purification 
by FC (CH2Cl2) afforded ester 53 (23 mg, 0.109 mmol, 97%, dr 47:53) as a clear oil. Data 
was consistent with that previously reported.30 53a: δH (CDCl3, 400 MHz) 7.37-7.23 
(5H, ArH), 3.79 (3H, s, OCH3), 3.13 (1H, m, ArCH), 1.53 (3H, s, C(OH)CH3), 1.43 (3H, d, J 
6.9 Hz, ArCHCH3). 53b: δH (CDCl3, 400 MHz) 7.37-7.23 (5H, ArH), 3.63 (3H, s, OCH3), 
3.13 (1H, m, ArCH), 1.28 (3H, d, J 7.0 Hz, ArCHCH3), 1.24 (3H, s, C(OH)CH3). MS (EI) m/z 
208 (8, M+), 105 (100), 91 (31), 43 (43). 
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(E)-4-(3-Picoline)but-3-en-2-one (54) 
 
4-Carbaldehyde-3-picoline (150 mg, 1.24 mmol, 1 eq.) and acetone (128 µL, 1.74 
mmol, 1.4 eq.) in EtOH (0.75 mL) and water (1.85 mL), was cooled to -10 °C. 10% NaOH 
(aq.) (1.51 mL) was added dropwise. The reaction was warmed to -4 °C over 50 min 
and was then neutralised with 1M HCl. 15% HCl/MeOH (15 mL) was added and the 
mixture was refluxed for 3 h. After allowing to cool to room temperature, the reaction 
mixture was neutralised with 1M NaOH and sat. NaHCO3 (aq.) and extracted with 
CH2Cl2 (4 x 20 mL). The combined organic extracts were dried over MgSO4 and then 
concentrated in vacuo to leave a yellow oil. Purification by FC (EtOAc/Et2O, 1:4 to 3:2) 
afforded enone 54 (124 mg, 0.768 mmol, 62%) as a pale yellow oil. Rf 0.35 
(EtOAc/Et2O, 1:4); νmax / cm
-1 (neat) 3392 (NH), 1674 (C=O), 1618 (C=N), 1361 (COCH3); 
δH (CDCl3, 400 MHz) 8.51 (2H, m, NCH), 7.70 (1H, d, J 16 Hz, COCHCH), 7.38 (1H, d, J 5.1 
Hz, NCHCH), 6.77 (1H, d, J 16 Hz, COCHCH), 2.43 (6H, s, CH3); δC (CDCl3, 400 MHz) 
197.60 (s), 151.87, 150.01, 148.08, 147.99, 137.80, 132.13, 120.07, 28.17 (q), 16.47 (q); 
MS (EI) m/z 161 (M+, 48), 146 (100), 117 (37), 91 (22); HRMS (EI) 161.0841 calcd for 
C10H11NO (M
+), found 161.0836, Δ = -3.1 ppm. 
or 
 
4-Bromo-3-picoline (54 mg, 0.314 mmol, 1 eq.) and MVK (90 µL, 1.26 mmol, 4 eq.) in 
DMF (1 mL) was added to a mixture of Pd(OAc)2 (7 mg, 0.0314 mmol, 0.1 eq.), PPh3 (31 
mg, 0.126 mmol, 0.4 eq.) and iPr2EtN (107 µL, 0.628 mmol, 2 eq.) in DMF (0.5 mL). The 
mixture was heated at 110 °C for 40 h then allowed to cool to room temperature and 
diluted with EtOAc. The suspension was passed through a plug of Celite® then 
concentrated in vacuo. Purification by FC (EtOAc/hexane, 1:19 to 1:4) afforded enone 
54 (7 mg, 0.0434 mmol, 14%) as a pale yellow oil. Data as above. 
 
 
  Experimental 
105 
 
or 
 
Aldehyde 69 (518 mg, 4.28 mmol, 1 eq.) and ylide 71 (2.88 g, 5.56 mmol, 1.3 eq.) were 
dissolved in water (20 mL) and heated at 100 °C for 2 h. After allowing to cool to room 
temperature, the aqueous solution was extracted with CH2Cl2 (4 x 30 mL) and the 
combined organic extracts were dried over MgSO4 then concentrated in vacuo to leave 
a pale yellow solid. Purification by FC (EtOAc/hexane, 1:9 to 1:4) afforded enone 54 
(380 mg, 2.36 mmol, 55%) as a pale yellow oil. Data as above. 
(2S*,3R*)-2-Hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoic acid and (2R*,3R*)-
2-Hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoic acid (55a and 55b) 
 
Ester 47 (27 mg, 0.121 mmol, dr 45:55) was dissolved in MeOH (2.7 mL) and 2M NaOH 
(2.7 mL) was added. The solution was stirred at 65 °C for 2 h after which time it had 
turned pale yellow. The solution was acidified to pH 5 with 2M HCl then concentrated 
in vacuo to leave a white solid. MeCN (10 mL) was added and the solution was 
sonicated for 15 min. The resulting suspension was purified by reverse phase C18 FC 
(MeCN) to afford monoacid 55 (21 mg, 0.100 mmol, 83%, dr 45:55) as a white solid. Rf 
0.15 (MeCN/H2O, 4:1); mp 108-109 °C (MeCN); νmax/cm
-1 (neat) 3379 (OH), 2974 (CH), 
1721 (C=O), 1636 (pyr), 1488 (pyr), 1254 (CH), 1167 (C-O), 829. 55a: δH (D2O, 400 MHz) 
8.54 (1H, s, NCH), 8.49 (1H, d, J 6.0 Hz, NCHCH), 8.08 (1H, d, J 6.2 Hz, NCHCH), 3.77 (1H, 
q, J 6.5 Hz, ArCH), 2.68 (1H, s, CCH3OH), 2.54 (3H, s, ArCH3), 1.26 (3H, d, J 7.7 Hz, 
ArCHCH3), 1.22 (3H, s, CCH3OH); δC (D2O, 100 MHz) 161.58 (s), 146.80 (s), 137.21 (d), 
139.62 (d), 136.38 (d), 125.70 (s), 48.03 (s), 40.59 (d), 22.62 (q), 15.26 (q), 13.14 (q). 
55b: δH (D2O, 400 MHz) 8.48 (1H, s, NCH), 8.45 (1H, d, J 5.5 Hz, NCHCH), 8.17 (1H, d, J 
5.9 Hz, NCHCH), 3.70 (1H, q, J 6.5 Hz, ArCH), 2.51 (1H, s, CCH3OH), 2.48 (3H, s, ArCH3), 
1.58 (3H, s, CCH3OH), 1.33 (3H, d, J 7.0 Hz, ArCHCH3); δC (D2O, 100 MHz) 162.86 (s), 
146.80 (s), 139.67 (d), 136.85 (d), 136.73 (d), 124.95 (s), 48.03 (s), 40.63 (d), 23.32 (q), 
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15.78 (q), 14.18 (q); MS (ESI) m/z 208 (22), 210 (MH+, 100), 213 (34), 215 (13); HRMS 
(ESI) 210.1125 calcd for C11H16NO3
+ (MH+), found 210.1052, Δ = -3.4 ppm. 
 (+)-(2S,3R)-2-Hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoic acid (55a) 
 
Ester (-)-47a (9 mg, 0.0403 mmol) was dissolved in MeOH (0.9 mL) and 1M NaOH (1 
mL) was added. The solution was heated at 60 °C for 1 h then concentrated in vacuo to 
remove MeOH. The aqueous solution was acidified to pH 5 with 1M HCl then 
concentrated under a flow of nitrogen to afford a white solid. MeCN (10 mL) was 
added and the mixture was sonicated for 15 min then passed through a pad of C18 
silica eluting with MeCN. Concentration under a flow of nitrogen afforded monoacid 
(+)-55a (2.5 mg, 0.0119 mmol, 30%) as a clear oil. Data as above. *α+20D +31.6 (c = 0.25, 
MeCN). 
(-)-(2S,3S)-2-Hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoic acid (55b) 
 
Ester (+)-47b (13 mg, 0.0582 mmol) was dissolved in MeOH (1.3 mL) and 2M NaOH (1.3 
mL) was added. The solution was heated at 60 °C for 1 h then concentrated in vacuo to 
remove all MeOH. The aqueous solution was acidified to pH 5 with 1M HCl then 
concentrated in vacuo to afford a white solid. MeCN (15 mL) was added and the 
mixture was sonicated for 15 min then passed through a pad of C18 silica eluting with 
MeCN to afford monoacid (-)-55b (10 mg, 0.0478 mmol, 82%) as a clear oil. Data as 
above. *α+20D -0.5 (c = 1.0, MeCN). 
(2S*, 3R*)- and (2R*, 3R*)-Methyl 2-hydroxy-2-methyl-3-ortho-tolylbutanoate (57a 
and 57b)  
 
A typical procedure for a Lewis acid promoted BER (entry 1, Table 2.14): 
Diketone 56 (35 mg, 0.184 mmol, 1 eq.) was dissolved in MeOH and warmed to 40 °C 
before CuCl (18 mg, 0.184 mmol, 1 eq.) was added. The solution was held at 40 °C for 3 
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d, then diluted with CH2Cl2 (10 mL) followed by the addition of brine (10 mL). The 
organic layer was extracted and the aqueous layer was further extracted with CH2Cl2 (3 
x 10 mL). The combined organic extracts were dried over MgSO4 and concentrated in 
vacuo to leave a yellow oil. Purification by FC (CH2Cl2) afforded an inseparable mixture 
of esters 57a and 57b (61 mg, 0.274 mmol, 80%, dr 45:55) as a clear oil. Rf 0.45 
(CH2Cl2); νmax/cm
-1 (neat) 3521 (OH), 1733 (C=O), 1456 (CH3), 1251 (ArH), 1162 
(R3COH). 57a: δH (CDCl3, 400 MHz) 7.22-7.09 (4H, m, ArH), 3.87 (3H, s, OCH3), 3.47 (1H, 
q, J 7.0 Hz, ArCHCH3), 2.40 (3H, s, ArCH3), 1.22 (3H, s, COHCH3), 1.20 (3H, d, J 7.1 Hz, 
ArCHCH3); δC (CDCl3, 100 MHz) 177.99 (s), 140.25 (s), 135.13 (s), 130.17 (d), 128.22 (d), 
126.43 (d), 126.12 (d), 77.53 (s), 53.06 (q), 24.53 (d), 19.68 (q), 16.74 (q), 15.41 (q). 
57b: δH (CDCl3, 400 MHz) 7.22-7.09 (4H, m, ArH), 3.52 (3H, s, OCH3), 3.40 (1H, q, J 7.1 
Hz, ArCHCH3), 2.32 (3H, s, ArCH3), 1.54 (3H, s, COHCH3), 1.36 (3H, d, J 7.1 Hz, ArCHCH3); 
δC (CDCl3, 100 MHz) 177.24 (s), 141.27 (s), 136.25 (s), 130.03 (d), 127.28 (d), 126.48 (d), 
126.07 (d), 76.92 (s), 52.30 (q), 24.95 (d), 20.39 (q), 16.75 (q), 15.41 (q). MS (EI) m/z 
222 (M+, 5), 119 (100), 84 (29), 49 (37); HRMS (EI) 222.1256 calcd for C13H18O3 (M
+), 
found 222.1259, Δ = +1.4 ppm. 
A typical procedure for a base promoted BER (entry 3, Table 2.19): 
Diketone 56 (30 mg, 0.158 mmol, 1 eq.) was dissolved in MeOH (3 mL) and warmed to 
40 °C. NaOH (50.5 mg, 1.262 mmol, 8 eq.) was added and the solution was stirred at 40 
°C for a further 16 h. The solution was diluted with CH2Cl2 (10 mL) and brine was added 
(10 mL). The organic layer was extracted and the aqueous layer was further extracted 
with CH2Cl2 (3 x 15 mL). The combined organic extracts were dried over MgSO4 and 
concentrated in vacuo to leave an orange oil. Purification by FC (CH2Cl2) afforded an 
inseparable mixture of esters 57a and 57b (12 mg, 0.054 mmol, 34%, dr 68:32) as a 
clear oil. Data as above. 
1-Phenylbutane-2,3-dione and (3Z)-3-Hydroxy-4-phenylbut-3-en-2-one (65)152 
 
1,2-Diol 153 (85 mg, 0.511 mmol, 1 eq.) was dissolved in DMSO (1 mL) and IBX (358 
mg, 1.28 mmol, 2.5 eq.) was added. The solution was allowed to stir at room 
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temperature for 16 h after which time it had turned bright yellow. CH2Cl2 (10 mL) was 
added and the suspension was passed through a plug of Celite® then washed with 
water (3 x 15 mL). The organic extract was dried over MgSO4 then concentrated in 
vacuo to afford a bright yellow liquid. Purification by FC (CH2Cl2) afforded 1,2-diketone 
65 (23 mg, 0.117 mmol, 23%, ketone:enol 45:55) as a bright yellow liquid. Data was 
consistent with that previously reported.152 Dione: Rf 0.65 (CH2Cl2); δH (CDCl3, 400 
MHz) 7.87 (2H, d, J 7.4 Hz, ArH), 7.45-7.23 (3H, ArH), 4.08 (2H, s, ArCH2), 2.35 (3H, s, 
COCH3). Enol: Rf 0.65 (CH2Cl2); δH (CDCl3, 400 MHz) 7.87 (2H, d, J 7.4 Hz, ArCH), 7.45-
7.23 (3H, ArH), 6.49 (1H, d, J 0.84 Hz, ArCH), 2.55 (3H, s, COCH3). MS (CI) m/z 163 (29, 
MH+), 180 (100, MNH4
+), 181 (24). 
(±)-2-Hydroxy-2-methyl-3-phenyl-propionic acid methyl ester (66)153 
 
Diketone 65 (3 mg, 0.0185 mmol, 1 eq.) was dissolved in MeOH (0.5 mL) and CuCl (2.7 
mg, 0.0185 mmol, 1 eq.) was added. The mixture was heated at 50 °C for 20 h the 
concentrated in vacuo. The resulting oil was dissolved in CH2Cl2 (10 mL) then washed 
with sat. NaHCO3 (aq.) (10 mL) and the organic extract was dried over MgSO4 then 
concentrated in vacuo to afford a clear film. Purification by FC (CH2Cl2) afforded methyl 
ester 66 (3.1 mg, 0.0160 mmol, 86%) as a clear film. Data was consistent with that 
previously reported.138,153 Rf 0.40 (CH2Cl2); δH (CDCl3, 400 MHz) 7.31-7.19 (5H, ArH), 
3.76 (3H, s, OCH3), 3.11 (1H, d, J 13 Hz, ArCHH), 3.04 (1H, s, OH), 2.94 (1H, d, J 13 Hz, 
ArCHH), 1.53 (3H, s, C(OH)CH3); MS (CI) m/z 213 (13), 212 (100, MNH4
+), 210 (16). 
1-Phenyl-1,2-propanedione (67)136 
 
Alkyne 149 (0.5 mL, 3.99 mmol, 1 eq.) was dissolved in a mixture of CCl4 (18 mL), 
MeCN (18 mL) and H2O (27 mL). NaIO4 (3.5 g, 16.4 mmol, 4.1 eq.) was added and the 
biphasic mixture was stirred vigorously for 5 min at room temperature before 
RuO2·XH2O (15 mg, 0.0828 mmol, 0.022 eq.) was added, turning the mixture black. 
After stirring for a further 1 h, H2O (70 mL) was added and the organic layer was 
removed. The aqueous layer was further extracted with CH2Cl2 (3 x 40 mL) and the 
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combined organic extracts were dried over MgSO4 and concentrated in vacuo. 
Purification by FC (CH2Cl2) afforded diketone 67 (422 mg, 2.85 mmol, 72%) as a bright 
yellow liquid. Data was consistent with that previously reported.154 Rf 0.70 (CH2Cl2); δH 
(CDCl3, 400 MHz) 8.04 (2H, d, J 8.1 Hz, o-H), 7.68 (1H, td, J 7.7 and 0.8 Hz, p-H), 7.53 
(2H, t, J 7.4 Hz, m-H), 2.56 (3H, s, C(O)CH3); MS (EI) m/z 148 (6, M
+), 105 (100, [M-
C(O)CH3]
+), 77 (62, [M-(CO)2CH3]
+), 51 (22). 
4-Carbaldehyde-3-picoline (69)63 
 
SeO2 (9.09 g, 81.9 mmol, 2.3 eq.) was stirred in 1,4-dioxane (8 mL) at room 
temperature and 3,4-lutidine (4 mL, 35.6 mmol, 1 eq.) was added dropwise. The 
reaction mixture was heated at 105 °C for 20 h and was filtered while hot, washing 
with ether and hot water. The filtrate was concentrated in vacuo, then water (50 mL) 
was added and the resulting suspension was extracted with CH2Cl2 (3 x 50 ml). The 
organic extracts were combined and dried over MgSO4 then concentrated in vacuo. 
Purification by FC (EtOAc/hexane, 1:4) yielded 4-carbaldehyde-3-picoline (2.03 g, 16.8 
mmol, 47%) as a pale yellow oil. Data was consistent with that previously reported.63 Rf 
0.42 (EtOAc/hexane, 1:4); δH (CDCl3, 400 MHz) 10.34 (1H, s, CHO), 8.72 (1H, d, J 4.9 Hz, 
NCHCH), 8.65 (1H, s, NCH),7.62 (1H, d, J 4.9 Hz, NCHCH), 2.66 (3H, s, CH3); MS (EI) m/z 
121 (M+, 100), 92 (73), 84 (60), 65 (48), 49 (78). 
4-Bromo-3-picoline (70)71 
 
4-Bromo-3-picoline-N-oxide (300 mg, 1.60 mmol, 1 eq.) was dissolved in EtOAc (20 mL) 
and PBr3 (0.60 mL, 6.38 mmol, 4 eq.) was added dropwise. The reaction was heated at 
70 °C for 30 min then allowed to cool to room temperature and extracted with Et2O 
(30 mL). The aqueous layer was basified to pH 10 with NaOH (aq.) then extracted with 
Et2O (5 x 30 mL). The combined organic extracts were then dried over MgSO4 and 
concentrated in vacuo to leave a pale yellow oil. Purification by FC (MeOH/CH2Cl2, 
1:49) afforded 4-bromo-3-picoline (210 mg, 1.22 mmol, 76%) as a pale yellow oil. Data 
was consistent with that previously reported.71 Rf 0.35 (MeOH/CH2Cl2, 1:19); δH (CDCl3, 
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400 MHz) 8.44 (1H, s, NCH), 8.25 (1H, d, J 4 Hz, NCHCH), 7.50 (1H, d, J 4 Hz, NCHCH); 
MS (EI) m/z 173 (M+, 98), 171 (M+, 100), 92 (64), 65 (59). 
4-Nitro-3-picoline-N-oxide (75)69 
 
3-Picoline-N-oxide (10 g, 91.6 mmol) was dissolved in conc. H2SO4 (35 mL) and cooled 
to 0 °C. HNO3 (27.5 mL) was added dropwise and the mixture was heated at 100 °C for 
2 h. The reaction mixture was cooled to 0 °C and water was added dropwise followed 
by Na2CO3 (aq.) until no more precipitate formed. The mixture was filtered under 
suction washing with water to leave a pale yellow solid. The solid was purified by FC 
(EtOAc/hexane, 2:3 to 7:3) to yield 4-nitro-3-picoline-N-oxide (7.46 g, 48.4 mmol, 53%) 
as yellow crystals. Data was consistent with that previously reported.69 Rf 0.55 
(MeOH/CH2Cl2, 1:20); mp 135-136 °C (CHCl3); δH (CDCl3, 400 MHz) 8.15 (1H, s, NCH), 
8.12 (1H, d, J 7.1 Hz, NCHCH), 8.03 (1H, d, J 7.1 Hz, NCHCH), 2.62 (3H, s, CH3); MS (EI) 
m/z 154 (M+, 100), 137 (11), 124 (9), 83 (15). 
4-Bromo-3-picolin-N-oxide (77)71 
 
4-Nitro-3-picoline-N-oxide (6.71 g, 43.6 mmol, 1 eq.) was dissolved in AcOH (92 mL) 
under a nitrogen atmosphere. AcBr (54.6 mL, 739 mmol, 17 eq.) was added dropwise 
and the reaction was stirred at 80 °C for 3 h, then allowed to cool to room 
temperature. Water (40 mL) was added and the mixture was neutralised with 1M 
NaOH and extracted with CH2Cl2 (5 x 30 mL). The combined organic extracts were dried 
over MgSO4 and concentrated in vacuo. Purification by FC (MeOH/CH2Cl2, 1:20) 
afforded 4-bromo-3-picoline-N-oxide (7.60 g, 40.4 mmol, 93%) as a white solid. Data 
was consistent with that previously reported.71 Rf 0.52 (MeOH/CH2Cl2, 1:9); δH (CDCl3) 
8.13 (1H, s, NCH), 7.96 (1H, d, J 6.2 Hz, NCHCH), 7.53 (1H, d, J 6.2 Hz, NCHCH), 2.34 (3H, 
s, CH3); MS (EI) m/z 189 (M
+, 98), 187 (M+, 100), 173 (24), 171 (25), 92 (21). 
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1-[(2R*,3S*)-3-(3-Methylpyridin-4-yl)oxiran-2-yl]ethan-1-one (78) 
 
Enone 54 (154 mg, 0.955 mmol, 1 eq.) was dissolved in MeOH (1.5 mL) and cooled to 0 
°C. 35% H2O2 (aq.) (300 µL, 3.09 mmol, 3.3 eq.) was added dropwise followed by 2M 
NaOH (296 µL). The reaction was stirred at 0 °C for 15 min and then allowed to warm 
to room temperature. After 1.5 h, the reaction was quenched with sat. Na2S2O3 (aq.) 
and neutralised with NaHCO3 (aq.). The mixture was extracted with CH2Cl2 (4 x 25 mL) 
and the combined organic extracts were dried over MgSO4, then concentrated in vacuo 
to leave a yellow oil. Purification by FC (EtOAc/Et2O, 3:17) afforded epoxy ketone 78 
(110 mg, 0.621 mmol, 65%) as a clear oil; Rf 0.27 (EtOAc/Et2O, 3:7); δH (CDCl3, 400 
MHz) 8.48 (1H, d, J 5 Hz, NCH), 8.44 (1H, s, NCHCH), 7.14 (1H, d, J 5 Hz, NCHCH), 4.12 
(1H, d, J 1.5 Hz, CHCOCH3), 3.39 (1H, d, J 1.5 Hz, ArCH), 2.38 (3H, s, ArCH3), 2.25 (3H, s, 
COCH3); δC (CDCl3, 400 MHz) 203.41 (s), 150.66 (s), 148.18 (d), 142.31 (d), 130.95 (s), 
118.29 (d), 62.12 (d), 54.50 (d), 24.93 (q), 25.65 (q); MS (EI) m/z 177 (M+, 29), 134 (19), 
120 (12), 107 (18), 85 (22), 43 (100); HRMS (EI) 177.0790 calcd for C10H11NO2 (M
+), 
found 177.0788, Δ = -1.1 ppm 
2-[(2R*,3S*)3-(3-Methylpyridin-4-yl)oxiran-2-yl]propan-2-ol (80) 
 
Epoxy ketone 78 (61 mg, 0.344 mmol, 1 eq.) was dissolved in CH2Cl2 (2 mL) and water 
(25 µL, 1.38 mmol, 4 eq.) and then cooled to -78 °C. Me3Al (2M solution in hexane, 690 
µL, 1.38 mmol, 4 eq.) was added dropwise and the reaction mixture was stirred at -78 
°C for 1 h then allowed to warm to 0 °C and stirred for a further 1 h. The reaction was 
quenched with sat. NH4Cl (aq.) and allowed to warm to room temperature. The 
mixture was then extracted with CH2Cl2 (3 x 20 mL) and the combined organic extracts 
were dried over MgSO4 then concentrated in vacuo to leave a yellow oil (123 mg). 
Purification by FC (EtOAc/Et2O, 1:4 to 1:1) afforded epoxy alcohol 80 (54 mg, 0.279 
mmol, 81%) as a clear oil. Rf 0.20 (EtOAc/Et2O, 1:4); νmax/cm
-1 (neat) 3229 (OH), 2974 
(CH3), 1601 (C=N), 1451 (C=C), 1408 (CH), 1378 (epoxide), 1186 (C-O),1105 (C-O); δH 
(CDCl3, 400 MHz) 8.44 (1H, d, J 5.0 Hz, NCHCH), 8.39 (1H, s, NCH), 7.17 (1H, d, J 5.0 Hz, 
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NCHCH), 4.09 (1H, d, J 2.1 Hz, ArCH), 2.86 (1H, d, J 2.1 Hz, CHCOH(CH3)2), 2.39 (3H, s, 
ArCH3), 1.42 (3H, s, COH(CH3)2), 1.36 (3H, s, COH(CH3)2); δC (CDCl3, 400 MHz) 149.88, 
147.69, 144.94, 130.66 (s), 118.50 (d), 68.43 (d), 67.72 (s), 52.26 (d), 27.72 (q), 25.27 
(q), 15.78 (q); MS (CI+) m/z 210 (MNH4
+,48), 194 (MH+, 100); HRMS (CI+) 194.1176 calcd 
for C11H16NO2 (MH
+), found 194.1182, Δ = +3.1 ppm. 
(R*)-1-[(2R*,3R*)- and (S*)-1-[(2R*,3R*)-3-(3-Methylpyridin-4-yl)oxiran-2-yl]ethanol 
(81) 
 
Epoxy ketone 78 (369 mg, 2.08 mmol, 1 eq.) was dissolved in anhydrous MeOH (6 mL) 
and cooled to 0 °C. NaBH4 (87 mg, 2.29 mmol, 1.1eq.) in MeOH (8 mL) was added 
dropwise and the reaction was stirred at 0 °C for 1 h 15 min, then at room temperature 
for a further 15 min. Water (5 mL) was added and the mixture was concentrated in 
vacuo to remove all MeOH, then extracted with CH2Cl2 (3 x 25 mL). The combined 
organic extracts were dried over MgSO4 and concentrated in vacuo to leave a pale 
yellow oil (393 mg). Purification by FC (EtOAc/Et2O, 1:2 to 2:3) afforded epoxy alcohol 
81 (311 mg, 1.73 mmol, 84%, dr 57:43) as a pale yellow oil. Rf 0.20 (EtOAc/Et2O, 1:2); 
νmax / cm
-1 (neat) 3228 (OH), 2972 (CH3), 1602 (C=N), 1450 (C=C), 1408 (CH), 1372 
(epoxide), 1106 (C-O), 1060 (C-O). Major diastereoisomer: δH (CDCl3, 400 MHz) 8.40 
(1H, d, J 5.0 Hz, NCHCH), 8.35 (1H, s, NCH), 7.12 (1H, d, J 5.0 Hz, NCHCH), 4.12 (1H, qd, 
J 6.4 and 2.9 Hz, CHOH), 4.06 (1H, d, J 2.0 Hz, ArCHO), 2.90 (1H, m, ArCHCH), 2.36 (3H, 
s, ArCH3), 1.35 (3H, d, J 6.4 Hz, CHOHCH3); δC (CDCl3, 400 MHz) 149.97 (d), 147.73 (d), 
144.84 (d), 130.77 (s), 118.49 (s), 65.66 (d), 64.38 (d), 51.46 (d), 19.20 (q), 15.72 (q). 
Minor diastereoisomer: δH (CDCl3, 400 MHz) 8.40 (1H, d, J 5.0 Hz, NCHCH), 8.35 (1H, s, 
NCH), 7.12 (1H, d, J 5.0 Hz, NCHCH), 3.96 (1H, d, J 2.0 Hz, ArCHO), 3.89 (1H, qd, J 6.5 
and 1.6 Hz, CHOH), 2.90 (1H, m, ArCHCH), 2.35 (3H, s, ArCH3), 1.37 (3H, d, J 6.5 Hz, 
CHOHCH3); δC (CDCl3, 400 MHz) 150.02 (d), 147.80 (d), 144.58 (d), 130.73 (s), 118.51 
(s), 66.96 (d), 66.05 (d), 53.02 (d), 20.02 (q), 15.72 (q). MS (EI) m/z 179 (M+, 9), 163 
(21), 136 (71), 122 (100), 106 (27), 94 (29), 58 (62); HRMS (EI) 179.0946 calcd for 
C10H13NO2 (M
+), found 179.0942, Δ = -2.2 ppm. 
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(2S*,3R*,4R*)- and (2R*,3S*,4R*)-4-(3-Methylpyridin-4-yl)pentane-2,3-diol (82) 
 
Epoxide 81 (1.60 g, 9.02 mmol, 1 eq., dr 52:48) was dissolved in MeCN (19 mL) and 
water (9.6 mL). 60% HClO4 (1.6 mL) was added dropwise and the solution was stirred 
at room temperature for 40 h. The solution was neutralised with sat. NaHCO3 (aq.) 
then concentrated in vacuo to remove all MeCN. The remaining aqueous solution was 
extracted with CH2Cl2 (4 x 30 mL) and the combined organic extracts were dried over 
MgSO4 then concentrated in vacuo to leave a pale yellow oil. Purification by FC 
(MeOH/CH2Cl2, 1:19) afforded 1,2-diol 82 (1.469 g, 7.52 mmol, 83%, dr 52:48) as a 
clear oil. Rf 0.34 (MeOH/CH2Cl2, 1:9); νmax/cm
-1 (neat) 3331 (OH), 2969 (CH3), 2926 
(CH3), 1600 (pyridyl), 1074 (C-O), 734 (pyridyl). Major diastereoisomer: δH (CDCl3, 400 
MHz) 8.40-8.30 (2H, NCH), 7.16 (1H, d, J 5.2 Hz, NCHCH), 4.00 (1H, qd, J 6.4 and 3.7 Hz, 
CHOHCH3), 3.87 (1H, dd, J 9.0 and 3.6 Hz, ArCHCHOH), 3.19-3.07 (1H, ArCH), 2.37 (3H, 
s, ArCH3), 1.19 (3H, d, J 7.0 Hz, ArCHCH3), 1.16 (3H, d, J 6.3 Hz, CHOHCH3); δC (CDCl3, 
100 MHz) 152.42 (s), 150.49 (d), 147.35 (d), 132.43 (s), 121.06 (d), 78.61 (d), 68.00 (d), 
37.05 (d), 16.99 (q), 16.64 (q), 16.01 (q). Minor diastereoisomer: δH (CDCl3, 400 MHz) 
8.40-8.30 (2H, NCH), 7.21 (1H, d, J 5.1 Hz, NCHCH), 3.81 (1H, dd, J 7.2 and 4.4 Hz, 
ArCHCHOH), 3.71 (1H, qd, J 6.3 and 4.5 Hz, CHOHCH3), 3.19-3.07 (1H, ArCH), 2.33 (3H, 
s, ArCH3), 1.34 (3H, d, J 6.9 Hz, ArCHCH3), 1.30 (3H, d, J 6.3 Hz, CHOHCH3); δC (CDCl3, 
100 MHz) 152.09 (s), 150.90 (d), 147.42 (d), 130.86 (s), 121.69 (d), 77.46 (d), 68.17 (d), 
36.47 (d), 17.56 (q), 16.62 (q), 16.28 (q). MS (ESI) m/z 196 (MH+, 100), 179 (4), 178 (7), 
150 (3); HRMS (ESI) 196.1332 calcd for C11H18NO2 (MH
+), found 196.1336, Δ = +2.4 
ppm. 
(±)-3-Methyl-4-[(E)-pent-3-en-2-yl]pyridine (83) 
 
Phosphonate ester 96 (9.74 g, 30.45 mmol, 1 eq.) was dissolved in THF (60 mL) and 
cooled to -78 ˚C. nBuLi (1.6 M solution in THF, 20.9 mL, 33.5 mmol, 1.1 eq.) was added 
dropwise and the brown solution was stirred at -78 ˚C for 40 min. Allylic bromide 84 
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(5.00 g, 33.5 mmol, 1.1 eq.) in THF (5 mL) was added dropwise and after 30 min the 
reaction mixture was allowed to warm to 0 ˚C and stirred for another 40 min. The 
mixture was cooled down to -78 ˚C again and nBuLi (1.6 M solution in THF, 41.8 mL, 
67.0 mmol, 2.2 eq.) was added. After the addition, the solution was allowed to warm 
to 0 ˚C and stirred for another 45 min. Et2O (20 mL) was added, followed by water (5 
mL). The mixture was concentrated in vacuo to leave an orange/yellow liquid. 
Purification by FC (1:9 to 1:3, EtOAc/hexane) afforded alkene 83 (2.60 g, 16.1 mmol, 
53%) as a pale yellow liquid. Rf 0.18 (EtOAc/hexane, 3:7); νmax/cm
-1
 (neat) 2965 (CH3), 
2929 (CH3), 2874 (CH3), 1593 (C=C), 1451 (pyridine), 1404 (pyridyl), 966 (CH), 834 (CH); 
δH (CDCl3, 400 MHz) 8.36 (1H, d, J 5.1 Hz, NCHCH), 8.31 (1H, s, NCH), 7.07 (1H, d, J 5.1 
Hz, NCHCH), 5.33-5.38 (2H, CHCHCH3), 3.58 (1H, p, J 6.9 Hz, ArCH), 2.27 (3H, s, ArCH3), 
1.66 (3H, dt, J 6.1 and 1.2 Hz, CHCHCH3), 1.29 (3H, d, J 7.1 Hz, ArCHCH3); δc (CDCl3, 100 
MHz) 152.97 (s), 150.81 (d), 147.81 (d), 133.78 (d), 130.99 (s), 125.02 (d), 120.92 (d), 
37.52 (d), 20.01 (q), 17.88 (q), 16.08 (q); MS (ESI) m/z 162 (MH+, 100), 155 (4), 150 (4), 
147 (4); HRMS (ESI) 162.1277 calcd for C11H16N
+ (MH+), found 162.1275, Δ = -1.2 ppm.  
(±)-(E)-4-Bromopent-2-ene (84)155 
 
3-Penten-2-ol (1 mL, 9.79 mmol, 1 eq.) was dissolved in Et2O (6 mL) and cooled to 0 °C. 
PBr3 (0.92 mL, 9.79 mmol, 1 eq.) was added dropwise. The solution was stirred at 0 °C 
for 2 h then allowed to warm to room temperature and stirred for a further 1 h. The 
yellow solution was cooled to 0 °C again and water (10 mL) was added dropwise. The 
aqueous layer was removed and the organic layer washed with water (2 x 10 mL). The 
organic layer was dried over MgSO4 and concentrated under a flow of nitrogen to 
afford allylic bromide 84 (986 mg, 6.62 mmol, 68%) as a pale yellow liquid. Data was 
consistent with that previously reported.156 δH (CDCl3, 400 MHz) 5.90-5.70 (2H, CHCH), 
4.73 (1H, p, J 6.8 Hz, CHBr), 1.79 (3H, d, J 6.6 Hz, CHBrCH3), 1.73 (3H, d, J 5.0 Hz, 
CHCHCH3); MS (EI) m/z 151 (MH
+, 9), 149 (MH+, 7), 111 (14), 109 (17), 97 (23), 95 (22), 
82 (98), 80 (100), 71 (39), 69 (54), 57 (56). 
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(±)-(E)-pent-3-en-2-yl acetate (85)157 
 
3-Penten-2-ol (4 mL, 39.2 mmol, 1 eq.) was dissolved in Et2O (40 mL). Pyridine (3.41 
mL, 43.1 mmol, 1.1 eq.) was added followed by Ac2O (4.07 mL, 43.1 mmol, 1.1 eq.). 
The solution was stirred at room temperature for 40 h then washed with 10% CuSO4 
(aq.) (2 x 20 mL). The organic layer was dried over MgSO4 then concentrated under a 
flow of nitrogen to afford allylic acetate 85 (3.42 g, 27.1 mmol, 69%) as a clear oil. Data 
was consistent with that previously reported.157 δH (CDCl3, 400 MHz) 5.76 (1H, ddd, J 
15, 6.3 and 0.8 Hz, CH=CH), 5.51 (1H, ddq, J 15, 5.4 and 1.5 Hz, CH=CH), 5.33 (1H, p, J 
6.5 Hz, CHOAc), 2.07 (3H, s, C(O)CH3), 1.72 (3H, dt, J 7.3 and 0.8 Hz, CHCH3), 1.31 (3H, 
d, J 6.5 Hz, CH(OAc)CH3). 
 (±)-(E)-Pent-3-en-2-yl picolinate (86)158 
 
2-Picolinic acid (2.89 g, 23.4 mmol, 1.2 eq.), DCC (5.25 g, 25.4 mmol, 1.3 eq.) and 4-
DMAP (2.87 g, 23.4 mmol, 1.2 eq.) were dissolved in CH2Cl2 (70 mL) and cooled to 0 °C. 
3-Penten-2-ol (2 mL, 19.6 mmol, 1 eq.) was added dropwise and after 10 min the 
reaction mixture was allowed to warm to room temperature and stirred for a further 1 
h. The reaction mixture was passed through a plug of silica eluting with CH2Cl2 and 
concentrated in vacuo to leave a pale yellow oil. Purification by FC (CH2Cl2) afforded 
(E)-pent-3-en-2-yl picolinate (3.56 g, 18.6 mmol, 95%) as a clear oil. Rf 0.60 
(MeOH/CH2Cl2, 1:9); δH (CDCl3, 400 MHz) 8.78 (1H, dd, J 4.1 and 1.7 Hz, NCH), 8.14 (1H, 
dd, J 7.8 and 1.1 Hz, NCCH), 7.84 (1H, dt, J 7.8 and 1.7 Hz, NCHCHCH), 7.47 (1H, ddd, J 
1.1, 4.8 and 7.7 Hz, NCHCH), 5.86 (1H, m, CHCH3), 5.67 (2H, m, CHO and CHOCH), 1.72 
(3H, d, J 6.8 Hz, CHOCH3), 1.49 (3H, d, J 6.2 Hz, CHCH3); δC (CDCl3, 400 MHz) 164.44 (s), 
149.82 (d), 148.53 (s), 136.86 (d), 130.34 (d), 129.03 (d), 126.63 (d), 125.02 (d), 72.94 
(d), 20.30 (q), 17.64 (q); MS (EI) m/z 190 (M+, 1), 146 (23), 124 (42), 120 (28), 106 (54), 
78 (90), 69 (100). 
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(±)-[(E)-pent-3-en-2-yloxy]trimethylsilane (87)159 
 
3-Penten-2-ol (0.2 mL, 1.96 mmol, 1 eq.) was dissolved in pyridine (0.33 mL) and 
cooled to 0 °C. TMSCl (273 µL, 2.15 mmol, 1.1 eq.) was added dropwise then the 
reaction mixture was allowed to warm to room temperature. Et2O (2 mL) was added to 
dissolve the white precipitate and the solution was stirred at room temperature for a 
further 2.5 h. The reaction was quenched with water (1 mL) and after addition of Et2O 
(10 mL), the organic layer was washed with 5% CuSO4 (aq.) (2 x 15 mL). The organic 
layer was dried over MgSO4 then concentrated under a flow of nitrogen to afford TMS 
ether 87 (200 mg, 1.41 mmol, 72%) as a clear oil. Data was consistent with that 
previously reported.159 δH (CDCl3, 400 MHz) 5.62-5.47 (2H, CH=CH), 4.26 (1H, p, J 6.3 
Hz, CHOTMS), 1.69 (3H, dt, J 6.0 and 0.88 Hz, CH=CHCH3), 1.23 (3H, d, J 6.2 Hz, 
CH(OTMS)CH3), 0.14 (9H, s, Si(CH3)3). 
(±)-Methyl (E)-pent-3-en-2-yl carbonate (88)160  
 
3-Penten-2-ol (0.5 mL, 4.89 mmol, 1 eq.) was dissolved in Et2O (5 mL) and pyridine (435 
µL, 5.38 mmol, 1.1 eq.) and cooled to 0 °C. Methyl chloroformate (416 µL, 5.38 mmol, 
1.1 eq.) was added dropwise and the mixture was allowed to warm to room 
temperature and stirred for a further 17 h. The mixture was filtered through a pad of 
Celite® then washed with 5% CuSO4 (aq.) (2 x 30 mL). The organic layer was dried over 
MgSO4 then concentrated under a flow of nitrogen to afford allylic formate ester 88 
(371 mg, 2.57 mmol, 53%) as a pale yellow oil. Data was consistent with that 
previously reported.160 δH (CDCl3, 400 MHz) 5.80 (1H, m, CH=CHCH3), 5.56 (1H, ddq, J 
14, 6.8 and 1.4 Hz, CH=CHCH3), 4.28 (1H, p, J 6.4 Hz, CH(OCO2CH3)), 3.78 (3H, s, OCH3), 
1.36 (3H, d, J 6.5 Hz, CH=CHCH3), 1.27 (3H, d, J 6.3 Hz, C(OR)CH3). 
(±)-Tributyl[(E)-pent-3-en-2-yl]stannane (89)161 
 
Bu3SnH (6.2 mL, 11.7 mmol, 1.5 eq.) was dissolved in THF (10 mL) and cooled to 0 °C. 
nBuLi (2.5M solution in hexane, 4.7 mL, 11.5 mmol, 1.5 eq.) was added dropwise and 
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the solution was stirred at 0 °C for 20 min. After cooling to -78 °C, Et2AlCl (1M solution 
in THF, 11.7 mL, 11.7 mmol, 1.5 eq.) was added and the solution was stirred at -78 °C 
for 1 h. A solution of Pd(PPh3)4 (225 mg, 0.195 mmol, 2.5 mol%) and allylic acetate 85 
(982 mg, 7.67 mmol, 1 eq.) in THF (2 mL) was added and the mixture was stirred at 0 °C 
for 30 min then room temperature for 18 h. The mixture was cooled in an ice bath and 
quenched with 26% NH3 (aq.) (2 mL). Water (20 mL) was added, then the mixture was 
extracted with Et2O (3 x 100 mL) and the combined organic extracts were dried over 
MgSO4 then concentrated in vacuo to afford a brown oil. Purification by FC (hexane) 
then washing the combined fractions with MeCN (2 x 40 mL) and concentrating in 
vacuo, afforded allylic stannane 89 (2.802 g, 5.46 mmol, 70%) contaminated with 30% 
tin impurities. Data was consistent with that previously reported.161 δH (CDCl3, 400 
MHz) 5.69 (1H, m, CH=CH), 5.17 (1H, ddd, J 15, 6.4 and 1.4 Hz, CH=CH), 2.12 (1H, p, J 
7.4 Hz, CHSn), 2.55-0.81 (33H, CH3 and CH2). 
(±)-1-Methyl-2-[(E)-pent-3-en-2-yl]benzene (92) 
 
2-Bromotoluene (990 µL, 8.23 mmol, 2 eq.) was added to magnesium turnings (200 
mg, 8.23 mmol, 2 eq.) in THF (4.5 mL). The mixture was heated at 65 °C for 2 h, after 
which time all the magnesium turnings had been consumed. After the reaction mixture 
had cooled to room temperature, it was transferred to a solution of CuBr·SMe2 (842 
mg, 4.11 mmol, 1 eq.) in THF (40 mL) at 0 °C and stirred for 30 min. The solution was 
then cooled to -78 °C and allylic ester 86 (786 mg, 4.11 mmol, 1 eq.) in THF (2 mL) was 
added dropwise. After 10 min the reaction mixture was allowed to warm to 0 °C and 
was kept at this temperature for 1 h. The mixture was partitioned between Et2O (30 
mL) and water (25 mL). The phases were separated and the aqueous layer was 
extracted with Et2O (3 x 30 mL). The combined organic extracts were dried over MgSO4 
and then concentrated in vacuo to leave a pale yellow liquid. Purification by FC 
(EtOAc/petroleum ether, 1:19) afforded alkene 92 (660 mg, 4.11 mmol, 99%) as a clear 
liquid. Rf 0.95 (EtOAc/petroleum ether, 1:20); νmax / cm
-1 (neat) 2966 (ArCH3), 2931 
(ArCH3), 1654 (C=C), 1458 (CH3); δH (CDCl3, 400 MHz) 7.10–7.22 (4H, ArH), 5.61 (1H, 
ddd, J 1.5, 6.3 and 16 Hz, ArCHCH), 5.45 (1H, m, ArCHCHCH), 3.67 (1H, m, ArCH), 2.37 
(3H, s, ArCH3), 1.70 (3H, dt, J 6.3 and 1.1 Hz, ArCHCH3), 1.34 (3H, d, J 6.9 Hz, CHCHCH3); 
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δC (CDCl3, 100 MHz)) 144.38, 135.86, 135.76, 132.41, 129.87, 129.35, 123.59, 123.59, 
37.78 (d), 20.78 (q), 19.88 (q), 18.00 (q); MS (EI) m/z 160 (M+, 38), 145 (100), 130 (18), 
105 (17), 91 (19), 86 (53), 84 (84); HRMS (EI) 160.1252 calcd for C12H16 (M
+), found 
160.1249, Δ = -1.9 ppm. 
(±)-3-Methyl-4-[(E)-pent-3-en-2-yl]pyridine (83) and 4-(Tributylstannyl)-3-
methylpyridine (94)162 
 
Pd(dppf)Cl2 (237 mg, 0.291 mmol, 5 mol%) was added to a solution of allylic acetate 85 
(1.12 g, 8.72 mmol, 1.5 eq.) and 4-bromo-3-picoline (1 g, 5.81 mmol, 1 eq.) in DMF (4 
mL). (SnBu3)2 (4.4 mL, 8.72 mmol, 1.5 eq.) was added and the reaction mixture was 
heated at 120 °C for 2 h. After allowing to cool to room temperature, the mixture was 
passed through a plug of silica and concentrated in vacuo to leave a dark oil. 
Purification by FC (EtOAc/hexane, 1:19 to 1:9) afforded alkene 83 (365 mg, 2.26 mmol, 
39%) as a clear oil and aryl stannane 94 (459 mg, 1.20 mmol, 21%) as a clear oil. Alkene 
83: Data as above. Stannane 94: Data was consistent with that previously reported.162 
Rf 0.50 (EtOAc/hexane, 1:4); δH (CDCl3, 400 MHz) 8.34 (1H, s, NCH), 8.30 (1H, d, J 4.4 
Hz, NCHCH), 7.41 (1H, d, J 4.4 Hz, NCHCH), 2.34 (3H, s, ArCH3), 1.51 (6H, m, CH2), 1.24 
(6H, m, CH2), 1.14 (6H, m, CH2), 0.80 (9H, t, J 13 Hz, CH2CH3). 
Diethyl 1-ethoxycarbonyl-1,4-dihydroxy-3-methylpyridine-4-phosphonate (96) 
 
3-Picoline (3.56 mL, 36.6 mmol, 1 eq.) was dissolved in MeCN (23 mL) and cooled to 0 
°C. Ethyl chloroformate (3.5 mL, 36.6 mmol, 1 eq.) was added dropwise and the red 
solution was stirred at 0 °C for 40 min. P(OEt)3 (5.89 mL, 36.6 mmol, 1 eq.) was added 
dropwise and the solution was allowed to warm to room temperature and stirred for a 
further 17 h, after which time, a colour change to yellow was observed. The mixture 
was concentrated in vacuo to leave phosphonate 96 (9.76 g, 32.2 mmol, 88%) as a 
yellow oil. Rf 0.21 (MeOH/CH2Cl2, 1:19); νmax/cm
-1 2982 (CH3), 1716 (C=O), 1312 (C-N), 
1018 (C-O), 958 (phosphonate), 746 (P-O-C); δH (CDCl3, 400 MHz) 6.72 (1H, bd, J 42 Hz, 
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NCH), 6.53 (1H, bd, J 46 Hz, NCH), 4.78 (1H, bd J 24 Hz, NCHCH), 4.08 (2H, q, J 7.2 Hz, 
NCO2CH2), 3.95 (4H, m, P(O)OCH2), 3.14 (1H, dd, J 27 and 4.7 Hz, PCH), 1.69 (3H, d, J 
2.1 Hz, NCHCCH3), 1.17-1.11 (9H, OCH2CH3); δc (CDCl3, 100 MHz) 170.73 (s), 124.74 (d, J 
27 Hz), 120.73 (d), 110.48 (d, J 46 Hz), 101.24 (d, J 46 Hz), 62.30 (t), 60.06 (t), 39.31 (d, J 
145 Hz), 20.66 (q), 14.17 (q), 13.92 (q); δP (CDCl3, 160 MHz) 21.20 (d, J 26 Hz); MS (ESI) 
m/z 230 ([M-COOEt]+), 180 (9), 162 (12); HRMS (ESI) 230.0941 calcd for C10H17NO3P
+ 
([M-COOEt]+), found 230.0940, Δ = -0.4 ppm. 
3-Methyl-4-((R*)-1-((2S*,3S*)-3-methyloxiran-2-yl)ethyl)pyridine and 3-Methyl-4-
((R*)-1-((2R*,3R*)-3-methyloxiran-2-yl)ethyl)pyridine (99) 
 
Alkene 83 (2.60 g, 16.1 mmol, 1 eq.) was dissolved in a mixture of THF (25 mL) and 
water (25 mL) and cooled to 0 ˚C. NBS (2.77 g, 16.1 mmol, 1 eq.) was added turning the 
solution yellow. After stirring at 0 ˚C for 1 h, NaHCO3 (aq.) (30 mL) was added. The 
aqueous solution was extracted with CH2Cl2 (5 x 20 mL) and the combined extracts 
dried over MgSO4 then concentrated in vacuo to leave a mixture of bromohydrins as a 
cream solid. MeCN (20 mL) was added, followed by 1M NaOH (20 mL) and the solution 
was heated at 65 ˚C for 1 h. MeCN was removed in vacuo and the remaining aqueous 
solution was extracted with CH2Cl2 (4 x 60 mL). The combined organic extracts were 
dried over MgSO4 then concentrated in vacuo to afford epoxide 99 (2.40 g, 13.6 mmol, 
84%, dr 52:48) as a clear oil. Rf 0.49 (MeOH/CH2Cl2, 1:9); νmax/cm
-1 (neat) 2970 (CH), 
1594 (pyridyl), 1404 (CH3), 1381 (CH3), 902 (epoxide), 834 (epoxide). Major 
diastereoisomer: δH (CDCl3, 400 MHz) 8.43 (1H, d, J 5.2 Hz, NCHCH), 8.38 (1H, s, NCH), 
7.20 (1H, d, J 5.1 Hz, NCHCH), 2.97 (1H, p, J 6.8 Hz, ArCH), 2.87-2.79 (2H, CHO), 2.31 
(3H, s, ArCH3), 1.35-1.28 (6H, CHCH3); δc (CDCl3, 100 MHz) 150.94 (d), 150.09 (s), 
147.83 (d), 131.49 (s), 120.92 (d), 62.46 (d), 53.47 (d), 36.21 (d), 17.52 (q), 16.73 (q), 
16.34 (q). Minor diastereoisomer: δH (CDCl3, 400 MHz) 8.42 (1H, d, J 5.1 Hz, NCHCH), 
8.39 (1H, s, NCH), 7.16 (1H, d, J 5.1 Hz, NCHCH), 3.06 (1H, p, J 7.1 Hz, ArCH), 2.87-2.79 
(2H, CHO), 2.32 (3H, s, ArCH3), 1.35-1.28 (6H, CHCH3); δc (CDCl3, 100 MHz) 151.03 (d), 
150.45 (s), 147.90 (d), 131.04 (s), 121.16 (d), 62.74 (d), 53.47 (d), 36.54 (d), 17.47 (q), 
16.73 (q), 16.31 (q). MS (ESI) m/z 178 (MH+, 100), 155 (3), 150 (3); HRMS (ESI) 
178.1226 calcd for C11H16NO
+ (MH+), found 178.1228, Δ = +1.1 ppm.  
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4-[(2R*,3S*)- and 4-[(2R*,3R*)-3-Carboxy-3-hydroxybutan-2-yl]pyridine-3-carboxylic 
acid (101) 
 
Mono-acid 55 (30 mg, 0.143 mmol, 1 eq., dr 25:75) was dissolved in 1M NaOH (3 mL) 
and stirred at room temperature for 5 min. KMnO4 (91 mg, 0.574 mmol, 4 eq.) was 
added and the mixture was heated at 100 °C for 1 h. After allowing to cool to room 
temperature MeOH (10 mL) was added and the MnO2 precipitate was removed by 
filtering under suction. The filtrated was concentrated in vacuo to afford a white solid. 
Salt removal of an aqueous solution by Ziptip® and concentration under a flow of 
nitrogen afforded diacid 101 (22 mg, 0.0920 mmol, 64%, dr 25:75) as a white solid. Rf 
0.15 (MeCN/H2O, 4:1); mp >250 ˚C (H2O); νmax/cm
-1 (neat) 3397 (OH), 1603 (C=O), 1571 
(C=O), 1397 (CH), 1387 (CH), 1163 (C-O); 101a: δH (D2O, 400 MHz) 8.59 (1H, s, NCH), 
8.53 (1H, d, J 5.8 Hz, NCHCH), 7.68 (1H, d, J 5.4 Hz, NCHCH), 3.82 (1H, q, J 7.2 Hz, ArCH), 
1.30 (3H, d, J 7.1 Hz, ArCHCH3). 101b: δH (D2O, 400 MHz) 8.55 (1H, s, NCH), 8.51 (1H, d, 
J 5.7 Hz, NCHCH), 7.66 (1G, d, J 5.4 Hz, NCHCH), 3.80 (1H, q, J 6.4 Hz, ArCH), 1.39 (3H, 
d, J 7.2 Hz, ArCHCH3), 1.39 (3H, s, ArCH3); δC (D2O, 100 MHz) 170.14 (s), 164.10 (s), 
149.69 (d), 146.99 (d), 145.96 (d), 127.85 (s), 122.81 (s), 77.53 (s), 41.57 (q), 22.35 (d), 
21.49 (q), 14.30 (q); MS (ESI) m/z 281 (22), 241 (13), 240 (100, MH+); HRMS (ESI) 
240.0866 calcd for C11H14NO5
+ (MH+), found 240.0870, Δ = +1.6 ppm. 
 (+)-[(2S,3R)-3-Carboxy-3-hydroxybutan-2-yl]pyridine-3-carboxylic acid (101a) 
 
Mono-acid 55 (2.0 mg, 0.00956 mmol, 1 eq.) was dissolved in 1M NaOH (0.5 mL) and 
stirred at room temperature for 5 min. KMnO4 (6 mg, 0.0382 mmol, 4 eq.) was added 
and the mixture was heated at 100 °C for 1 h. After allowing to cool to room 
temperature, MeOH (5 mL) was added and the MnO2 precipitate was removed by 
filtration under suction. The filtrate was concentrated in vacuo to remove all MeOH. 
After neutralisation to pH 5 with 1M HCl the aqueous solution was concentrated under 
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a flow of nitrogen. Salt removal from an aqueous solution by Ziptip® and purification 
by reverse phase (C18 silica) HPLC (MeCN/H2O, 9:1), afforded diacid (+)-101a (1.9 mg, 
0.00794 mmol, 83%) as a white solid. Data as above. *α+20D +12.8 (c = 0.20, H2O). 
(+)-[(2S,3S)-3-Carboxy-3-hydroxybutan-2-yl]pyridine-3-carboxylic acid (101b) 
 
Mono-acid 55 (10 mg, 0.0478 mmol, 1 eq.) was dissolved in 1M NaOH (1 mL) and 
stirred at room temperature for 5 min. KMnO4 (30 mg, 0.191 mmol, 4 eq.) was added 
and the mixture was heated at 100 °C for 1 h. After allowing to cool to room 
temperature, MeOH (5 mL) was added and the MnO2 precipitated was removed by 
filtration under suction. The filtrate was concentrated in vacuo to remove all MeOH. 
After neutralisation to pH 5 with 1M HCl (aq.) the aqueous solution was concentrated 
under a flow of nitrogen. Salt removal from an aqueous solution by Ziptip® and 
purification by reverse phase (C18 silica) HPLC (MeCN/H2O, 9:1), afforded diacid (+)-
101b (2.7 mg, 0.0113 mmol, 24%) as a white solid. Data as above. *α+20D +6.7 (c = 0.25, 
H2O). 
(2S*,3R*)- and (2S*,3S*)-2-Methyl-3-(3-methylpyridin-4-yl)butane-1,2-diol (102) 
 
Ester 47 (20 mg, 0.0896 mmol, 1 eq., dr 45:55) was dissolved in THF (0.6 mL) and LiAlH4 
(27 mg, 0.716 mmol, 8 eq.) was added. The suspension was stirred at room 
temperature for 15 h then water (5 mL) was added and the resulting solution was 
extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were dried over 
MgSO4 then concentrated in vacuo. Purification by FC (MeOH/CH2Cl2, 1:49 to 1:4) 
afforded 1,2-diols 102a and 102b (15 mg, 0.0768 mmol, 80%, dr 45:55) as a clear oil. Rf 
0.35 (MeOH/CH2Cl2, 1:49); νmax/cm
-1 (neat) 3355 (OH), 2974 (CH), 2925 (CH), 1599 
(pyr), 1457 (CH), 1052 (C-O). 102a: δH (CDCl3, 400 MHz) 8.35 -8.33 (2H, NCH), 7.34 (1H, 
d, J 5.2 Hz, NCHCH), 3.58-3.44 (2H, CH2OH), 3.23 (1H, q, J 7.1 Hz, ArCH), 2.38 (3H, s, 
ArCH3), 1.33 (3H, d, J 7.1 Hz, ArCHCH3), 1.15 (3H, s, ArCH3); 151.56 (s), 150.78 (d), 
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147.06 (d), 132.15 (s), 122.73 (d), 74.58 (s), 68.24 (d), 39.89 (t), 22.28 (q), 17.04 (q), 
15.46 (q). 102b: δH (CDCl3, 400 MHz)8.35-8.33 (1H, NCHCH), 8.31 (1H, s, NCH), 7.31 
(1H, d, J 5.2 Hz, NCHCH), 3.58 -3.44 (2H, CH2OH), 3.35 (1H, q, J 7.2 Hz, ArCH), 2.37 (3H, 
s, ArCH3), 1.30 (3H, d, J 7.2 Hz, ArCHCH3), 1.26 (3H, s, C(CH3)OH); δC (CDCl3, 100 MHz) 
151.48 (s), 150.59 (d), 146.80 (d), 132.84 (s), 123.05 (d), 75.36 (s), 68.60 (d), 39.39 (t), 
21.35 (q), 17.25 (q), 15.82 (q). MS (ESI) m/z 197 (12), 196 (100, MH+), 159 (4); HRMS 
(ESI) 196.1332 calcd for C11H18NO2
+ (MH+), found 196.1330, Δ = -1.0 ppm. 
(3S*,4R*)- and (3S*,4S*)-3-Hydroxy-3-methyl-4-(3-methylpyridin-4-yl)pentan-2-one 
 
Ester 47 (10 mg, 0.0448 mmol, 1 eq., dr 50:50) and (1S)-(−)-2,10-camphorsultam (13 
mg, 0.0538 mmol, 1.2 eq.) were dissolved in 1,3-diisopropyl benzene (0.5 mL). Me3Al 
(2M solution in hexanes, 147 µL, 0.296 mmol, 6.6 eq.) was added and the solution was 
heated at 160 ˚C for 15 h. After allowing the solution to cool to room temperature, sat. 
NaHCO3 (aq.) (5 mL) was added and extracted with CH2Cl2 (3 x 10 mL). The combined 
organic extracts were dried over MgSO4 then concentrated in vacuo. Purification by FC 
(MeOH/CH2Cl2, 1:49 to 3:17) afforded the titled compound (7 mg, 0.0338 mmol, 75%, 
dr 55:45) as a clear oil. Rf 0.45 (MeOH/CH2Cl2, 1:9); νmax/cm
-1 (neat) 3162 (OH), 2970 
(CH3), 1707 (C=O), 1597 (pyr), 1454 (CH), 1408 (CH), 1181 (C-O), 841 (C-O). Major 
diastereoisomer: δH (CDCl3, 400 MHz) 8.43 (1H, d, J 5.2 Hz, NCHCH), 8.43 (1H, s, NCH), 
7.55 (1H, d, J 5.2 Hz, NCHCH), 3.41 (1H, q, J 7.0 Hz, ArCH), 2.41 (3H, s, ArCH3), 2.38 (3H, 
s, OCH3), 1.13 (3H, s, C(CH3)(OMe)), 1.09 (3H, d, J 7.0 Hz, ArCHCH3); δC (CDCl3, 100 
MHz) 211.65 (s), 150.81 (d), 149.26 (s), 147.80 (d), 131.33 (s), 123.27 (d), 80.77 (s), 
39.34 (q), 25.13 (q), 23.74 (d), 17.03 (q), 15.80 (q). Minor diastereoisomer: δH (CDCl3, 
400 MHz) 8.53 (1H, s, NCH), 8.33 (1H, d, J 5.2 Hz, NCHCH), 7.48 (1H, d, J 5.2 Hz, 
NCHCH), 3.31 (1H, q, J 7.0 Hz, ArCH), 2.34 (3H, s, ArCH3), 1.99 (3H, s, OCH3), 1.50 (3H, s, 
C(CH3)(OMe)), 1.38 (3H, d, J 7.0 Hz, ArCHCH3); δC (CDCl3, 100 MHz) 211.28 (s), 151.08 
(d), 150.49 (s), 148.00 (d), 130.08 (s), 121.78 (d), 81.02 (s), 39.91 (q), 24.00 (q), 23.74 
(d), 16.52 (q), 15.68 (q). MS (ESI) m/z 198 (8), 208 (MH+, 100), 209 (14); HRMS (ESI) 
208.1332 calcd for C12H18NO2
+ (MH+), found 208.1328, Δ = -1.0 ppm.  
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(2S*, 3R*, 1’S*)- and (2S*, 3R*, 1’R*)-2-Methyl-3-(1-ortho-tolylethyl)oxirane (103) 
 
Alkene 92 (242 mg, 1.51 mmol, 1 eq.) was dissolved in a solution of MeCN (11 mL) and 
Na2·EDTA (4x10
-4 M aqueous solution, 7.6 mL) and was cooled to 0 °C. CF3COCH3 (1.48 
mL, 16.6 mmol, 11 eq.) was added via a cooled syringe. NaHCO3 (981 mg, 11.3 mmol, 
7.5 eq.) and Oxone® (1.45 g, 7.55 mmol, 5 eq.) were added in portions over 1 h. After 2 
h at 0 °C, water (10 mL) was added and the resulting solution was extracted with 
CH2Cl2 (3 x 20 mL). The combined organic extracts were dried over MgSO4 and 
concentrated in vacuo to leave a yellow oil. Purification by FC (EtOAc/hexane, 1:49 to 
1:19) afforded epoxide 103 (236 mg, 1.34 mmol, 89%, dr 57:43) as a clear oil. Rf 0.41 
(EtOAc/hexane, 1:19); νmax/cm
-1 (neat) 2968 (ArCH3), 2929 (ArCH3), 2361, 1653, 1558, 
1490 (epoxide), 1457 (CH3), 1379, 757 (epoxide). Major diastereoisomer: δH (CDCl3, 
400 MHz) 7.14-7.40 (4H, m, ArH), 3.22 (1H, m, ArCH), 2.88 (2H, m, CHO), 2.37 (3H, s, 
ArCH3), 1.36 (3H, d, J 5.3 Hz, ArCHCH3), 1.27 (3H, d, J 7.0 Hz, CHOCH3); δC (CDCl3, 100 
MHz) 141.35, 135.92, 130.37, 126.35, 126.31, 126.23, 63.26 (d), 53.16 (d), 36.00 (d), 
20.50 (q), 17.83 (q), 16.67 (q). Minor diastereoisomer: δH (CDCl3, 400 MHz) 7.14-7.40 
(4H, ArH), 3.12 (1H, m, ArCH), 2.96 (1H, m, CHO), 2.88 (1H, m, CHO), 2.36 (3H, s, 
ArCH3), 1.36 (3H, d, ArCHCH3), 1.31 (3H, d, J 5.0 Hz, CHOCH3); δC (CDCl3, 100 MHz) 
141.84, 135.49, 126.35, 126.23, 126.16, 63.91 (d), 53.92 (d), 37.07 (d), 19.69 (q), 17.83 
(q), 16.67 (q). MS (EI) m/z 176 (M+, 9), 143 (39), 132 (32), 119 (100), 117 (84), 91 (33); 
HRMS (EI) 176.1201 calcd for C12H16O (M
+), found 176.1200, Δ = -0.6 ppm.  
4-ortho-Tolylpentane-2,3-diol (104) 
 
2-Methyl-3-(1-o-tolylethyl)oxirane (235 mg, 1.33 mmol) was dissolved in MeCN (5 mL) 
and water (1.2 mL) and cooled to 0 °C. 60% HClO4 (206 µL) was added dropwise. After 
5 min, the mixture was allowed to warm to room temperature and stirred for a further 
19 h. The reaction mixture was quenched with NaHCO3 (aq.) then extracted with 
CH2Cl2 (3 x 20 mL). The organic extracts were combined, dried over MgSO4 and then 
concentrated in vacuo to leave a clear oil. Purification by FC (EtOAc/hexane, 1:4 to 9:1) 
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afforded 1,2-diol 104 (186 mg, 0.959 mmol, 72%) as a colourless oil and a complex 
mixture of diastereoisomers. Rf 0.11 (EtOAc/hexane, 2:3); νmax/cm
-1 (neat) 3381 (OH), 
2970 (CH3), 2927 (CH3), 1461 (CH3), 1376 (CH), 1057 (C-O). δH (CDCl3, 400 MHz) 7.37-
7.13 (4H, ArH), 4.46-4.03 (1H, CHOHCHOHCH3), 3.86-3.44 (1H, CHOHCH3), 3.26-2.99 
(1H, ArCHCH3), 2.40-2.36 (3H, ArCH3), 1.9 (2H, bs, OH), 1.35-1.11 (6H, CHCH3); δC 
(CDCl3, 100 MHz) 137.86, 137.10, 130.73, 130.59, 127.77, 126.60, 126.41, 126.25, 
126.17, 126.11, 125.99, 125.82, 79.16, 78.38, 69.29, 68.49, 68.30, 67.88, 522.94, 50.77, 
37.25, 36.91, 22.29, 20.38, 19.96, 19.77, 19.61, 18.11, 17.65, 16.85, 15.71; MS (EI) m/z 
194 (M+, 5), 149 (27), 132 (92), 120 (100), 117 (59), 105 (72), 91 (48); HRMS (EI) 
194.1307 calcd for C12H18O2 (M
+), found 194.1306, Δ = -0.5 ppm.  
or 
 
Epoxy alcohol 125 (500 mg, 2.81 mmol, 1 eq., dr 64:36) was dissolved in hexane (20 
mL) and cooled to -78 °C. Me3Al (2M solution in hexane, 4.21 mL, 8.42 mmol, 3 eq.) 
was added dropwise and the reaction was stirred a -78 °C for 1h then at 0 °C for 3 h. 
10% potassium sodium tartrate (aq.) (50 mL) was added and the aqueous layer was 
extracted with Et2O (4 x 30 mL). The combined organic extracts were dried over MgSO4 
then concentrated in vacuo to leave a clear oil. Purification by FC (EtOAc/hexane, 1:3 
to 2:3) afforded 1,2-diol 104 (362 mg, 1.86 mmol, 67%, dr 66:34) as a clear oil. Major 
diastereoisomer: δH (CDCl3, 400 MHz) 7.19-7.13 (4H, ArH), 3.66 (1H, m, CHOH), 3.45 
(1H, dd, J 10 and 5.2 Hz, CHOH), 3.26 (1H, p, J 6.9 Hz, ArCH), 2.39 (3H, s, ArCH3), 2.11 
(1H, bs, OH), 2.07 (1H, bd, J 5.4 Hz, OH), 1.32 (3H, d, J 6.9 Hz, ArCHCH3), 1.23 (3H, d, J 
6.4 Hz, CH(OH)CH3). Minor diastereoisomer: δH (CDCl3, 400 MHz) 7.24-7.17 (4H, ArH), 
3.88 (1H, m, CHOH), 3.73 (1H, m, CHOH), 3.13 (1H, p, J 6.9 Hz, ArCH), 2.36 (3H, s, 
ArCH3), 2.12 (1H, bs, OH), 1.36 (1H, bs, OH), 1.34 (3H, d, J 6.9 Hz, ArCHCH3), 1.13 (3H, d, 
J 6.3 Hz, CH(OH)CH3). Data as above. 
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(±)-2,2-Dimethoxy-4-ortho-tolylpentan-3-one (105) 
 
Typical Procedure (entry 2, Table 2.16): 
Diketone 56 (8 mg, 0.042 mmol, 1 eq.) was dissolved in MeOH (0.8 mL) and RuCl3 (8.7 
mg, 0.042 mmol, 1 eq.) was added. The reaction was heated at 40 °C for 72 h then 
diluted with CH2Cl2 (5 mL) and brine was added. The organic layer was extracted and 
the aqueous layer was further extracted with CH2Cl2 (2 x 8 mL). The combined organic 
layers were dried over MgSO4 and concentrated in vacuo to leave a pale yellow oil. 
Purification by FC (CH2Cl2) afforded acetal 105 (9 mg, 0.038 mmol, 91%) as a clear oil. 
Rf 0.52 (CH2Cl2); νmax/cm
-1 (neat) 2969 (CH3), 2933 (CH3), 2834 (CH3), 1725 (C=O), 1492 
(C-O-C), 1146 (acetal), 1125 (acetal), 1045 (aromatic CH); δH (CDCl3, 400 MHz) 7.20-
7.10 (4H, m, ArH), 4.63 (1H, q, J 7.0 Hz, ArCHCH3), 3.17 (3H, s, OCH3), 3.11 (3H, s, 
OCH3), 2.47 (3H, s, ArCH3), 1.35 (3H, d, J 7.0 Hz, ArCHCH3), 1.15 (3H, s, C(OCH3)2CH3; δC 
(CDCl3, 100 MHz) 210.04 (s), 138.51 (s), 135.88 (s), 130.60 (d), 126.97 (d), 126.67 (d), 
126.11 (d), 102.91 (s), 49.81 (q), 49.38 (q), 42.54 (d), 20.98 (q), 19.58 (q), 18.30 (q); MS 
(CI) m/z 398 (88), 380 (48), 254 (MNH4
+, 49), 222 (100), 208 (28), 190 (91), 89 (20), 52 
(32); HRMS (CI) 254.1756 calcd for C14H24O3N (MNH4
+), found 254.1748, Δ = -3.1 ppm. 
(2S*,3R*)- and (2R*,3R*)-Methyl 2-acetoxy-2-methyl-3-ortho-tolylbutanoate (110a 
and 110b) 
 
Ester 57 (20 mg, 0.0900 mmol, 1 eq., dr 45:55) was dissolved in acetic anhydride (1.2 
mL) and conc. H2SO4 (0.02 mL) was added dropwise. The reaction was heated at 40 °C 
for 19 h then cooled in an ice bath before quenching with sat. NaHCO3 (aq.) (5 mL) and 
extracting with CH2Cl2 (3 x 30 mL). The combined organic extracts were dried over 
MgSO4 then concentrated in vacuo. Purification by FC (CH2Cl2/ pet. ether, 1:1 to 1:0) 
afforded acetate 110 (15 mg, 0.059 mmol, 62%, dr 45:55) as a clear oil. Rf 0.30 (CH2Cl2/ 
pet. ether, 1:1); νmax/cm
-1 (neat) 1738 (C=O), 1454 (CH), 1371 (CH), 1245 (COC), 1118 
(COC). 110a: δH (CDCl3, 400 MHz) 7.42 (1H, d, J 7.6 Hz, ArH), 7.28-7.16 (3H, ArH), 3.70 
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(3H, s, CO2CH3), 3.48 (1H, q, J 7.1 Hz, ArCH), 2.38 (3H, s, ArCH3), 2.15 (3H, s, C(O)CH3), 
1.56 (3H, s, C(OAc)CH3), 1.35 (3H, d, J 7.1 Hz, ArCHCH3); δC (CDCl3, 100 MHz) 172.36 (s), 
169.82 (s), 139.73 (s), 136.35 (s), 130.33 (d), 127.94 (d), 126.69 (d), 125.96 (d), 83.64 
(s), 52.17 (q), 41.55 (d), 21.52 (q), 20.26 (q), 17.79 (q), 16.59 (q). 110b: δH (CDCl3, 400 
MHz) 7.27-7.16 (4H, ArH), 3.68 (3H, s, CO2CH3), 3.65 (1H, q, J 7.2 Hz, ArCH), 2.44 (3H, s, 
ArCH3), 2.04 (3H, s, C(O)CH3), 1.61 (3H, s, C(OAc)CH3), 1.30 (3H, d, J 7.2 Hz, ArCHCH3); 
δC (CDCl3, 100 MHz) 172.10 (s), 169.82 (s), 139.29 (s), 137.22 (s), 130.33 (d), 128.10 (d), 
126.69 (d), 125.50 (d), 84.04 (s), 52.17 (q), 41.00 (d), 21.27 (q), 20.32 (q), 17.79 (q), 
15.91 (q). MS (CI) m/z 282 (100, MNH4
+), 265 (12, MH+), 222 (28); HRMS (CI) 265.1434 
calcd for C15H21O4
+ (MH+), found 265.1421, Δ = -4.9 ppm. 
 (2S*, 3R*)-2-Methyl-3-ortho-tolylbutane-1,2-diol (111a) 
 
Epoxy alcohol 112 (27 mg, 0.152 mmol, 1 eq.) was dissolved in hexane (1.5 mL) and 
cooled to -78 °C. Me3Al (2M solution in hexane, 0.23 mL, 0.455 mmol, 3 eq.) was added 
dropwise and the reaction was stirred at -78 °C for 1 h, then allowed to warm to 0 °C, 
and was stirred for a further 3 h. Water (5 mL) was added and after sonification, the 
organic layer was extracted. The aqueous layer was further extracted with CH2Cl2 (3 x 
10 mL), and the combined organic extracts were dried over MgSO4 and concentrated in 
vacuo to leave a clear oil. Purification by FC (EtOAc/hexane, 2:3) afforded 1,2-diol 111a 
(19 mg, 0.116 mmol, 76%) as a clear oil. Rf 0.14 (EtOAc/hexane, 2:3); νmax/cm
-1 (neat) 
3379 (OH), 2973 (CH3), 1460 (ArCH3), 1276 (CH3), 1261 (CH3), 1024 (CO); δH (CDCl3, 400 
MHz) 7.38 (1H, d, J 7.8 Hz, ArH), 7.23-7.13 (3H, ArH), 3.61 (1H, d, J 11 Hz, CH2OH), 3.41 
(1H, d, J 11 Hz, CH2OH), 3.28 (1H, q, J 7.2 Hz, ArCH), 2.41 (3H, s, ArCH3), 1.91 (2H, bs, 
OH), 3.05 (3H, d, J 7.2 Hz, ArCHCH3), 1.19 (3H, s, COHCH3); δC (CDCl3, 100 MHz) 141.70 
(s), 136.53 (s), 130.53 (d), 127.52 (d), 126.24 (d), 125.98 (d), 75.32 (s), 68.33 (t), 40.25 
(d), 22.16 (q), 20.47 (q), 15.94 (q); MS (CI) m/z 212 (100, MNH4
+), 194 (18), 159 (21); 
HRMS (EI) 212.1651 calcd for C12H22O2N
 (MNH4
+), found 212.1649, Δ = -0.9 ppm. 
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(2S*, 3R*)- and (2R*, 3R*)-2-Methyl-3-ortho-tolylbutane-1,2-diol (111a and 111b) 
 
Ester 57 (41 mg, 0.185 mmol, 1 eq., dr 44:45) was dissolved in THF (1.2 mL) and cooled 
to 0 °C. LiAlH4 (16 mg, 3.96 mmol, 2.2 eq.) was added and after 5 min the suspension 
was allowed to warm to room temperature and then stirred for a further 2 h. Et2O (2 
mL) was added and the mixture was filtered through Celite® and concentrated in vacuo 
to afford 1,2-diols 111a and 111b (111a:111b, 45:55 by 1H NMR) as a clear oil. 
Purification by FC (EtOAc/hexane, 1:4 to 3:7) afforded 1,2-diols 111a (16 mg, 0.082 
mmol, 100%) and 111b (20 mg, 0.103 mmol, 100%), both as clear oils. Data for 1,2-diol 
111a as above. 7b: Rf 0.19 (EtOAC/hexane, 2:3); δH (CDCl3, 400 MHz) 7.38 (1H, d, J 6.8 
Hz, ArH), 7.25-7.14 (3H, ArH), 3.57 (1H, dd, J 11 and 6.2 Hz, CH2OH), 3.49 (1H, dd, J 11 
and 6.4 Hz, CH2OH), 3.43 (1H, q, J 7.2 Hz, ArCH), 2.42 (3H, s, ArCH3), 1.85 (1H, t, J 6.3 
Hz, CH2OH), 1.69 (1H, s, CCH3OH), 1.32 (3H, d, J 7.2 Hz, ArCHCH3), 1.24 (3H, s, CCH3OH); 
δC (CDCl3, 100 MHz) 141.72 (s), 136.53 (s), 130.52 (d), 127.53 (d), 126.44 (d), 125.98 
(d), 75.33 (s), 68.32 (t), 40.25 (d), 21.13 (q), 20.45 (q), 15.93 (q); MS (CI) m/z 212 (100, 
MNH4
+), 194 (18), 159 (21); HRMS (EI) 212.1651 calcd for C12H22O2N (MNH4
+), found 
212.1649, Δ = -0.9 ppm.  
[(2R*,3R*)-2-Methyl-3-ortho-tolyloxiran-2-yl]methanol (112) 
 
Allylic alcohol 113 (18 mg, 0.111 mmol, 1 eq.) and VO(acac)2 (3 mg, 0.011 mmol, 0.1 
eq.) were dissolved in toluene (0.5 mL) and warmed to 40 °C. A solution of tBuOOH 
(3.67M solution in toluene, 36 µL, 0.133 mmol, 1.2 eq.) was added dropwise turning 
the green solution deep orange/red. The reaction was stirred at 40 °C for 16 h during 
which time it had returned to green in colour. After dilution with CH2Cl2 (10 mL), 10% 
Na2S2O3 (10 mL) was added. The organic layer was extracted and the aqueous layer 
was further extracted with CH2Cl2 (2 x 10 mL). The combined organic extracts were 
washed with sat. aq. NaHCO3 (10 mL), dried over MgSO4 and concentrated in vacuo to 
leave a pale green oil. Purification by FC (EtOAc/hexane, 3:7) afforded epoxy alcohol 
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112 (15 mg, 0.0841 mmol, 76%) as a clear oil. Rf 0.25 (EtOAc/hexane, 3:7); νmax/cm
-1 
(neat) 3410 (OH), 2926 (CH3), 1459 (ArCH3), 1069 (C-O), 1040 (C-O); δH (CDCl3, 400 
MHz) 7.33-7.18 (4H, ArH), 4.22 (1H, s, ArCH), 3.92 (1H, dd, J 12 and 4.3 Hz, CH2OH), 
3.84 (1H, J 12 and 8.8 Hz, CH2OH), 2.35 (3H, s, ArCH3), 2.02 (1H, dd, J 8.8 and 4.3 Hz, 
OH), 1.06 (3H, s, CH3); δC (CDCl3, 100 MHz) 153.27 (s), 134.13 (s), 129.55 (d), 127.38 (d), 
126.20 (d), 125.70 (d), 65.00 (t), 63.12 (s), 59.33 (d), 18.73 (q), 13.76 (q); MS (EI) m/z 
178 (M+, 32), 160 (27), 145 (56), 121 (83), 104 (100), 91 (68), 78 (80); HRMS (EI) 
178.0994 calcd for C11H14O2, found 178.1001, Δ = +3.9 ppm. 
(E)-2-Methyl-3-ortho-tolylprop-2-en-1-ol (113)114 
 
LiAlH4 (12 mg, 0.315 mmol, 0.6 eq.) was stirred in Et2O (1 mL) and cooled to 0 °C. AlCl3 
(14 mg, 0.105 mmol, 0.2 eq.) was added in two portions followed by the dropwise 
addition of (E)-methyl 2-methyl-3-o-tolylacrylate (100 mg, 0.526 mmol, 1 eq.) in Et2O 
(1.5 mL). After 10 min the mixture was allowed to warm to room temperature and 
then stirred for a further 2 h. Water (10 mL) was added and the Et2O layer extracted. 
The aqueous layer was further extracted with CH2Cl2 (2 x 10 mL) and the combined 
organic extracts were dried over MgSO4 and concentrated in vacuo to leave a clear oil. 
Purification by FC (EtOAc/hexane, 1:4) afforded allylic alcohol 113 (75 mg, 0.462 mmol, 
82%) as a clear oil. Data was consistent with that previously reported.114 Rf 0.25 
(EtOAc/hexane, 1:4); δH (CDCl3, 400 MHz) 7.26-7.17 (4H, ArH), 6.55 (1H, s, ArCH), 2.37 
(2H, s, CH2OH), 2.28 (3H, s ArCH3), 1.79 (3H, s, CHCCH3), 1.57 (1H, bs, OH). 
Methyl(triphenylphosphoranylidene)propionate (115)163 
 
Methyl (triphenylphosphoranylidene)acetate (1.00g, 2.99 mmol, 1 eq.) was dissolved 
in CH2Cl2 (6 mL) and cooled to 0 °C. Methyl iodide (279 µL, 4.49 mmol, 1.5 eq.) was 
added and after 15 min the solution was allowed to warm to room temperature. The 
pale yellow solution was stirred at room temperature for a further 18 h then 
concentrated in vacuo to leave a pale yellow foam. NaOH (240 mg, 5.98 mmol, 2 eq.) in 
water (10 mL) was added. After vigorous shaking the organic layer was extracted and 
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the aqueous layer was further extracted with CH2Cl2 (2 x 15 mL). The combined organic 
extracts were dried over MgSO4 and concentrated in vacuo to leave a pale yellow solid 
(1.117 g). The solid was dissolved in hot EtOAc and the white precipitate was filtered 
off while still hot. The solution was concentrated in vacuo to afford ylide 115 (784 mg, 
2.25 mmol, 75%, rotamers 1:1) as a pale yellow solid. Data was consistent with that 
previously reported.164 δH (CDCl3, 400 MHz) 7.81-7.48 (30H, ArH), 5.32 (3H, s, OCH3), 
3.67 (3H, s, OCH3), 1.94 (3H, s, CH3), 1.91 (3H, s, CH3); MS (EI) m/z 348 (M+, 18), 277 
(100), 262 (19), 201 (20), 183 (26), 152 (14), 77 (19). 
(E)-Methyl 2-methyl-3-ortho-tolylacrylate (116)114 
 
Methyl(triphenylphosphoranylidene)propionate (162 mg, 0.465 mmol, 1 eq.) was 
dissolved in CH2Cl2 (1.5 mL) and o-tolylaldehyde (65 µL, 0.558 mmol, 1.2 eq.) was 
added. The mixture was stirred at room temperature for 17 h then concentrated in 
vacuo. Hexane (2 mL) was added and the white precipitate was filtered off under 
suction, washing with hexane (4 x 5 mL). The filtrate was concentrated in vacuo to 
leave a clear oil (131 mg). Purification by FC (EtOAc/hexane, 1:19) afforded the 
unsaturated ester 116 (109 mg, 0.573 mmol, 49%) as a clear oil. Data was consistent 
with that previously reported.114 Rf 0.43 (EtOAc/petroleum ether, 1:9); δH (CDCl3, 400 
MHz) 7.77 (1H, s, ArCH), 7.23-7.21 (4H, ArH), 3.84 (3H, s, OCH3), 2.27 (3H, ArCH3), 1.98 
(3H, s, CH3). 
(±)-2-[13C] 4-ortho-Tolylpentane-2,3-dione (119) 
 
2-[13C] 4-o-Tolylpentane-2,3-diol (40 mg, 0.205 mmol, 1 eq.) was dissolved in DMSO 
(0.25 mL) and 59% IBX (245 mg, 0.512 mmol, 2.5 eq.) was added. The suspension was 
stirred at room temperature for 18 h after which time the reaction mixture was bright 
yellow. CH2Cl2 (5 mL) was added and the mixture was passed through a pad of Celite® 
eluting with CH2Cl2. Water (20 mL) was added and the organic layer was extracted, 
dried over MgSO4 and concentrated in vacuo to leave a bright yellow oil. Purification 
by FC (CH2Cl2) afforded 1,2-diketone 119 (31 mg, 0.162 mmol, 79%) as a bright yellow 
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oil. Rf 0.86 (CH2Cl2); δH (CDCl3, 400 MHz) 7.24-7.13 (3H, ArH), 6.95 (1H, m, ArH), 4.78 
(1H, q, J 6.9 Hz, ArCH), 2.47 (3H, s, ArCH3), 2.25 (3H, d, J 6.4 Hz, 
13COCH3), 1.39 (3H, d, J 
6.9 Hz, ArCHCH3); δC (CDCl3, 100 MHz) 198.44 (s). MS (CI) m/z 209 (100, MNH4
+), 182 
(27), 146 (19), 132 (16), 119 (44); HRMS (CI) 209.1360 calcd for 13C1
12C11H18O2N, found 
209.1371, Δ = +5.3 ppm. 
(E)-4-ortho-Tolylbut-3-en-2-one (120)115 
 
Acetone (1.65 mL, 22.5 mmol, 1.3 eq.) was dissolved in EtOH (4.5 mL) and water (7.4 
mL) and then cooled to 0 °C. NaOH (820 mg, 21.0 mmol, 1.18 eq.) was added followed 
by the dropwise addition of 2-methylbenzaldehyde (2 mL, 17.3 mmol, 1 eq.). The 
mixture was stirred at 0 °C for 4 h then quenched with sat. NH4Cl (aq.) (30 mL) and 
extracted with CH2Cl2 (5 x 30 mL). The combined organic extracts were dried over 
MgSO4 then concentrated in vacuo to leave a bright yellow oil. Purification by FC 
(EtOAc/hexane, 3:97) afforded enone 120 (2.09 g, 13.0 mmol, 75%) as a yellow oil. 
Data was consistent with that previously reported.115 Rf 0.25 (EtOAc/hexane, 1:9); δH 
(CDCl3, 400 MHz) 7.85 (1H, d, J 16 Hz, ArCH), 7.60 (1H, d, J 7.3 Hz, ArH), 7.34-7.23 (3H, 
ArH), 6.70 (1H, d, J 16 Hz, ArCHCH), 2.48 (3H, s, CH3), 2.42 (3H, s, CH3). 
(±)-(E)-4-ortho-Tolylbut-3-en-2-ol (123)165 
 
Enone 120 (580 mg, 3.58 mmol, 1 eq.) was dissolved in MeOH (8.8 mL) and cooled to 0 
°C. NaBH4 was added in 3 portions and the reaction was allowed to warm to room 
temperature and stirred for a further 30 min. Water (20 mL) was added and the 
mixture was extracted with CH2Cl2 (3 x 30 mL) then the combined organic extracts 
were dried over MgSO4 and concentrated in vacuo to leave a clear oil. Purification by 
FC (EtOAc/hexane, 1:9 to 3:17) afforded allylic alcohol 123 (351 mg, 2.19 mmol, 61%) 
as a clear oil. Data was consistent with that previously reported.165 Rf 0.60 
(EtOAc/hexane, 2:3); δH (CDCl3, 400 MHz) 7.48 (1H, m, ArH), 7.20-7.17 (3H, ArH), 6.81 
(1H, d, J 15 Hz, ArCH), 6.19 (1H, dd, J 15 and 6.4 Hz, ArCHCH), 4.55 (1H, pd, J 6.4 and 
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1.1 Hz, CHOH), 2.38 (3H, s, ArCH3), 1.64 (1H, bs, OH), 1.42 (3H, d, J 6.4 Hz , CH(OH)CH3); 
MS (EI) m/z 162 (33, M+), 144 (100), 119 (82), 104 (83), 91 (54), 55 (52). 
(R*)-1-(2R*,3R*)- and (S*)-1-[(2R*,3R*)-3-ortho-Tolyloxiran-2-yl]ethanol (125) 
 
Alcohol 123 (8 mg, 0.0449 mmol, 1 eq.) and VO(acac)2 (1.5 mg, 0.449 µmol, 1 mol%) 
were dissolved in toluene and warmed to 40 °C. TBHP (3.67M solution in toluene, 16 
µL, 0.0591 mmol, 1.2 eq.) was added dropwise and the reaction turned red after 1 min 
and was allowed to stir at 40 °C for 16 h after which time the green colour had 
returned. CH2Cl2 (10 mL) was added and washed with 10% Na2S2O3 (aq.) (10 mL). The 
organic layer was dried over MgSO4 then concentrated in vacuo to leave a pale yellow 
oil. Purification by FC (EtOAc/hexane, 1:9) afforded epoxy alcohol 125 (6.8 mg, 0.0383 
mmol, 85%, dr 62:38) as a clear oil. Rf 0.35 (EtOAc/hexane, 3:7); νmax/cm
-1 (neat) 3422 
(OH), 2975 (CH), 1492 (epoxide), 1461 (CH), 1070 (C-O), 892 (epoxide). Major 
diastereoisomer: δH (CDCl3, 400 MHz) 7.29-7.18 (4H, ArH), 4.19 (1H, m, ArCH(O)CH), 
4.14 (1H, d, J 2.4 Hz, ArCH), 3.00 (1H, t, J 2.6 Hz, CHOH), 2.45 (3H, s, ArCH3), 1.41 (3H, d, 
J 7.4 Hz, CH(OH)CH3); δC (CDCl3, 100 MHz) 135.75 (s), 135.29 (s), 129.84 (d), 127.70 (d), 
126.17 (d), 124.21 (d), 65.08 (d), 64.59 (d), 52.72 (d), 20.01 (q), 18.89 (q). Minor 
diastereoisomer: δH (CDCl3, 400 MHz) 7.29-7.18 (4H, ArH), 4.04 (1H, d, J 2,2 Hz, ArCH), 
3.89 (1H, m, ArCH(O)CH), 2.97 (1H, dd, J 5.0 and 2.1 Hz, CHOH), 2.42 (3H, s, ArCH3), 
1.42 (3H, d, J 6.5 Hz, CH(OH)CH3); δC (CDCl3, 100 MHz) 135.29 (s), 135.06 (s), 129.84 (d), 
127.79 (d), 126.21 (d), 124.30 (d), 67.71 (d), 65.74 (d), 54.84 (d), 20.01 (q), 18.93 (q). 
MS (EI) m/z 178 (9, M+), 121 (100), 105 (38), 84 (52), 49 (58); HRMS (EI) 178.0994 calcd 
for C11H14O2
+, found 178.0994, Δ = -1.7 ppm. 
(±)-2-[13C] (E)-4-ortho-Tolylbut-3-en-2-ol (126) 
 
To a solution of NaOH (247 mg, 6.17 mmol, 1.2 eq.) in EtOH (1.4 mL) and H2O (2.3 mL), 
was added 2-[13C] acetone (500 µL, 6.81 mmol, 1.3 eq.). The solution was cooled to 0 
°C and 2-methylbenzaldehyde (0.61 mL, 5.14 mmol, 1 eq.) was added dropwise turning 
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the solution green. The mixture was stirred at 0 °C for 4 h then sat. NH4Cl (aq.) (10 mL) 
was added. The solution was extracted with CH2Cl2 (5 x 20 mL), dried over MgSO4 and 
concentrated in vacuo to leave a bright yellow oil. Purification by FC (EtOAC/hexane, 
2:48) afforded 2-[13C] (E)-4-o-tolylbut-3-en-2-one as a pale yellow oil which was 
reacted directly. [Rf 0.85 (Et2O); δH (CDCl3, 400 MHz) 7.58 (1H, dd, J 16 and 6.4 Hz, 
ArCHCH), 7.60 (1H, d, J 7.4 Hz, ArH), 7.34-7.23 (3H, ArH), 6.68 (1H, dd, J 16 and 2.7 Hz, 
ArCH), 2.48 (3H, s, ArCH3), 2.42 (3H, d, J 5.8 Hz, COCH3); δC (CDCl3, 100 MHz) 198.41 (s); 
MS (EI) m/z 161 (23, M+), 146 (73), 115 (38), 91 (21), 84 (86), 49 (100); HRMS (EI) 
161.0922 calcd for 13C1
12C10H12O, found 161.0922, Δ = 0 ppm.] This oil was dissolved in 
MeOH (7.8 mL) and cooled to 0 °C. CeCl3.7H2O (681 mg, 1.83 mmol, 1 eq.) was added. 
NaBH4 (104 mg, 2.75 mmol, 1.5 eq.) was then added in portions and the mixture was 
allowed to warm to room temperature. After stirring at room temperature for 15 min, 
brine (10 mL) was added and the solution was extracted with CH2Cl2 (4 x 15 mL), dried 
over MgSO4 and concentrated in vacuo to leave a clear oil. Purification by FC 
(EtOAc/hexane, 1:4) afforded allylic alcohol 126 (423 mg, 2.59 mmol, 51%) as a clear 
oil. Rf 0.47 (EtOAc/petroleum ether, 3:7); δH (CDCl3, 400 MHz) 7.48 (1H, m, ArH), 7.23-
7.17 (3H, ArH), 6.82 (1H, dd, J 16 and 7.0 Hz, ArCH), 6.19 (1H, ddd, J 16, 6.5 and 3.6 Hz, 
ArCHCH), 4.53 (1H, ddd, J 150, 6.4 and 1.0 Hz, CHCOH), 2.36 (3H, s, ArCH3), 1.74 (1H, 
bs, OH), 1.42 (3H, dd, J 6.4 and 124 Hz, CHOHCH3); δC (CDCl3, 100 MHz) 69.19 (d); MS 
(EI) m/z 163 (M+, 23), 145 (37), 130 (21), 119 (21), 104 (28), 84 (100), 49 (84); HRMS 
(EI) 163.1078 calcd for 13C1
12C10H14O, found 163.1072, Δ = -3.7 ppm. 
1-[13C] 1-(3-ortho-Tolyloxiran-2-yl)ethanol (127)  
 
Allylic alcohol 126 (35 mg, 0.215 mmol, 1 eq.) and VO(acac)2 (6 mg, 0.022 mmol, 0.1 
eq.) were dissolved in toluene (0.5 mL) and warmed to 40 °C. A solution of TBHP 
(3.67M solution in toluene, 36 µL, 0.133 mmol, 1.2 eq.) was added dropwise turning 
the green mixture deep red. The mixture was stirred at 40 °C for 16 h and then diluted 
with CH2Cl2 (10 mL) after allowing to cool to room temperature. 10% Na2S2O5 (aq.) (10 
mL) was added and the organic layer was extracted. The aqueous layer was further 
extracted with CH2Cl2 (2 x 10 mL) then the combined organic extracts were dried over 
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MgSO4 and concentrated in vacuo to leave a pale green oil. Purification by FC 
(EtOAc/hexane, 3:7) afforded epoxy alcohol 127 (25 mg, 0.140 mmol, 65%, dr 41:59) as 
a clear oil. Rf 0.28 (EtOAc/petroleum ether, 3:7); νmax/cm
-1 (neat) 3422 (OH), 2975 
(CH3), 2928 (CH2), 1492 (epoxide), 1461 (CH3), 1372 (CH3), 1285 (CH), 1070 (C-O), 892 
(epoxide). Major diastereoisomer: δH (CDCl3, 400 MHz) 7.26-7.19 (4H, ArH), 4.22 (1H, 
dm, J 116 Hz, ArCHCH), 4.13 (1H, m, ArCH), 2.99 (1H, m, 13CH), 2.44 (3H, s, ArCH3), 2.04 
(1H, t, J 2.5 Hz, OH), 1.39 (3H, dd, J 6.3 and 4.4 Hz, 13CHCH3); δC (CDCl3, 100 MHz) 64.51 
(d). Minor diastereoisomer: δH (CDCl3, 400 MHz) 7.26-7.19 (4H, ArH), 4.03 (1H, m, 
ArCH), 3.89 (1H, dm, J 128 Hz, ArCHCH), 2.95 (1H, m, 13CH), 2.42 (3H, s, ArCH3), 1.96 
(1H, dd, J 6.1 and 2.7 Hz, OH), 1.42 (3H, dd, J 6.6 and 4.4 Hz, 13CHCH3); δC (CDCl3, 100 
MHz) 67.60 (d). MS (EI) m/z 179 (M+, 9), 146 (22), 134 (17), 121 (100), 119 (33), 105 
(59), 93 (40), 91 (39); HRMS (EI) 179.1027 calcd for 13C1
12C10H14O2, found 179.1027.  
2-[13C ] 4-ortho-Tolylpentane-2,3-diol (128) 
 
Epoxy alcohol 127 (75 mg, 0.419 mmol, 1 eq.) was dissolved in hexane (4 mL) and 
cooled to -78 °C. Me3Al (2M solution in hexane, 630 µL, 1.26 mmol, 3 eq.) was added 
dropwise and the mixture stirred was stirred at -78 °C for 1 h, then at 0 °C for a further 
3 h. Water (15 mL) and hexane (10 mL) were added and the emulsion was sonicated 
until two layers formed. The organic layer was extracted and the aqueous layer was 
further extracted with CH2Cl2 (3 x 10 mL). The organic extracts were combined and 
dried over MgSO4 then concentrated in vacuo to leave a clear oil. Purification by FC 
(EtOAc/hexane, 35:65) afforded the 1,2-diol 128 (55 mg, 0.282 mmol, 67%, dr 43:57) as 
a clear oil. Rf 0.11 (EtOAc/hexane, 2:3); νmax/cm
-1 (neat) 3381 (OH), 2970 (CH3), 2927 
(CH3), 1461 (CH3), 1376 (CH), 1057 (C-O). Major diastereoisomer: δH (CDCl3, 400 MHz) 
7.29-7.12 (4H, ArH), 4.18-3.11 (3H, CH), 2.37 (3H, s, ArCH3), 1.36-1.13 (6H, CHCH3). 
Minor diastereoisomer: δH (CDCl3, 400 MHz) 7.29-7.12 (4H, ArH), 4.18-3.11 (3H, CH), 
2.40 (3H, s, ArCH3), 1.36-1.13 (6H, CHCH3). δC (CDCl3, 100 MHz) 68.35 (d), 67.85 (d). MS 
(EI) m/z 195 (7, M+), 149 (27), 131 (22), 120 (100), 105 (77), 91 (34), 57 (32), 43 (32); 
HRMS (EI) 195.1340 calcd for 13C1
12C11H18O2, found 195.1340, Δ = 0 ppm. 
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(2S*,3R*)- and (2R*, 3R*)-Methyl 2-hydroxy-2-methyl-3-ortho-tolylbutanoate (129a 
and 129b) 
 
Method A (Lewis acid promoted BER): 
Diketone 119 (15 mg, 0.079 mmol, 1 eq.) was dissolved in MeOH (1.5 mL) and CuCl (7.8 
mg, 0.079 mmol, 1 eq.) was added. The mixture was stirred at 40 °C for 66 h then 
allowed to cool to room temperature and diluted with CH2Cl2 (6 mL). Brine (10 mL) was 
added and the organic layer was extracted. The aqueous layer was further extracted 
with CH2Cl2 (3 x 10 mL) and the combined organic extracts were dried over MgSO4 and 
concentrated in vacuo to leave a yellow oil. Purification by FC (CH2Cl2) afforded esters 
129a and 129b (dr 45:55) as a clear oil. 129a: δH (CDCl3, 400 MHz) 7.55-7.49 (1H, ArH), 
7.18-7.11 (3H, ArH), 3.88 (3H, s, OCH3), 3.49 (1H, qd, J 7.0 and 3.1 Hz, ArCH), 3.33 (1H, 
d, J 2.9 Hz, OH), 2.40 (3H, s, ArCH3), 1.23 (3H, d, J 4.2 Hz, 
13CCH3), 1.20 (3H, dd, J 7.0 
and 4.5 Hz, ArCHCH3); δC (CDCl3, 100 MHz) 77.52. 129b: δH (CDCl3, 400 MHz) 7.55-7.49 
(1H, ArH), 7.18-7.11 (3H, ArH), 3.52 (3H, s, OCH3), 3.41 (1H, qd, J 7.1 and 2.8 Hz, ArCH), 
3.25 (1H, d, J 2.8 Hz, OH), 2.40 (3H, s, ArCH3), 1.55 (3H, d, J 4.3 Hz, 
13CCH3), 1.36 (3H, 
dd, J 7.0 and 4.2 Hz, ArCHCH3). δC (CDCl3, 100 MHz) 76.92. MS (EI) m/z 223 (5, M
+), 164 
(18), 119 (100), 105 (22), 91 (20), 84 (18), 44 (19); HRMS (EI) 223.1289 calcd for 
13C1
12C12H18O3, found 223.1295, Δ = +2.7 ppm. 
Method B (Base promoted BER): 
Diketone 119 (15 mg, 0.079 mmol, 1 eq. ) was dissolved in MeOH (1.5 mL) and NaOH 
(25 mg, 0.629 mmol, 8 eq.) was added. The solution was stirred at 40 °C for 16 h then 
allowed to cool to room temperature and diluted with CH2Cl2 (6 mL). Brine (10 mL) was 
added and the organic layer extracted. The aqueous layer was further extracted with 
CH2Cl2 (3 x 10 mL) and the combined organic extracts were dried over MgSO4 and 
concentrated in vacuo to leave a yellow oil. Purification by FC (CH2Cl2) afforded esters 
129a and 129b (dr 59:41) as a clear oil. Data as above. 
 
 
 
  Experimental 
135 
 
1,4,5,8-Tetrahydro-naphthalene (130)60 
 
A 3 L round-bottomed flask was fitted with a mechanical stirrer, an acetone/cardice 
cold finger and a pressure-equalising dropping funnel. The flask was cooled to -78 °C 
and ammonia was condensed through a KOH drying tower. Sodium lumps (100 g, 4.35 
mmol, 5.6 eq.) were added over 45 min with vigorous stirring. A solution of 
naphthalene (100 g, 0.78 mmol, 1 eq.) in a mixture of EtOH (230 mL) and Et2O (300 
mL), was added via the dropping funnel over a course of 2.5 h. Residual naphthalene 
was washed from the apparatus using Et2O (30 mL). The reaction mixture was left to 
stir at -78 °C for a further 3 h, then the cooling bath was removed and the mixture was 
left to stand for 16 h. The residual solid was cautiously quenched with ice-cooled 
MeOH (300 mL) followed by H2O (2 L). The aqueous mixture was extracted with Et2O (3 
x 300 mL), dried over MgSO4 and concentrated in vacuo to leave an off-white solid. 
Purification by recrystallisation from MeOH afforded tetrahydro-naphthalene 130 
(92.0 g, 696 mmol, 89%) as white plates. Data was consistent with that previously 
reported.60 δH (CDCl3, 400 MHz) 5.73 (4H, s, CH=CH), 2.54 (8H, s, CH2). 
11-Oxa-tricyclo[4.4.1.01,6]undeca-3,8-diene (131)60 
 
Tetrahydronaphthalene 130 (1 g, 7.56 mmol, 1 eq.) and NaOAc (1.12 g, 13.6 mmol, 1.8 
eq.) were dissolved in CH2Cl2 (8 mL) and cooled to 0 °C. Peracetic acid (76.3 mmol, 32% 
wt. solution in AcOH, 9.07 mmol, 1.2 eq.) was added dropwise over 15 min. The 
mixture was stirred at 0 °C for 30 min then at rt 1 h. Water (7 mL) was added and the 
solution was stirred for 30 min then the organic layer was removed. The aqueous layer 
was extracted with CH2Cl2 (3 x 20 mL) then the combined organic extracts were 
washed with 5% NaOH (aq.), dried over MgSO4 and concentrated in vacuo to leave a 
white crystalline solid. Purification by FC (EtOAc/hexane, 1:49) afforded epoxide 131 
(748 mg, 5.05 mmol, 67%) as a white crystalline solid. Data was consistent with that 
previously reported.60 δH (CDCl3, 400 MHz) 5.48 (4H, m, HC=CH), 2.57-2.49 (4H, m, 
CH2), 2.40-2.34 (4H, m, CH2). 
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8a-Hydroxy-1,5,8,8a-tetrahydro-4H-naphthalene-4a-carbonitrile (132)60 
 
Epoxide 131 (31 g, 209 mmol, 1 eq.) and KCN (136.1 g, 2.09 mol, 10 eq.) was dissolved 
in a mixture of water (1800 mL) and MeCN (1200 mL). The solution was heated at 85 °C 
for 4 days, during which time it turned black. After allowing to cool to room 
temperature, water (100 mL) was added followed by CHCl3 (200 mL). The mixture was 
slowly acidified with 3M HCl and the organic layer was removed. The aqueous layer 
was further extracted with CHCl3 (6 x 500 mL). The combined organic fractions were 
dried over MgSO4 and concentrated in vacuo to leave a brown/white solid. The solid 
was passed through a plug of silica eluting with 20-50% MeOH/CH2Cl2. Purification FC 
(EtOAc/hexane, 2:3) followed by recrystallisation from EtOAc afforded cyanohydrin 
132 (23.5 g, 134 mmol, 64%) as a white crystalline solid. Data was consistent with that 
previously reported.60 Rf 0.54 (EtOAc/hexane, 1:1); δH (CDCl3, 400 MHz) 5.73 (4H, m, 
HC=CH), 2.60-2.47 (4H, CH2), 2.36-2.28 (4H, CH2). 
9β-Cyano-(2α,3α),(6α,7α)-dioxido-10α-hydroxy-1,2,3,4,5,6,7,8,9,10-
decahydronaphthalene (133)60 
 
Diene 132 (10 g, 57.1 mmol, 1 eq.) was dissolved in CH2Cl2 (61 mL) and VO(acac)2 (1.51 
g, 5.71 mmol, 0.1 eq.) was added and the solution was cooled to 0 °C. TBHP (3.75M 
solution in toluene, 60.9 mL, 228 mmol, 4 eq.) was added dropwise over 20 min 
turning the green solution orange/red. The solution was then heated at 70 °C for 21 h 
and the pale yellow solution was allowed to cool to room temperature. 10% Na2SO3 
was cautiously added, which returned the solution to a green colour. After stirring at 
room temperature for 30 min, the organic layer was removed and the aqueous was 
further extracted with CH2Cl2 (3 x 150 mL). The combined organic extractions were 
dried over MgSO4 and concentrated in vacuo to leave white/brown solid. Purification 
by FC (CH2Cl2 to MeOH/CH2Cl2, 3:7), followed by recrystallisation (EtOAc) afforded bis-
epoxide 133 (8.53 g, 41.2 mmol, 72%) as a white crystalline solid. Data was consistent 
with that previously reported.60 Rf 0.25 (EtOAc/hexane, 1:1); δH (CDCl3, 400 MHz) 3.44 
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(1H, s, OH), 3.38-3.32 (4H, CHO), 2.45-2.35 (4H, CH2), 2.16 (2H, dd, J 16 and 2.1 Hz, 
CH2), 2.07 (2H, d, J 16 Hz, CH2). 
9β-Cyano-2β,7β-dimethyl-3α,6α,10α-trihydroxy-1,2,3,4,5,6,7,8,9,10-
decahydronaphthalene (134)60 
 
Bis-epoxide 133 (5 g, 24.13 mmol, 1 eq.) was dissolved in CH2Cl2 (150 mL) and Me3Al 
(2.0 M solution in hexane, 48.3 mL, 96.51 mmol, 4 eq.) was added. The reaction 
mixture was heated to reflux for 16 h then cooled in an ice-bath. With constant 
cooling, 2 M aq. HCl (250 mL) was added cautiously. The organic layer was extracted 
and the aqueous phase was further extracted with CHCl3 (3 x 100 mL). The combined 
organic extracts were dried over MgSO4 and concentrated in vacuo to leave trihydroxy 
134 (5.02 g, 21.0 mmol, 87%) as a white solid. Data was consistent with that previously 
reported.60 Rf 0.34 (MeOH/DCM, 1:9); δH (CDCl3, 400 MHz) 2.19-2.13 (6H, CH2 and 
CHCH3), 1.89 (2H, dd, J 15 and 2.2 Hz, CH2), 1.62 (2H, d, J 12 Hz, CH2), 1.33 (6H, d, J 7.8 
Hz, CH3). 
9β-Cyano-2β,7β-dimethyl-3α,6α-dimethylsulfonate-10α-hydroxy-1,2,3,4,5,6,7,8,9,10-
decahydronaphthalene (135)60 
 
To a suspension of trihydroxy 134 (3 g, 12.5 mmol, 1 eq.) in CH2Cl2 (70 mL), Et3N (5.24 
mL, 37.6 mmol, 3 eq.) was added. The mixture was cooled to -10 °C in a water/NaCl 
bath and MsCl (2.92 mL, 37.6 mmol, 3 eq.) was added dropwise ensuring the 
temperature of the reaction mixture did not rise above 10 °C. The mixture was left to 
stir at room temperature for 17 h and then partitioned by the addition of saturated aq. 
NH4Cl (70 mL) and CH2Cl2 (70 mL). The organic phase was separated and the aqueous 
layer was further extracted with CH2Cl2 (3 x 70 mL). The combined organic extracts 
were dried over MgSO4 and concentrated in vacuo to leave a brown/orange, viscous 
oil. Purification by FC (EtOAc/hexane, 1:4 to 1:1) afforded mesylate 135 (3.40 g, 8.60 
mmol, 69%) as a white solid. Data was consistent with that previously reported.60 Rf 
0.36 (EtOAc/hexane, 1:1); δH (CDCl3, 400 MHz) 4.87 (2H, dd, J = 7.7 and 3.8 Hz, 
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CHOMs), 3.24 (1H, s, OH), 3.05 (6H, s, SO2CH3), 2.48-2.43 (2H, CH2), 2.37 (2H, dd, J 16 
and 4.6 Hz, CH2), 2.20-2.15 (4H, CH2 and CHCH3), 1.72 (2H, dd, J 14 and 3.0 Hz, CH2), 
1.35 (6H, d, J 7.7 Hz, CHCH3); MS (EI) m/z 394 ([M-H]
-, 23). 
9β-Cyano-2β-7β-dimethyl-10α-hydroxy-1,2,7,8,9,10-hexahydronaphthalene (136)60 
 
A suspension of mesylate 135 (3.4 g, 8.60 mmol) in DBU (8 mL) was heated at 110 °C 
for 17 h. After allowing to cool to room temperature, the black solution was diluted 
with CH2Cl2 (70 mL) and 1M citric acid (aq.) (100 mL). The organic phase was extracted 
and the aqueous layer was then further extracted with CH2Cl2 (3 x 60 mL). The 
combined organic extracts were dried over MgSO4 and then concentrated in vacuo to 
leave a white crystalline solid and a brown oil. The mixture was passed through a pad 
of alumina silica eluting with CH2Cl2 to afford diene 136 (1.29 g, 6.36 mmol, 74%) as a 
white crystalline solid. Data was consistent with that previously reported.60 Rf 0.50 
(EtOAc/hexane, 1:9); δH (CDCl3, 400 MHz) 5.95 (2H, dd, J = 9.9 and 2.2 Hz, OCCH=CH), 
5.90 (2H, dd, J = 10 and 2.7 Hz, OCCH=CH), 2.56 (2H, m, CHCH3), 2.22 (2H, dd, J = 8.6 
and 14 Hz, CH2), 1.73 (2H, d, J 14 Hz, CH2), 1.35 (6H, d, J = 7.7 Hz, CHCH3). 
(-)-(1S,2R,3aR,5S,7aR,7bS)-7a-Hydroxy-2,5-dimethyl-1a,2,3,3a,4,5,7a,7b-
octahydronaphtho[1,2-b]oxirene-3a-carbonitrile (137)60 
 
L-(+)-DIPT (114 μL, 0.57 mmol, 1.1 eq.) was added to Zr(OiPr)4·
iPrOH (210 mg, 0.57 
mmol, 1.1 eq.) in CH2Cl2 (3.5 mL). The mixture was cooled to -42 °C and TBHP (3.75M 
solution in toluene, 315 μL, 1.25 mmol, 2.4 eq.) was added dropwise. After stirring for 
15 min, diallylic alcohol 136 (100 mg, 0.52 mmol, 1 eq.) in CH2Cl2 (1.6 mL) was added 
dropwise over 5 min. The reaction mixture was left to stand at -20 °C for 42 h. The 
reaction was quenched with 20% Na2SO3 (6 mL) and the organic layer extracted. The 
aqueous layer was further extracted with CHCl3 (3 x 15 mL)and the combined organic 
extractions were dried over MgSO4 and concentrated in vacuo to leave a pale 
yellow/orange oil. Purification by FC (EtOAc/hexane, 1:10 to 3:10) using silica gel 
washed prior with 1% Et3N/hexane, afforded epoxide 137 (102 mg, 0.465 mmol, 95%, 
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ee 48%) as a white solid. Data was consistent with that previously reported.60 Rf 0.30 
(EtOAc/hexane, 1:3); δH (CDCl3, 400 MHz) 6.00 (1H, dd, J 9.9 and 3.2 Hz, COHCH=CH), 
5.93 (1H, dd, J 9.9 and 2.3 Hz, COHCH=CH), 3.48 (1H, d, J 3.7 Hz, CHO), 3.31 (1H, d, J 3.7 
Hz, CHO), 2.98 (1H, s, OH), 2.56 (1H, m, CHCH3), 2.42 (1H, t, J Hz, CHCH3), 2.16 (1H, dd, 
J 14 and 8.5 Hz, CH2), 1.77 (1H, dd, J 14 and 8.6 Hz, CH2), 1.58 (1H, d, J 14 Hz, CH2), 1.45 
(3H, d, J 8/6 Hz, CH3), 1.41 (1H, d, J 14 Hz, CH2), 1.33 (3H, d, J 7.7 Hz, CH3). 
(-)-(2’S)-((1aS,2R,3aR,5S,7aR,7bS)-3a-Cyano-2,5-dimethyl-1a,2,3,3a,4,5,7a,7b-
octahydronaphtho[1,2-b]oxiren-7a-yl) 2-methoxypropanoate (139)7 
 
Triethylamine (67 µL, 0.239 mmol, 1.05 eq., ee 22%) was added to a solution of (-)-(S)-
2-methoxypropionic acid (44 µL, 0.239 mmol, 1.05 eq.) in toluene (1 mL). 2,4,6-
Trichlorobenzoyl chloride (75 µL, 0.239 mmol, 1.05 eq.) was added and the solution 
was left to stir at room temperature for 1.5 h. Allylic alcohol 137 (50 mg, 0.228 mmol, 
1 eq., ee 22%) and 4-DMAP (31 mg, 0.125 mmol, 0.55 eq.) in toluene (1 mL) was 
added, turning the solution pale yellow. The solution was heated at 60 °C for 20 h then 
concentrated in vacuo to leave a yellow solid. Purification by FC (EtOAc/hexane, 3:17) 
afforded ester 139 (55 mg, 0.180 mmol, 79%, de 48%) as a clear oil. Data was 
consistent with that previously reported.7 Rf 0.27 (EtOAc/hexane, 1:4); Major 
diastereoisomer: δH (CDCl3, 400 MHz) 6.47 (1H, dd, J 9.9 and 2.6 Hz, C=CH, H-7), 5.99 
(1H, dd, J 9.9 and 2.9 Hz, C=CH, H-6), 3.83 (1H, q, J 8.2 Hz, CHOCH3), 3.67 (1H, d, J 3.3 
Hz, CH(O), H-4), 3.40 (3H, s, OCH3), 3.21 (1H, d, J 3.2 Hz, CH(O), H-3), 2.55 (1H, m), 2.45 
(1H, dd, J 8.0 and 2.6 Hz), 2.25 (1H, dd, J 14 and 8.4 Hz, CHH, H-9), 1.94 (1H, dd, J 14 
and 8.4 Hz, CHH, H-1), 1.69 (1H, d, J 14 Hz, CHH, H-9), 1.49-1.45 (4H, CH3 and CHH, H-
1), 1.36 (3H, d, J 6.9 Hz, CHCH3), 1.35 (3H, d, J 7.7 Hz, CHCH3). Minor diastereoisomer: 
δH (CDCl3, 400 MHz) 6.47 (1H, dd, J 9.9 and 2.6 Hz, C=CH, H-7), 5.99 (1H, dd, J 9.9 and 
2.9 Hz, C=CH, H-6), 3.83 (1H, q, J 8.2 Hz, CHOCH3), 3.67 (1H, d, J 3.3 Hz, CH(O), H-4), 
3.37 (3H, s, OCH3), 3.21 (1H, d, J 3.2 Hz, CH(O), H-3), 2.55 (1H, m), 2.45 (1H, dd, J 8.0 
and 2.6 Hz), 2.25 (1H, dd, J 14 and 8.4 Hz, CHH, H-9), 1.94 (1H, dd, J 14 and 8.4 Hz, 
CHH, H-1), 1.70 (1H, d, J 14 Hz, CHH, H-9), 1.49-1.45 (4H, CH3 and CHH, H-1), 1.36 (3H, 
d, J 6.9 Hz, CHCH3), 1.35 (3H, d, J 7.7 Hz, CHCH3).  
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(-)-(3R,3aR,4S,5aS,7R,8S,9bR)-2,3,3a,4,5,5a,6,7,8,9b-Decahydro-8-hydroxy-3-
methoxy-3,4,7-trimethyl-2-oxonaphtho[1,2-b]furan-5a-carbonitrile (140a)  
and (-)-(3S,3aR,4S,5aS,7R,8S,9bR)-2,3,3a,4,5,5a,6,7,8,9b-Decahydro-8-hydroxy-3-
methoxy-3,4,7-trimethyl-2-oxonaphtho[1,2-b]furan-5a-carbonitrile (140b)7 
 
Ester 139 (50 mg, 0.164 mmol, 1 eq.) was dissolved in THF (0.5 mL) and cooled to -78 
:C. TMSCl (46 µL, 0.360 mmol, 2.2 eq.) was added followed by 1M LHMDS in THF (360 
µL, 0.180 mmol, 1.1 eq.). The solution was stirred at -78 :C for 30 min, then at room 
temperature for 30 min, then heated at 60 :C for 14.5 h. The solution was diluted with 
Et2O (5 mL) and water (10 mL) was added. The mixture was concentrated in vacuo to 
remove all THF, and the mixture was extracted with CH2Cl2 (4 x 15 mL). The combined 
organic extracts were dried over MgSO4 and concentrated in vacuo to leave a pale 
yellow oil. Purification by FC (1:4 to 3:7, EtOAc/hexane) afforded lactone 140a (19 mg, 
0.0623 mmol, 38%) as white crystalline solid and lactone 140b (10 mg, 0.0327 mmol, 
20%) as a clear oil. Data was consistent with that previously reported.7 Epimer 140a: Rf 
0.30 (2:3, EtOAc/hexane); δH (CDCl3, 400 MHz) 5.91 (1H, t, J 2.4 Hz, C=CH), 5.31 (1H, dt, 
J 8.1 and 2.4 Hz, CHOC(O)), 3.92 (1H, m, CHOH), 3.24 (3H, s, OCH3), 2.35 (1H, m, 
CHCH3), 2.31 (1H, dd, J 7.8 and 3.2 Hz, CHCCH3OCH3), 2.20 (1H, dd, J 13 and 6.0 Hz, 
CHH, H-9), 1.99 (1H, s, CHCH3), 1.97 (1H, d, J 2.3 Hz, CHH, H-1), 1.87 (1H, dd, J 13 and 
4.3 Hz, CHH, H-9), 1.69 (1H, dt, J 13 and 6.9 Hz, CHH, H-1), 1.59 (1H, bs, OH), 1.41 (3H, 
s, CH3), 1.40 (3H, d, J 6.2 Hz, CH3), 1.16 (3H, d, J 6.8 Hz, CH3); δC (CDCl3, 100 MHz) 
174.21 (s), 132.84 (s), 126.14 (d), 123.91 (s), 76.53 (s), 74.89 (d), 70.97 (d), 53.79 (d), 
51.32 (q), 42.09 (d), 39.27 (t), 33.25 (s), 33.04 (t), 25.54 (d), 22.57 (q), 17.95 (q), 17.31 
(q). Epimer 140b: Rf 0.15 (2:3, EtOAc/hexane); δH (CDCl3, 400 MHz) 5.98 (1H, dd, J 3.3 
and 2.2 Hz, C=CH), 5.32 (1H, dt, J 9.7 4.6 Hz, CHOC(O)), 4.01 (1H, m, CHOH), 3.42 (3H, s, 
OCH3), 2.75 (1H, dd, J 9.7 and 7.5 Hz, CHCOCH3, H-7), 2.03-1.88 (6H, m), 1.39 (3H, s, 
CH3COCH3), 1.24 (3H, d, J 6.7 Hz, CH3), 1.23 (3H, d, J 7.0 Hz, CH3); δC (CDCl3, 100 MHz) 
176.23 (s), 132.52 (s), 126.24 (d), 123.21 (s), 78.72 (s), 77.23 (d), 69.24 (d), 51.73 (q), 
48.10 (d), 42.68 (d), 37.10 (t), 33.53 (t), 31.95 (s), 26.33 (d), 20.69 (q), 20.47 (q), 17.20 
(q). 
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(-)-(2’R)-2-[(1R,2R,3S,4aS,6R,7S)-4a-Cyano-1,7-dimethoxy-3,6-dimethyl-
1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl]-2-methoxypropionic acid methyl ester 
(142)7 
 
Lactone 140a (20 mg, 0.0655 mmol, 1 eq.) was dissolved in THF (0.8 mL). KOH (37 mg, 
0.655 mmol, 10 eq.) was added, followed by MeI (41 µL, 0.655 mmol, 10 eq.) to form a 
pale yellow solution. The solution was heated at 60 :C for 3 h then allowed to cool to 
room temperature. EtOAc (10 mL) followed by water (10 mL) was added and the 
organic layer was separated. The aqueous layer was further extracted with EtOAc (3 x 
10 mL) and the combined organic extracts were dried over MgSO4 and concentrated in 
vacuo to afford ester 142 (23 mg, 0.0629 mmol, 96%) as a pale yellow oil. No further 
purification was required. Data was consistent with that previously reported.7 Rf 0.75 
(EtOAc/hexane, 2:3); δH (CDCl3, 400 MHz) 5.96 (1H, t, J 1.8 Hz, C=CH), 4.21 (1H, dt, J 5.2 
and1.8 Hz, CHOCH3), 3.72 (3H, s, OCH3), 3.60 (1H, dt, J 6.5 and 2.4 Hz, CHCOCH3), 3.43 
(3H, s, OCH3), 3.36 (3H, s, OCH3), 3.19 (3H, s, OCH3), 2.45 (1H, p, J 7.5 Hz, CHCOCH3), 
2.35-2.30 (2H, CH), 1.93-1.79 (3H, CH and CH2), 1.73 (1H, d, J 13 Hz, CH2), 1.45 (3H, d, J 
7.7 Hz, CHCH3), 1.43 (3H, s, C(OCH3)CH3), 1.11 (3H, d, J 6.5 Hz, CHCH3); δC (CDCl3, 100 
MHz) 174.75 (s), 133.51 (s), 125.64 (s), 122.94 (d), 80.44 (s), 79.02 (d), 77.24 (d), 58.02 
(q), 52.95 (q), 51.42 (q), 51.34 (d), 41.15 (t), 40.38 (t), 34.88 (s), 30.34 (d), 28.56 (d), 
22.34 (q), 21.38 (q), 17.47 (q). 
(-)-(1R,2R,3S,4aS,6R,7S)-2-[(1’R)-2-Hydroxy-1-methoxy-1-methyl-ethyl]-1,7-
dimethoxy-3,6-dimethyl-1,3,4,5,6,7-hexahydro-2H-naphthalene-4a-carbonitrile 
(143)7 
 
Ester 142 (49 mg, 0.134 mmol, 1 eq.) was dissolved in THF and cooled to -5 ˚C. LiAlH4 
(21 mg, 0.562 mmol, 4.2 eq) was added in 2 portions. The suspension was stirred at 0 
˚C for 2.5 h then diluted with EtOAc (15 mL) and washed with water (15 mL). The 
aqueous layer was further extracted with EtOAc and the combined organic extracts 
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were dried over MgSO4 then concentrated in vacuo to leave a clear oil. Purification by 
FC (EtOAc/hexane, 1:4 to 1:3) afforded alcohol 143 (28 mg, 0.0830 mmol, 63%) as a 
clear oil. Rf 0.25 (EtOAc/hexane, 2:3); νmax/cm
-1 (neat) 3484 (OH), 2934 (CH), 2165 
(CΞN), 1726 (C=C), 1458 (CH), 1085 (C-O); δH (CDCl3, 400 MHz) 5.93 (1H, s, C=CH), 4.29 
(1H, m, CHOCH3), 3.83 (1H, dd, J 11 and 4.4 Hz, CH2OH), 3.58-3.54 (2H, CH2OH and 
CHOCH3), 3.46 (3H, s, OCH3), 3.42 (1H, m, CHOCH3), 3.39 (3H, s, OCH3), 3.10 (3H, s, 
OCH3), 2.45 -2.35 (2H, C7, C9 eq.), 2.05 (1H, d, J 5.0 Hz, C9 ax.), 1.94-1.83 (3H, CH2 and 
CHCH3), 1.71 (1H, d, J 13 Hz, CHCH3), 1.44 (3H, d, J 7.4 Hz, CHCH3), 1.27 (3H, s, 
C(OCH3)CH3), 1.12 (3H, d, J 6.6 Hz, CHCH3); δC (CDCl3, 100 MHz) 133.36 (s), 125.47 (s), 
123.43 (d), 79.83 (d), 79.27 (s), 66.27 (d), 57.77 (t), 55.62 (q), 51.53 (q), 49.01 (q), 41.20 
(d), 40.38 (t), 35.40 (s), 30.63 (d), 29.20 (d), 22.61 (q), 20.91 (q), 17.72 (q); MS (ESI) m/z 
338 (62, MH+), 339 (17), 360 (58, MNa+), 363 (100); HRMS (ESI) 360.2140 calcd for 
C19H31NNaO4
+ (MNa+), found 360.2151, Δ = +3.05 ppm; *α+D
20 -6.9 (c = 2.6, CH2Cl2). 
(+)-Acetic acid (1R,2R,3S,4R,6R,8S,9R,10R,12R)-6 -hydroxy-3,12-dimethoxy-4,8,10-
trimethyl-11-oxatricyclo[7.2.1.01,6]dodec-10-ylmethyl ester (144)7 
 
Alcohol 143 (10 mg, 0.0293 mmol, 1 eq.) was dissolved in pyridine (1 mL). 4-DMAP (4 
mg, 0.0293 mmol, 1 eq.) was added followed by Ac2O (8 µL, 0.0878 mmol, 3 eq.). The 
solution was stirred at room temperature for 1 h then concentrated in vacuo to leave a 
yellow oil. Purification by FC (1:3, EtOAc/hexane) afforded acetate 144 (11 mg, 0.0290 
mmol, 99%) as a colourless oil. Data was consistent with that previously reported.7 Rf 
0.40 (1:3, EtOAc/hexane); δH (CDCl3, 400 MHz) 5.99 (1H, t, J 1.7 Hz, C=CH), 4.47 (1H, d, 
J 12 Hz, CHHOAc), 4.20 (1H, dt, J 4.4 and 1.4 Hz, CHOCH3), 4.10 (1H, d, J 12 Hz, 
CHHOAc), 3.55 (1H, dt, J 6.4 and 2.1 Hz, CHOCH3), 3.42 (3H, s, OCH3), 3.33 (3H, s, 
OCH3), 3.17 (3H, s, OCH3), 2.42 (1H, m, CHC(CH3)(OCH3)), 2.21 (1H, dd, J 14 and 7.1 Hz, 
C9HH), 2.13 (1H, t, J 4.2 Hz), 2.09 (3H, s, C(O)CH3), 1.91-1.78 (3H, d, CH2 and CHCH3), 
1.75 (1H, d, J 14 Hz, C9HH), 1.44 (3H, d, J 7.6 Hz, CHCH3), 1.28 (3H, s, C(CH3)(OCH3), 
1.16 (3H, d, J 6.4 Hz, CHCH3); δC (CDCl3, 100 MHz) 170.87 (s), 134.16 (d), 125.19 (2C, s), 
80.05 (d), 78.81 (s), 78.59 (d), 68.50 (t), 57.09 (q), 56.46 (q), 49.87 (q), 49.63 (q), 41.07 
(d), 49.63 (q), 41.07 (d), 40.27 (t), 34.13 (s), 31.34 (t), 27.84 (d), 22.60 (d), 21.07 (q), 
20.08 (q), 18.22 (q). 
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(-)-(2R)-2-[(S,R,1bR,3S,4R,5R,5aR,5bR)-1b-Cyano-5-dimethoxy-3-dimethyl-octahydro-
H-naphtho[1,8a-b]oxiren-4-yl]-2-methoxypropylacetate (145a)7 
 
Alkene 144 (10 mg, 0.0264 mmol, 1 eq.) was dissolved in CH2Cl2 (1 mL) and m-CPBA (6 
mg, 0.034 mmol, 1.3 eq.) was added. The solution was stirred at room temperature for 
3.5 h, then diluted with CH2Cl2 and sat. NaHCO3 (aq.) (10 mL) was added. The organic 
layer was extracted and the aqueous layer was further extracted with CH2Cl2 (3 x 10 
mL). The combined organic extracts were dried over MgSO4 then concentrated in 
vacuo. Purification by FC (1:4, EtOAc/hexane) afforded epoxide 145a (10 mg, 0.0253 
mmol, 96%) as a white crystalline solid. Data was consistent with that previously 
reported.7 Rf 0.35 (EtOAc/hexane, 1:3); mp 88-89 ˚C (CH2Cl2); δH (CDCl3, 400 MHz) 4.50 
(1H, d, J 11 Hz, CHHOAc), 4.28 (1H, d, J 11 Hz, CHHOAc), 4.08 (1H, d, J 5.3 Hz, CH-(O)), 
3.50 (4H, s, OCH3 and CHOCH3), 3.42 (3H, s, OCH3), 3.22 (3H, s, OCH3), 2.92 (1H, d, J 9.6 
Hz, CHOCH3), 2.55-2.51 (2H, CHCHCOCH3 and C9), 2.14 (1H, d, J 5.3 Hz, C2), 2.11 (3H, s, 
C(O)CH3), 1.69-1.62 (2H, CHCH3 and CH2), 1.54 (1H, m, CH2), 1.50 (3H, d, J 7.6 Hz, 
CHCH3), 1.45 (1H, dd, J 9.8 and 3.7 Hz, CH2), 1.29 (3H, s, C(CH3)(OCH3)), 0.99 (3H, d, J 
6.3 Hz, CHCH3); δC (CDCl3, 100 MHz) 170.74 (s), 124.61 (s), 81.87 (d), 78.78 (s), 76.35 
(d), 69.50 (t), 62.91 (s), 60.40 (d), 60.26 (q), 57.93 (q), 49.73 (q), 49.13 (q), 37.67 (t), 
37.13 (s), 36.20 (t), 29.28 (d), 28.75 (d), 22.02 (d), 21.06 (q), 20.52 (q), 18.21 (q); *α+D
20 -
9.9 (c = 0.6, CH2Cl2). 
(-)-(2R)-2-[(S,R,1bR,3S,4R,5R,5aR,5bR)-1b-Cyano-5-dimethoxy-3-dimethyl-octahydro-
H-naphtho[1,8a-b]oxiren-4-yl]-2-methoxypropylacetate (145a)7 
and (-)-(2R)-2-[(S,R,1bR,3S,4R,5R,5aS,5bS)-1b-Cyano-5-dimethoxy-3-dimethyl-
octahydro-H-naphtho[1,8a-b]oxiren-4-yl]-2-methoxypropylacetate (145b) 
 
Alkene 144 (26 mg, 0.0686 mmol, 1 eq.) was dissolved in CH2Cl2 (2.6 mL) and m-CPBA 
(15 mg, 0.0892 mmol, 1.3 eq.) was added. The solution was stirred at room 
temperature for 3.5 h then diluted with CH2Cl2 and sat. NaHCO3 (aq.) (10 mL) was 
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added. The organic layer was extracted and the aqueous layer was further extracted 
with CH2Cl2 (3 x 10 mL). The combined organic extracts were dried over MgSO4 then 
concentrated in vacuo to afford a 66:34 mixture of epoxides 145a and 145b. 
Purification by FC (1:8 to 1:4, EtOAc/hexane) afforded epoxide 145a (8 mg, 0.0202 
mmol, 29%) (data identical as above), a 3:1 mixture of 145a:145b (16 mg, 0.0404 
mmol, 59%) and epoxide 145b (8.5 mg, 0.0214 mmol, 30%) as fine white crystals. 
(Overall yield of 88% of both diastereoisomers). Data for 145a was as above. 145b: Rf 
0.39 (EtOAc/hexane, 1:3); mp 57-59 ˚C (CHCl3); νmax/cm
-1 2932 (CH), 1740 (C=O), 1385 
(CH), 1462 (C-O), 1242 (C-O); δH (CDCl3, 400 MHz) 4.51 (1H, d, J 11 Hz, CHHOAc), 4.31 
(1H, d, J 11 Hz, CHHOAc), 3.82 (1H, d, J 5.4 Hz, CH(O)), 3.53 (3H, s, OCH3), 3.43 (1H, s, 
CHOCH3), 3.40 (3H, s, OCH3), 3.26 (3H, s, OCH3), 2.82 (1H, d, J 9.9 Hz, CHOCH3), 2.44 
(1H, m, CHCHOCH3), 2.33 (1H, dd, J 14 and 5.9 Hz, CHCHOCH3), 2.11 (3H, s, OCOCH3), 
2.03 (1H, d, J 5.4 Hz, CH2), 1.78 (1H, d, J 14 Hz, CH2), 1.62 (1H, m, CH2), 1.29 (3H, s, 
C(OCH3)CH3), 1.28 (1H, m, CH), 1.12 (1H, d, J 14 Hz, CH2), 1.05 (3H, d, J 7.6 Hz, CHCH3), 
0.99 (3H, d, J 6.4 Hz, CHCH3); δC (CDCl3, 100 MHz) 205.34 (s), 121.35 (s), 82.66 (d), 
78.74 (s), 69.58 (d), 63.86 (t), 60.04 (q), 57.89 (d), 57.06 (q), 49.89 (s), 49.68 (q), 48.57 
(q), 33.85 (t), 33.57 (t), 28.55 (d), 23.34 (q), 21.07 (q), 20.39 (d), 18.66 (q); MS 416 (44), 
413 (MNH4
+, 9), 399 (63), 367 (MH+-MeOH, 49), 131 (100); HRMS (CI) 367.2115 calcd 
for C20H31O6
+ ([M-HCN]+), found 367.2124, Δ = +2.5 ppm; *α+D
20 -0.7 (c = 0.13, CH2Cl2). 
(-)-Acetic acid (1R,2R,3S,4R,6R,8S,9R,10R,12R)-6-cyano-2-hydroxy-3,12-dimethoxy-
4,8,10-trimethyl-11-oxatricyclo[7.2.1.01,6]dodec-10-ylmethyl ester (146a)7 
 
Epoxide 145a (8 mg, 0.0202 mmol, 1 eq.) was dissolved in CH2Cl2 (1 mL) and LiI (14 mg, 
0.101 mmol, 5 eq.) was added. The mixture was cooled to -78 ˚C and BBr3 (1M solution 
in CH2Cl2, 61 µL, 0.0607 mmol, 3 eq.) was added. The mixture was stirred at -78 ˚C for 3 
h then quenched with sat. NaHCO3 (aq.) (5 mL) and extracted with CH2Cl2 (3 x 10 mL). 
The combined organic extracts were dried over MgSO4 then concentrated in vacuo to 
leave a yellow residue. Purification by FC (7:13, EtOAc/hexane) afforded alcohol 146a 
(6 mg, 0.0157 mmol, 78%) as a colourless oil. Rf 0.30 (EtOAc/hexane, 1:1); νmax/cm
-1 
(neat) 3498 (OH), 2924 (CH), 2230 (CΞN), 1740 (C=O), 1462 (CH), 1387 (CH), 1245 (C-O), 
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1109 (C-O), 1039 (C-O); δH (CDCl3, 400 MHz) 4.52 (1H, s, CHOH), 4.40 (1H, d, J 11 Hz, 
CHHOAc), 4.16 (1H, d, J 11 Hz, CHHOAc), 3.45 (3H, s, OCH3), 3.39 (3Hs, OCH3), 3.29 (1H, 
dd, J 5.6 and 3.4 Hz, CHOCH3), 2.87 (1H, d, J 3.8 Hz, CHOCH3), 2.37-2.32 (2H, C7 and 
C9), 2.12 (1H, m, C2), 2.09 (3H, s, C(O)CH3), 1.99-1.88 (3H, s,  CHCH3 and C9), 1.75 (1H, 
dd, J 14 and 6.1 Hz, C2), 1.62 (1H, bs, OH), 1.40 (3H, d, J 7.2 Hz, CHCH3), 1.36 (3H, s, 
C(CH3)CH2OAc), 1.27 (3H, d, J 7.4 Hz, CHCH3); δC (CDCl3, 100 MHz) 170.62 (s), 126.08 
(s), 87.23 (s), 85.80 (s), 85.32 (d), 84.03 (d), 71.33 (d), 70.03 (t), 57.65 (q), 55.53 (q), 
46.03 (t), 40.58 (t), 36.28 (s), 31.00 (d), 30.32 (q), 29.69 (d), 20.94 (d), 20.08 (q), 19.45 
(q), 18.45 (q); MS (ESI) m/z 382 (51, MH+), 404 (100), 405 (32); HRMS (ESI) 382.2224 
calcd for C20H32NO6
+ (MH+), found 382.2222, Δ = -0.5 ppm; *α+D
20 -21.1 (c = 0.2, CH2Cl2). 
(-)-Acetic acid (1R,2S,3S,4R,6R,8S,9R,10R,12R)-6-cyano-2-hydroxy-3,12-dimethoxy-
4,8,10-trimethyl-11-oxatricyclo[7.2.1.01,6]dodec-10-ylmethyl ester (146b) 
 
Epoxide 145b (4 mg, 0.0101 mmol, 1 eq.) and LiI (7 mg, 0.0505 mg, 5 eq.) was 
dissolved in CH2Cl2 (0.5 mL) and cooled to -78 ˚C. BBr3 (1M solution in CH2Cl2, 31 µL, 
0.0303 mmol, 3 eq.) was added dropwise and the solution was stirred at -78 ˚C for 3 h 
then with sat. NaHCO3 (aq.) (5 mL) and extracted with CH2Cl2 (3 x 10 mL). The 
combined organic extracts were dried over MgSO4 then concentrated in vacuo to leave 
a yellow residue. Purification by FC (7:13, EtOAc/hexane) afforded alcohol 146b (2 mg, 
0.00524 mmol, 52%) as a colourless oil. Rf 0.36 (EtOAc/hexane, 1:1); νmax/cm
-1 (neat) 
3417 (OH), 2924 (CH), 2168 (CΞN), 1739 (C=O), 1383 (CH), 1264 (C-O), 1101 (C-O); δH 
(CDCl3, 400 MHz) 4.86 (1H, d, J 11 Hz, CHHOAc), 4.16-4.13 (2H, CHHOAc and CHOH), 
3.66 (1H, d, J 3.0 Hz, CHOCH3), 3.44 (3H, s, OCH3), 3.39 (3H, s, OCH3), 3.25 (1H, d, J 11 
and 2.8 Hz, CHOCH3), 3.09 (1H, s, CHCHOCH3), 2.51-2.48 (2H, CHCH3), 2.22 (1H, m, 
CH2), 2.11 (3H, s, C(O)CH3), 1.87 (1H, m, CH2), 1.67 (1H, d, J 14 Hz, CH2), 1.56 (1H, m, 
CH2), 1.32 (3H, s, CH3), 1.06 (H, d, J 7.1 Hz, CHCH3), 1.05 (3H, d, J 6.4 Hz, CHCH3); δC 
(CDCl3, 100 MHz) 170.86 (s), 129.19 (s), 82.01 (d), 78.48 (d), 75.30 (s), 71.01 (s), 66.74 
(d), 65.82 (t), 57.11 (q), 56.50 (q), 52.22 (s), 41.12 (q), 35.52 (t), 31.81 (t), 28.68 (d), 
27.23 (d), 23.34 (q), 21.49 (q), 20.95 (d), 18.01 (q); MS (CI) m/z 402 (51), 390 (91), 388 
(100), 374 (49, M-CN+NH4), 273 (33); *α+D
19 -4.1 (c = 0.26, CH2Cl2). 
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(-)-Acetic acid (1R,2S,3S,4R,6R,8S,9R,10R,12R)-6-cyano-2-hydroxy-3,12-dimethoxy-
4,8,10-trimethyl-11-oxatricyclo[7.2.1.01,6]dodec-10-ylmethyl ester (146b) 
 
Ketone 147 (6 mg, 0.0157 mmol, 1 eq.) was dissolved in THF (0.6 mL) and MeMgCl (2M 
solution in THF, 63 µL, 0.126 mmol, 8 eq.). The solution was stirred at room 
temperature for 4 h then H2O (3 mL) was added. The solution was extracted with Et2O 
(3 x 15 mL) and the combined organic extracts were dried over MgSO4 and 
concentrated in vacuo to afford an off-white solid. Purification by FC (EtOAc/hexane, 
2:3) afforded alcohol 146b (3 mg, 0.00764 mmol, 50%) as a white solid. Data as above. 
(-)-Acetic acid (1S,3S,4R,6R,8S,9R,10R,12R)-6-cyano-3,12-dimethoxy-4,8,10-trimethyl-
2-oxo-11-oxatricyclo[7.2.1.01,6]dodec-10-ylmethyl ester (147)7 
 
Alcohol 146a (6 mg, 0.0157 mmol, 1 eq.) was dissolved in CH2Cl2 (0.4 mL) and Dess-
Martin periodinane (0.3 M solution in CH2Cl2, 79 µL, 0.0236 mmol, 1.5 eq.) was added. 
The mixture was stirred at room temperature for 2 h then concentrated in vacuo. The 
white solid was dissolved in EtOAc (10 mL) and washed with saturated NaHCO3 (aq.) (4 
x 15 mL), dried over MgSO4 then concentrated in vacuo to leave a white solid. 
Purification by FC (EtOAc) afforded ketone 147 (5.5 mg, 0.0144mmol, 92%) as a white 
crystalline solid. Rf 0.55 (EtOAc/hexane, 1:1); mp 118-119 ˚C (EtOAc); δH (CDCl3, 400 
MHz) 4.59 (1H, d, J 11 Hz, CHHOAc), 4.48 (1H, s, CHOCH3), 4.38 (1H, d, J 11 Hz, 
CHHOAc), 4.21 (1H, d, J 7.4 Hz, CHOCH3), 3.50 (3H, s, OCH3), 3.37 (3H, s, OCH3), 2.40-
2.34 (2H, C7 and C9), 2.26-2.14 (2H, C8 and C3), 2.10 (3H, s, C(O)CH3), 1.94 (1H, dd, J 15 
and 7.1 Hz, CH2), 1.83 (1H, d, J 14 Hz, CH2), 1.66 (1H, d, J 13 Hz, CH2), 1.43 (3H, d, J 7.3 
Hz, CHCH3), 1.38 (3H, d, J 7.4 Hz, CHCH3), 1.37 (3H, s, CCH3(CH2OAc)); δC (CDCl3, 100 
MHz) 203.51 (s), 170.55 (s), 124.95 (s), 88.60 (s), 87.14 (d), 86.49 (s), 85.97 (s), 69.80 
(t), 58.92 (q), 58.14 (q), 50.68 (q), 42.72 (s), 38.30 (d), 35.44 (t), 34.14 (t), 30.43 (d), 
29.70 (d), 21.00 (q), 10.15 (q), 19.89 (q), 18.59 (q); MS (CI) m/z 397 (MNH4
+, 100), 383 
(35), 348 (MH+ -MeOH, 100); HRMS (CI) 397.2702 calcd for C21H37N2O5 (MNH4
+), found 
397.2706, Δ = 1.0 ppm; *α+22D -2.1 (c = 1.2, CH2Cl2). 
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(±)-1-Methylcyclohexan-1-ol (148)166 
 
Cyclohexanone (50 µL, 0.483 mmol, 1 eq.) was dissolved in THF (3 mL). MeMgCl (3M 
solution in THF, 480 µL, 1.45 mmol, 3 eq.) was added dropwise at room temperature 
and the solution was stirred for 3 h. Sat. NH4Cl (aq.) (5 mL) was added and mixture was 
extracted with Et2O (3 x 10 mL) and the combined organic extracts were dried over 
MgSO4 then concentrated in vacuo to afford alcohol 148 (52 mg, 0.455 mmol, 94%) as 
a clear oil. Data was consistent with that previously reported.167 δH (CDCl3, 400 MHz) 
1.76-1.29 (10H, CH2), 1.23 (3H, s, CH3); MS (EI) m/z 114 (24, M
+), 99 (73), 84 (84), 71 
(100), 55 (57). 
(±)-1-Phenyl-3-buten-2-ol (151)168 
 
Aldehyde 150 (0.56 g, 4.66 mmol, 1 eq.) was dissolved in THF (10 mL) and cooled to 0 
°C. Vinyl magnesiumbromide (1M in THF, 5.1 mL, 5.12 mmol, 1.1 eq.) was added 
dropwise and the yellow solution was stirred at 0 °C for 30 min. The reaction was 
quenched with water (10 mL) and the mixture concentrated in vacuo to remove the 
THF. The aqueous solution was acidified to pH 3 with 1M HCl and extracted with CH2Cl2 
(3 x 20 mL). The combined organic extracts were dried over MgSO4 then concentrated 
in vacuo to leave a pale yellow liquid. Purification by FC (1:9, EtOAc/hexane) afforded 
alcohol 151 (280 mg, 1.89 mmol, 40%) as a pale yellow liquid. Data was consistent with 
that previously reported.169 Rf 0.50 (CH2Cl2); δH (CDCl3, 400 MHz) 7.37-7.26 (5H, Ar), 
5.97 (1H, ddd, J 17, 10 and 5.8 Hz, CH=CH2), 5.29 (1H, dt, J 17 and 1.3 Hz, Hcis), 5.17 
(1H, dt, J 10 and 1.1 Hz, Htrans), 4.39 (1H, m, CHOH), 2.92 (1H, dd, J 14 and 5.1 Hz, 
ArCH2), 2.82 (1H, dd, J 14 and 7.9 Hz, ArCH2), 1.64 (1H, d, J 3.8 Hz, OH); MS (CI) m/z 148 
(26), 149 (5, MH+), 166 (100, MNH4
+), 167 (28). 
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(2R*,3S*)- and (2R*,3R*)-3,4-Epoxy-1-phenyl-2-butanol (152)170 
 
Allylic alcohol 151 (180 mg, 1.21 mmol, 1 eq.) was dissolved in CH2Cl2 (10 mL). After 
cooling to 0 °C, µ-CPBA (252 mg, 1.46 mmol, 1.2 eq.) was added and after 10 min the 
reaction mixture was allowed to warm to room temperature. After stirring for 16 h, 
sat. NaHCO3 (aq.) (30 mL) was added and the aqueous layer was extracted with CH2Cl2 
(3 x 20 mL). The combined organic extracts were washed with sat. NaHCO3 (aq.), dried 
over MgSO4 and concentrated in vacuo to leave a clear liquid. Purification by FC (1:4, 
EtOAc/hexane to CH2Cl2) afforded epoxides 152a and 152b (anti:syn 58:42, 195 mg, 
1.19 mmol, 98%) as a clear liquid. Data consistent with that previously reported.171 Rf 
0.15 (3:7, EtOAc/hexane); Major diastereoisomer: δH (CDCl3, 400 MHz) 7.37-7.27 (5H, 
ArH), 4.05 (1H, m, CHOH), 3.08 (1H, m, CHO), 3.03-2.78 (4H), 2.67 (1H, dd, J 4.9 and 2,7 
Hz, CHO). Minor diastereoisomer: δH (CDCl3, 400 MHz) 7.37-7.27 (5H, ArH), 3.77 (1H, 
m, CHOH), 3.08 (1H, m, CHO), 3.03-2.78 (5H). MS (CI) m/z 182 (100, MNH4
+), 183 (22). 
(2S*,3S*)- and (2R*,3S*)-1-Phenyl-2,3-butanediol (153)172 
 
Epoxide 152 (188 mg, 1.14 mmol, 1 eq.) was dissolved in THF (5 mL) and cooled to 0 °C. 
LiAlH4 (48 mg, 1.26 mmol, 1.1 eq.) was added and the solution was allowed to warm to 
room temperature and stirred for a further 18 h. Et2O (15 mL) and water (20 mL) was 
added and the mixture was stirred for 5 min. The layers were separated and the 
aqueous layer was further extracted with CH2Cl2 (3 x 20 mL). The combined organic 
extracts were dried over MgSO4 and concentrated in vacuo to leave a clear oil. 
Purification by FC (1:1, EtOAc/hexane) afforded 1,2-diols 153 (176 mg, 1.06 mmol, 
93%, dr 40:60) as a clear oil. Data was consistent with that previously reported.172 Rf 
0.60 (1:19, MeOH/CH2Cl2); Major diastereoisomer: δH (CDCl3, 400 MHz) 7.38-7.34 (2H, 
ArH), 7.28 (3H, ArH), 3.73 (1H, m, CHOH), 3.64 (1H, m, CHOH), 2.94 (1H, dd, J 14 and 
4.0 Hz, ArCH2), 2.77-2.69 (1H, ArCH2), 2.22 (1H, d, J 4.6 Hz, OH), 1.99 (1H, d, J 4.6 Hz, 
OH), 1.30 (3H, d, J 6.3 Hz, CH3). Minor diastereoisomer: δH (CDCl3, 400 MHz) 7.38-7.34 
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(2H, ArH), 7.28 (3H, ArH), 3.92 (1H, m, CHOH), 3.86 (1H, m, CHOH), 2.88 (1H, dd, J 14 
and 3.7 Hz, ArCH2), 2.77-2.69 (1H, ArCH2), 1.96 (1H, d, J 4.8 Hz, OH), 1.86 (1H, d, J 3.3 
Hz, OH), 1.30 (3H, d, J 6.4 Hz, CH3). MS (CI) m/z 184 (100, MNH4
+), 185 (13). 
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Appendix 1 - X-ray Data 
(-)- (2S,3R)-Methyl 2-hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoate 
 
 
Formula     C12 H17 N O3 
Formula weight    223.27 
Temperature     173 K 
Diffractometer wavelength   Cu Kα, 1.54178 
Crystal system, space group   P2(1)2(1)2(1) 
Unit cell dimensions    a = 7.5034(2) Å α = 90 ° 
      b = 12.2919(4) Å β = 90 ° 
      c = 13.0178(4) Å γ = 90 ° 
Volume, Z     1200.65(6) Å3, 4 
Reflns collected / unique   11172 / 2448 [R(int) = 0.0143] 
Reflns observed [F>4σ(F)]   2448 
Absorption correction    Analytical 
Max. transmission    0.80 
Final R indices  [F>4σ(F)]   R1 = 0.0302, wR2 = 0.0734 
R indices (all data)     R1 = 0.0338, wR2 = 0.0760 
Absolute structure parameter  x+ = -0.03(17)  
Bond Lengths (Å) 
C(30)-H(33) 0.9799 
C(30)-H(32) 0.9798 
C(30)-H(31) 0.9806 
C(25)-H(28) 0.9787 
C(25)-H(27) 0.9796 
C(25)-H(26) 0.9795 
C(24)-C(29) 1.5336 
C(24)-C(25) 1.5239 
C(20)-H(23) 0.9791 
C(20)-H(22) 0.9802 
C(20)-H(21) 0.9798 
C(18)-H(19) 0.9994 
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C(18)-C(24) 1.5678 
C(18)-C(20) 1.5328 
C(17)-C(18) 1.5237 
C(15)-H(16) 0.9501 
C(15)-C(17) 1.3924 
C(13)-H(14) 0.9500 
C(13)-C(15) 1.3837 
C(11)-H(12) 0.9495 
C(7)-H(10) 0.9800 
C(7)-H(9) 0.9800 
C(7)-H(8) 0.9804 
C(6)-C(7) 1.5076 
C(6)-C(17) 1.4043 
C(6)-C(11) 1.3971 
N(5)-C(13) 1.3475 
N(5)-C(11) 1.3357 
O(4)-C(30) 1.4495 
O(4)-C(29) 1.3419 
O(3)-C(29) 1.2072 
O(1)-H(2) 0.8682 
O(1)-C(24) 1.4067 
  
Angles (Å) 
H(33)-C(30)-H(32) 109.5231 
H(33)-C(30)-H(31) 109.4233 
H(33)-C(30)-O(4) 109.4336 
H(32)-C(30)-H(31) 109.4818 
H(32)-C(30)-O(4) 109.5237 
H(31)-C(30)-O(4) 109.4417 
C(24)-C(29)-O(4) 112.1861 
C(24)-C(29)-O(3) 124.3634 
O(4)-C(29)-O(3) 123.4347 
H(28)-C(25)-H(27) 109.5144 
H(28)-C(25)-H(26) 109.4912 
H(28)-C(25)-C(24) 109.4704 
H(27)-C(25)-H(26) 109.5124 
H(27)-C(25)-C(24) 109.4184 
H(26)-C(25)-C(24) 109.4205 
C(29)-C(24)-C(25) 110.1975 
C(29)-C(24)-C(18) 107.2273 
C(29)-C(24)-O(1) 109.4630 
C(25)-C(24)-C(18) 110.9242 
C(25)-C(24)-O(1) 106.5089 
C(18)-C(24)-O(1) 112.5354 
H(23)-C(20)-H(22) 109.4707 
H(23)-C(20)-H(21) 109.4732 
H(23)-C(20)-C(18) 109.4998 
H(22)-C(20)-H(21) 109.4231 
H(22)-C(20)-C(18) 109.4544 
H(21)-C(20)-C(18) 109.5061 
H(19)-C(18)-C(24) 107.6107 
H(19)-C(18)-C(20) 107.6499 
H(19)-C(18)-C(17) 107.6622 
C(24)-C(18)-C(20) 111.8304 
C(24)-C(18)-C(17) 110.8388 
C(20)-C(18)-C(17) 111.0431 
C(18)-C(17)-C(15) 120.1407 
C(18)-C(17)-C(6) 122.4029 
C(15)-C(17)-C(6) 117.4221 
H(16)-C(15)-C(17) 119.7764 
H(16)-C(15)-C(13) 119.7713 
C(17)-C(15)-C(13) 120.4522 
H(14)-C(13)-C(15) 118.5702 
H(14)-C(13)-N(5) 118.5028 
C(15)-C(13)-N(5) 122.9270 
H(12)-C(11)-C(6) 117.3644 
H(12)-C(11)-N(5) 117.3773 
C(6)-C(11)-N(5) 125.2581 
H(10)-C(7)-H(9) 109.3933 
H(10)-C(7)-H(8) 109.4931 
H(10)-C(7)-C(6) 109.5063 
H(9)-C(7)-H(8)  109.4237 
H(9)-C(7)-C(6)  109.5354 
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H(8)-C(7)-C(6)  109.4754 
C(7)-C(6)-C(17) 123.8017 
C(7)-C(6)-C(11) 118.5719 
C(17)-C(6)-C(11) 117.5906 
C(13)-N(5)-C(11) 116.3459 
C(30)-O(4)-C(29) 114.8420 
H(2)-O(1)-C(24) 111.9738 
 
(+)-(2S,3S)-Methyl 2-hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoate 
 
 
Identification code AS1101 
Formula C12 H17 N O3 
Formula weight 223.27 
Temperature 173 K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 5.97836(4) Å α = 90° 
 b = 12.67070(7) Å β = 90° 
 c = 15.76352(9) Å γ = 90° 
Volume, Z 1194.087(12) Å3, 4 
Density (calculated) 1.242 Mg/m3 
Absorption coefficient 0.729 mm-1 
F(000) 480 
Crystal colour / morphology Colourless shards 
Crystal size 0.35 x 0.22 x 0.10 mm3 
Ѳ range for data collection 4.48 to 72.48° 
Index ranges -7<=h<=6, -15<=k<=15, -19<=l<=19 
Reflns collected / unique 44547 / 2366 [R(int) = 0.0283] 
Reflns observed [F>4σ(F)] 2337 
Absorption correction Analytical 
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Max. and min. transmission 0.939 and 0.839 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2366 / 1 / 152 
Goodness-of-fit on F2 1.049 
Final R indices [F>4σ(F)] R1 = 0.0262, wR2 = 0.0723 
 R1+ = 0.0262, wR2+ = 0.0723 
 R1- = 0.0264, wR2- = 0.0729 
R indices (all data) R1 = 0.0264, wR2 = 0.0726 
Absolute structure parameter x+ = 0.00(16), x- = 1.05(16) 
Extinction coefficient 0.0157(11) 
Largest diff. peak, hole 0.161, -0.104 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
Bond lengths (Å)  
N(1)-C(2) 1.3299(18) 
N(1)-C(6) 1.3372(16) 
C(2)-C(3) 1.3888(16) 
C(3)-C(4) 1.4083(14) 
C(3)-C(7) 1.5014(17) 
C(4)-C(5)      1.3915(16) 
C(4)-C(8) 1.5158(14) 
C(5)-C(6) 1.3877(15) 
C(8)-C(13) 1.5373(16) 
C(8)-C(9) 1.5496(14) 
C(9)-O(14) 1.4115(12) 
C(9)-C(15) 1.5345(15) 
C(9)-C(10) 1.5371(15) 
C(10)-O(10) 1.1985(14) 
C(10)-O(11) 1.3395(14) 
O(11)-C(12) 1.4454(15)
 
Angles (°) 
C(2)-N(1)-C(6) 116.67(10) 
N(1)-C(2)-C(3) 125.38(10) 
C(2)-C(3)-C(4) 117.38(10) 
C(2)-C(3)-C(7) 118.95(10) 
C(4)-C(3)-C(7) 123.65(10) 
C(5)-C(4)-C(3) 117.63(9) 
C(5)-C(4)-C(8) 122.27(9) 
C(3)-C(4)-C(8) 119.98(10) 
C(6)-C(5)-C(4) 119.82(10) 
N(1)-C(6)-C(5) 123.10(11) 
C(4)-C(8)-C(13) 108.21(9) 
C(4)-C(8)-C(9) 115.95(8) 
C(13)-C(8)-C(9) 110.53(9) 
O(14)-C(9)-C(15) 110.30(8) 
O(14)-C(9)-C(10) 108.97(9) 
C(15)-C(9)-C(10) 106.97(9) 
O(14)-C(9)-C(8) 108.75(8) 
C(15)-C(9)-C(8) 109.99(9) 
C(10)-C(9)-C(8) 111.85(8) 
O(10)-C(10)-O(11) 123.63(10) 
O(10)-C(10)-C(9) 125.23(10) 
O(11)-C(10)-C(9) 111.04(9) 
C(10)-O(11)-C(12) 116.19(10) 
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Appendix 2 - HPLC Data 
Esters 47a and 47b (dr 45:55). 
 
 
Peak 1 – 21.1 min, (-)-(S,R)-ester 47a; Peak 2 – 27.3 min, (+)-(R,S)-ester 47a; Peak 3 – 
29.5 min, (R*,R*)-ester 47b; Peak 4 – 31.7 min, (R*,R*)-ester 47b. Conditions; Chiralcel 
IC; 5 µm; Column Size: 0.46 cmI.D. x 25 cmL; Column number: IC00CE-LL027; 
Temperature: 10 °C; Flow Rate: 1.2 ml/min; Injection: 5 µL; Solvent: n-hexane/IPA = 
85:15; Sample conc.: 10 mg/ml (IPA). 
Esters 47a and 47b (dr 45:55). 
 
 
Peak 1 – 21.3 min, (+)-(S,S)-ester 47b; Peak 2 – 26.6 min, (S,R)- and (R,S)-ester 47a; 
Peak 3 – 30.2 min, (-)-(R,R)-ester 47b. Conditions; Chiralcel ODH; 5 µm; Column Size: 
0.46 cmI.D. x 25 cmL; Column number: ODH0CE-KK122; Temp: 8 °C; Flow Rate: 0.75 
ml/min; Injection: 7 µL; Solvent: n-hexane/IPA, 90:10; Sample conc.: 10 mg/mL 
(IPA/EtOAc, 9:1). 
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(-)-(2S,3R)-Methyl 2-hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoate (47a) 
 
 
Retention time: 20.2 min. Conditions: Chiralcel IC; 5 µm; Column Size: 0.46 cmI.D. x 25 
cmL; Column number IC00CE-LL027; Temperature: 10 °C; UV wavelength: 250 nm; 
Flow Rate: 1.2 ml/min; Injection: 5 µL; Solvent: n-hexane/IPA, 85:15; Pressure: 50 bar; 
Sample Conc. 0.3 mg/mL (IPA). 
(+)-(2S,3S)-Methyl 2-hydroxy-2-methyl-3-(3-methylpyridin-4-yl)butanoate (47b) 
 
 
Retention time: 19.1 min. Conditions: Chiralcel OD-H; 5 µm; Column Size: 0.46 cmI.D. x 
25 cmL; Column number ODH0CE-KK122; Temperature: 8 °C; UV wavelength: 254 nm; 
Flow Rate: 0.9ml/min; Injection: 1 µL; Solvent: n-hexane/IPA, 95:5; Pressure: 44 bar; 
Sample Conc. 7 mg/mL (EtOAc/IPA, 1:1). 
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(-)-(1S,2R,3aR,5S,7aR,7bS)-7a-Hydroxy-2,5-dimethyl-1a,2,3,3a,4,5,7a,7b-
octahydronaphtho[1,2-b]oxirene-3a-carbonitrile (137)60 
 
 
Retention times: (-)-137 = 11.1 min, (+)-137 = 12.2 min. Conditions: Chiralcel OD-H; 5 
µm; Column Size: 0.46 cmI.D. x 25 cmL; Column number ODH0CE-KK122; Temperature: 
10 °C; UV wavelength: 210 nm; Flow Rate: 0.75 ml/min; Injection: 7 µL; Solvent: n-
hexane/IPA, 80:20; Pressure: 46 bar; Sample Conc. 10 mg/mL (EtOAc/IPA, 5:1). 
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